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At the informal meeting of global health agency 
leaders in New York, United States, on 24 Septem-
ber 2013, it was decided to establish a group of sen-
ior focal points from the participating global health 
agencies to review critically the respective agency 
requirements for reporting from countries with the 
aim of reducing the reporting burden for countries. 
An interagency Working Group on Indicators and 
Reporting Burden, consisting of 19 agency repre-
sentatives and chaired by the Director-General of 
WHO, was established and a rapid assessment of 
the burden of indicators and reporting require-
ments for health monitoring was conducted. The 
assessment included an analysis of the situation 
from both global and country perspectives. Key 
findings and recommendations were published in 
A rapid assessment of the burden of indicators and 
reporting requirements for health monitoring.1
The report revealed how global investments in 
disease- and programme-specific monitoring and 
evaluation programmes by different agencies have 
contributed to very large numbers of indicators, 
diverse indicator definitions and reporting fre-
quencies, fragmented data collection, and uncoor-
dinated efforts to strengthen national institutional 
capacity, resulting in an unnecessary reporting 
burden on countries and inefficiencies in strength-
ening country health information systems.
One of the priority actions identified by the inter-
agency working group was that global agencies 
should bring greater alignment and efficiency to 
their investments by rationalizing existing report-
ing demands in order to reduce reporting require-
ments and ease the reporting burden on countries. 
To achieve this end, WHO collaborated with inter-
national and multilateral partners and countries 
to develop and agree on a global reference list of 
100 core health indicators that the global com-
munity would prioritize for the purposes of mon-
itoring national and global progress, maintaining 
programme support and advocating for resources 
and funding. The list was developed from existing 
lists that had been recommended in the context 
of international governing bodies of internation-
al organizations and forums, global and regional 
health initiatives, technical reference groups and 
programmes.
Scope
The Global Reference List of 100 Core Health Indi-
cators for results monitoring, referred to herafter as 
“The Global Reference List,” is a standard set of 100 
core indicators prioritized by the global communi-
ty to provide concise information on the health sit-
uation and trends, including responses at national 
and global levels. The Global Reference List contains 
indicators of relevance to country, regional and 
global reporting across the spectrum of global 
health priorities relating to the post-2015 health 
goals of the Sustainable Development Goals.2 
These include the Millennium Development Goals 
(MDGs) agenda, new and emerging priorities such 
as noncommunicable diseases, universal health 
coverage and other issues in the post-2015 devel-
opment agenda. 
The Global Reference List is not an exclusive list of 
indicators and it is not intended to limit informa-
tion collection only to that which meets manage-
ment and programmatic needs. Rather, the list 
is intended as a general reference and guide for 
1 A rapid assessment of the burden of indicators and reporting requirements for health monitoring. Prepared for the 
multi-agency working group on indicators and reporting requirements by WHO’s Department of Health Statistics and 
Information Systems. Geneva: World Health Organization; 2014.
2 Sustainable Development Goals. https://sustainabledevelopment.un.org/topics/sustainabledevelopmentgoals.
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standard indicators and definitions that countries 
can use for monitoring in accordance with their 
own health priorities and capacity.
Purpose
The aim of the Global Reference List is to contribute 
to the reduction of reporting requirements and to 
promote greater alignment with, and investment 
in, one country-led health sector platform for re-
sults and accountability that forms the basis for 
global reporting.3 The Global Reference List aims 
at rationalization and encourages stakeholders to 
consider only the most important and critical indi-
cators.
The Global Reference List is a means to an end. 
The main objectives are:
• to guide monitoring of health results nationally 
and globally; 
• to reduce excessive and duplicative reporting 
requirements; 
• to enhance efficiency of data collection  
investments in countries; 
• to enhance availability and quality of data on 
results; and
• to improve transparency and accountability.
The outcome statement of the meeting of global 
health agency leaders on 24 September 2015, pre-
sented hereafter, puts The Global Reference List in 
a broader context.
3 Monitoring, evaluation and review of national health strategies. A country-led platform for information and  
accountability. Geneva: World Health Organization; 2011. 
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Outcome statement of the Working Group on Indicators
and Reporting Burden, September 2014
Preamble
a. This statement is the result of the work of a multi-agency working group, established by Global Health Agency Leaders in September 2013 
and chaired by the DG-WHO, aiming to reduce the indicators reporting burden for countries. On 27–28 August 2014 the working group, 
country and civil society representatives met under the auspices of IHP+ in Geneva to discuss and produce a statement for consideration by 
the Global Health Agency Leaders.
b. As described in the IHP+ Monitoring & Evaluation (M&E) framework, strong country M&E systems are characterized by a comprehensive 
national M&E plan; institutional capacity among state and non-state actors; an M&E framework that specifies core indicators; data sources, 
analysis and use; and inclusive transparent country mechanisms for review and action. A tested, relevant, balanced and parsimonious set 
of core indicators is one critical element that contributes to the overall strengthening of country M&E systems and accountability.
Global Reference List of 100 Core Health Indicators
a. The Global Reference List of 100 Core Health Indicators for results monitoring is a standard set of 100 indicators prioritized by the global 
community to provide concise information of the health situation and trends, including responses at national and global levels. The Global 
Reference List reflects indicators of relevance for country, regional and global reporting across the full spectrum of global health priorities 
relating to the MDG agenda, as well as to new and emerging priorities such as NCDs, universal health coverage and other key issues in the 
post-2015 development agenda. This list will be a “living document”, updated periodically as technologies develop, new priorities emerge 
and interventions change.
b.  The Global Reference List will contribute to reduced reporting requirements and to greater alignment and smarter investment in country 
data and M&E systems. The list does not focus on those indicators that are required for more detailed programme management at 
national and sub-national levels or for financial tracking of specific grants and projects. It is recommended, however, that investments in 
monitoring of specific project management indicators be made in a way that strengthens the country M&E systems, and minimizes the 
use of parallel reporting systems that are not interoperable with the national health information system. The Global Reference List and the 
behaviours described below are drafted in the spirit of the IHP+ and should be understood within that framework.
c.  The purpose of The Global Reference List is to:
• reduce excessive and duplicative reporting requirements;
• serve as a general reference and guidance for standard indicators and definitions;
• enhance efficiency of data collection investments in countries;
• enhance availability and quality of data on results; and
• improve transparency and accountability.
d.  The Global Reference List should be used as normative guidance, rather than as a required or exclusive list, to:
• guide monitoring of health results nationally and globally;
• guide the selection of priority indicators;
• provide a basis for the rationalization and alignment of reporting requirements on results by global partners;
• contribute to higher quality global data bases of health results;
• facilitate more harmonized investments in country data systems and analytical capacity;
• reflect evolving public health priorities and as such be updated and maintained in a sustainable way.
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Global partners should aspire to the following behaviours
a.  Use of core indicators for rationalizing reporting requirements: focus results reporting requirements on The Global Reference List, including 
disaggregation (by gender, age, socioeconomic status, place of residence), and the related M&E system strengthening investments.
b.  Align reporting cycles: rationalize reporting requirements in terms of contents and frequency and progressively align with countries’ own 
monitoring practices.
c. Ensure global data collection investments meet country health data and M&E systems needs, including data quality, in the most efficient 
manner.
d.  Include a significant proportion of investments for country institutional capacity and M&E system strengthening, including government 
and non-government actors.
e.  Broaden monitoring to focus on measuring overall country results, which may include specific contributions to collective results.
Good behaviours at the country level (with examples of actions)
a.  Countries lead and invest in strengthening their M&E and review platforms that have the key attributes and characteristics of the IHP+ 
monitoring framework. Examples include:
• existence of a good quality comprehensive costed national M&E plan;
• adequate and qualified staffing of the M&E system, centrally and sub-nationally;
• institutionalization of routine mechanisms to independently assess data quality, including transparent accessible quality databases and 
explicit mechanisms for data sharing and use by state and non-state actors;
• regular system of household surveys;
• high quality timely results reports for national joint annual health reviews and other accountability processes;
• systematic use of common, sustainable and interoperable digital solutions where feasible and appropriate; and
• existence of an effective country-led coordination mechanism for M&E and review with active involvement and support of relevant 
development partners, civil society and other non-state actors.
b.  Development partners support the strengthening of a single country-led platform for information and accountability, as described in the 
IHP+ framework for monitoring national health strategies. Examples include:
• support for the country M&E plan, including a process for progressive alignment of program-specific monitoring and reviews with the 
overall health strategy, using the same indicators, data collection, and time cycles;
• use of a common investment framework based on comprehensive assessment of country needs for a multi-year period;
• alignment of results reporting requirements related to specific grants with the country monitoring system including a process of 
progressive alignment, using the same indicators;
• investments in data collection and quality verification investments that strengthen the national monitoring and accountability 
platforms including surveys and health facility data collection; and
• investment in and use of common, sustainable and interoperable digital solutions where feasible and appropriate.
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Many indicators and indicator definitions have 
been developed by international organizations, 
reference groups, interagency groups, countries, 
academics, advocacy groups and others. The in-
dicators are often used for different purposes, in-
cluding programme management, allocation of 
resources, monitoring in-country progress, perfor-
mance-based disbursement and global reporting. 
The Global Reference List presents the indicators 
according to multiple dimensions. First, each indi-
cator belongs to one of four domains: health status, 
risk factors, service coverage and health systems. 
This last domain includes service delivery which 
includes quality of care, health financing, essential 
medicines, the health workforce and health infor-
mation. 
Second, each indicator is further categorized into 
subdomains. These include communicable diseas-
es (HIV/AIDS, sexually transmitted infections [STIs], 
tuberculosis [TB], malaria, neglected tropical dis-
eases, outbreaks, epidemic diseases), reproductive, 
maternal, newborn, child and adolescent health 
(including sexual health and reproductive rights 
and immunization), noncommunicable diseases 
(including chronic disease, health promotion, nu-
trition, mental health and substance abuse), inju-
ries and violence and the environment. 
The third dimension presents the indicators accord-
ing to levels of the results chain framework (input, 
output, outcome and impact), as defined for the 
International Health Partnership (IHP+) technical 
monitoring and evaluation (M&E) framework.4 This 
framework not only facilitates the identification of 
core indicators along each link in the results chain 
but also links indicators to underlying country data 
systems and data collection methods, highlights 
the need for analysis and synthesis of data from 
multiple sources, emphasizes regular data quality 
assessment, and demonstrates how the data need 
to be communicated and used for both country 
and global reporting purposes.
The results chain framework has also been used 
to develop a monitoring framework for universal 
health coverage.5 The monitoring of universal 
health coverage focuses on coverage of interven-
tions and financial risk protection, supported by 
evidence on selected indicators of health system 
inputs, service delivery and quality, and health and 
developmental outcomes.
Indicator classification
4 Monitoring, evaluation and review of national health strategies. A country-led platform for information and  
accountability. Geneva: World Health Organization; 2011. 
5 Monitoring progress towards universal health coverage at country and global levels: framework, measures  
and targets. Geneva: World Health Organization and The World Bank; 2014  
(http://www.who.int/healthinfo/universal_health_coverage/en/, accessed 7 July 2014).
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Process
The process of selecting a global reference set of 
100 core health indicators was guided by the prior-
ity global monitoring requirements relating to the 
MDGs, as well as by consideration of the measure-
ment requirements for universal health coverage, 
noncommunicable diseases, other new global 
health challenges and the post-2015 development 
agenda.
To this end, an initial landscaping exercise was un-
dertaken to take stock of existing global indicator 
sets and related reporting requirements that have 
been developed through global agreements, initi-
atives and reference groups. The exercise took into 
consideration the indicators and reporting require-
ments relating to: 
1.  Monitoring of international commitments 
and resolutions by which governments 
have committed their countries, such as 
United Nations and World Health Assembly 
declarations and resolutions. 
 
Examples include:
• United Nations MDGs
• World Health Assembly resolutions 
associated with monitoring of international 
commitments6 
• Declaration of Commitment of the United 
Nations General Assembly Special Session 
(UNGASS) on HIV/AIDS 
• The recommended indicators of the 
Commission on Information and 
Accountability for Women’s and Children’s 
Health7 
• Framework of actions for the follow-up to 
the Programme of Action of the International 
Conference on Population and Development 
(ICPD) beyond 2014.
2. Disease- and programme-specific indicators 
and reporting requirements recommended 
through technical monitoring and evaluation 
reference groups and processes involving 
United Nations, multilateral and bilateral 
agencies, and countries. 
 
Examples include: 
• Monitoring and Evaluation Technical 
Reference Group for Roll-Back Malaria
• WHO/UNICEF joint reporting for 
immunization
• UNICEF/WHO Every Newborn action plan to 
end preventable deaths
• WHO/PEPFAR/UNAIDS guide to monitoring 
and evaluation for collaborative TB/HIV 
activities. 
The landscaping assessment resulted in an initial 
master list of over 800 global indicators that includ-
ed many similar indicators of varying definitions 
and periodicities. 
Indicator prioritization
After duplications and variations of similar indica-
tors were removed from the master list, a prioriti-
zation process was applied. This resulted in a first 
draft core list of indicators that was circulated to 
the members of the working group and was fur-
Process and criteria for selecting indicators
Process and criteria for selecting indicators
6 Where a World Health Assembly resolution is associated with the monitoring of international commitments on a specific 
indicator, the indicator’s metadata includes a link to the WHO Governing Body documentation section of  
the WHO website (http://apps.who.int/gb/or/)
7 http://www.who.int/woman_child_accountability/progress_information/recommendation2/en/
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ther distributed to several agency M&E groups. The 
current version of The Global Reference List reflects 
as far as possible the comments and inputs from 
those groups.
An indicator is prioritized as part of the 100 core 
health indicators if it meets the following criteria: 
1. The indicator is prominent in the monitoring 
of major international declarations to which 
all member states have agreed, or has been 
identified through international mechanisms 
such as reference or interagency groups as a 
priority indicator in specific programme areas.
2. The indicator is scientifically robust, useful, 
accessible, understandable as well as specific, 
measurable, achievable, relevant and time-
bound (SMART).
3. There is a strong track record of extensive 
measurement experience with the indicator 
(preferably supported by an international 
database).
4. The indicator is being used by countries in the 
monitoring of national plans and programmes.
Within the core set it may be important to fur-
ther identify a small set of the most “powerful” 
indicators that can guide political commitment 
to health from beyond the health sector. Some 
health-related MDG indicators, such as the child 
mortality rate and the maternal mortality ratio, are 
examples of this. Some of the indicators prioritized 
as part of the 100 core health indicators could be 
considered aspirational. Many countries will not be 
able to report regular data on several core indica-
tors – such as causes of death in the population. Yet, 
few would argue that cause-of-death indicators 
should not be included as core, whether mortality 
is due to human immunodeficiency virus/acquired 
immunodeficiency syndrome (HIV/AIDS), malaria, 
road traffic accidents or lung cancer. The indicators 
are fundamental for health resource allocation and 
planning, and for the monitoring of progress and 
impact.
The list does not focus on those indicators that are 
required for more detailed programme manage-
ment at national and sub-national levels or for fi-
nancial tracking of specific grants and projects. The 
indicators for grant and project monitoring differ 
in multiple ways: they are often input or output 
indicators and tend to be based on crude data (i.e. 
counting of events). The scope is often subnational 
and limited to a certain population, area or set of 
clinics engaged in the project. The indicators tend 
to be computed against a grant or project target 
rather than the population as a whole. 
 
It will be important over the longer term to work 
towards further rationalization of this category of 
indicators. A key principle is that grant and project 
monitoring should be carried out in such a way that 
the national monitoring and evaluation system as a 
whole is strengthened. 
An additional list of indicators is included in 
Annex 2 for reference. These are indicators which 
are considered relevant and desirable but did not 
meet all the criteria mentioned above or currently 
have serious measurement challenges.
Indicator metadata 
For many of the indicators in The Global Reference 
List, a comprehensive set of metadata is available 
(Annex 1). The metadata have been derived from 
existing sources such as the WHO Indicator and 
Metadata Registry and programme-specific mon-
itoring and evaluation guides. Key metadata in-
clude:
• Indicator definition, including numerator 
and denominator. Further work is required to 
fine-tune the definitions of some indicators. For 
some indicators only a numerator is reported by 
the country, while models are used to estimate 
the denominator (although models also need 
reported data).
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• Disaggregations that include equity stratifiers 
(e.g. age and sex, geography, socioeconomic 
status, place of residence). 
• In some cases, additional dimensions are used 
to include further breakdowns of the indicator 
(e.g. mortality rates by main cause of death or 
neglected disease incidence rates of neglected 
tropical diseases by disease).
• Data sources: The main (preferred) data source 
or data collection methodology is specified for 
each indicator, including:
• civil registration and vital statistics systems;
• population-based health surveys;
• facility-generated data that include routine 
facility information systems and health  
facility assessments and surveys;
• administrative data sources such as financial 
and human resources information systems; 
• indicators from other sources, including  
modelling.
• Further information and related links i.e. the key 
reference group, governing body, resolution, 
or programme publication that specifies 
monitoring of that particular indicator. 
The extent to which an indicator is associated with 
a reporting burden differs by data source. House-
hold surveys require a large investment and are 
conducted at a relatively low frequency. Adding an 
indicator or disaggregation is often considered a 
relatively small burden, although there are always 
concerns about the potential effect of over-long 
interviews on data quality. Facility data are col-
lected continuously and are reported at short time 
intervals. The bulk of the burden of collecting and 
reporting often falls on health service providers. A 
simple new disaggregation may double the record-
ing workload for health workers.
Rationalization of indicators needs to go hand in 
hand with rationalization of reporting require-
ments. Annual reporting is desirable for some indi-
cators – i.e. those that can change rapidly and can 
be measured with great accuracy.
The Global Reference List will be reviewed and up-
dated periodically as global and country priorities 
evolve and measurement methods improve. The 
review will be conducted under the auspices of the 
multi-agency working group on indicators and re-
porting requirements. This document contains the 
2015 version.
Process for updating
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100 Core Health Indicators
100 Core Health Indicators 2015
Health status
✓
Risk factors
Mortality by age and sex
• Life expectancy at birth
• Adult mortality rate between 15 and 60 years of age
• Under-five mortality rate 
• Infant mortality rate
• Neonatal mortality rate
• Stillbirth rate 
Mortality by cause
• Maternal mortality ratio
• TB mortality rate
• AIDS-related mortality rate
• Malaria mortality rate
• Mortality between 30 and 70 years of age from cardiovascular  
diseases, cancer, diabetes or chronic respiratory diseases
• Suicide rate 
• Mortality rate from road traffic injuries
Fertility
• Adolescent fertility rate
• Total fertility rate
Morbidity
• New cases of vaccine-preventable diseases 
• New cases of IHR-notifiable diseases and other notifiable diseases
• HIV incidence rate
• HIV prevalence rate
• Sexually transmitted infections (STIs) incidence rate 
• TB incidence rate
• TB notification rate
• TB prevalence rate
• Malaria parasite prevalence among children aged 6−59 months
• Malaria incidence rate
• Cancer incidence, by type of cancer
Nutrition
• Exclusive breastfeeding rate 0–5 months of age
• Early initiation of breastfeeding
• Incidence of low birth weight among newborns
• Children under 5 years who are stunted 
• Children under 5 years who are wasted 
• Anaemia prevalence in children
• Anaemia prevalence in women of reproductive age
Infections
• Condom use at last sex with high-risk partner
Environmental risk factors
• Population using safely managed drinking-water services
• Population using safely managed sanitation services
• Population using modern fuels for cooking/heating/lighting
• Air pollution level in cities
Noncommunicable diseases
• Total alcohol per capita (age 15+ years) consumption 
• Tobacco use among persons aged 18+ years
• Children aged under 5 years who are overweight 
• Overweight and obesity in adults (Also: adolescents)
• Raised blood pressure among adults
• Raised blood glucose/diabetes among adults
• Salt intake 
• Insufficient physical activity in adults (Also: adolescents)
Injuries
• Intimate partner violence prevalence 
2015
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Service coverage Health systems
Reproductive, maternal, newborn, child and adolescent
• Demand for family planning satisfied with modern methods
• Contraceptive prevalence rate
• Antenatal care coverage
• Births attended by skilled health personnel 
• Postpartum care coverage
• Care-seeking for symptoms of pneumonia 
• Children with diarrhoea receiving oral rehydration solution (ORS) 
• Vitamin A supplementation coverage
Immunization
• Immunization coverage rate by vaccine for each vaccine in the  
national schedule
HIV 
• People living with HIV who have been diagnosed
• Prevention of mother-to-child transmission 
• HIV care coverage
• Antiretroviral therapy (ART) coverage
• HIV viral load suppression 
HIV/TB
• TB preventive therapy for HIV-positive people newly enrolled in  
HIV care
• HIV test results for registered new and relapse TB patients
• HIV-positive new and relapse TB patients on ART during TB treatment
Tuberculosis
• TB patients with results for drug susceptibility testing
• TB case detection rate 
• Second-line treatment coverage among multidrug-resistant 
tuberculosis (MDR-TB) cases
Malaria
• Intermittent preventive therapy for malaria during pregnancy (IPTp)
• Use of insecticide treated nets (ITNs) 
• Treatment of confirmed malaria cases 
• Indoor residual spraying (IRS) coverage
Neglected tropical diseases 
• Coverage of preventive chemotherapy for selected neglected  
tropical diseases 
Screening and preventive care 
• Cervical cancer screening
Mental Health
• Coverage of services for severe mental health disorders
Quality and safety of care
• Perioperative mortality rate 
• Obstetric and gynaecological admissions owing to abortion
• Institutional maternal mortality ratio
• Maternal death reviews
• ART retention rate 
• TB treatment success rate 
• Service-specific availability and readiness
Access
• Service utilization
• Health service access
• Hospital bed density
• Availability of essential medicines and commodities
Health workforce
• Health worker density and distribution
• Output training institutions
Health information
• Birth registration coverage
• Death registration coverage
• Completeness of reporting by facilities
Health financing
• Total current expenditure on health (% of gross domestic product)
• Current expenditure on health by general government and compulsory 
schemes (% of current expenditure on health)
• Out-of-pocket payment for health (% of current expenditure on health)
• Externally sourced funding (% of current expenditure on health)
• Total capital expenditure on health (% current + capital expenditure on 
health)
• Headcount ratio of catastrophic health expenditure
• Headcount ratio of impoverishing health expenditure
Health security
• International Health Regulations (IHR) core capacity index 
2015
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Inputs and 
processes
Output Outcome Impact
100 Core Health Indicators by results chain
Health financing
• Total current expenditure on health  
(% of gross domestic product)
•  Current expenditure on health by 
general government and compulsory 
schemes (% of current expenditure on 
health)
•  Externally sourced funding  
(% of current expenditure on health)
•  Total capital expenditure on health  
(% current + capital expenditure on 
health)
•  Out-of-pocket payment for health  
(% of current expenditure on health)
Health workforce
•  Health worker density and distribution
•  Output training institutions
Health infrastructure
•  Health service access
•  Hospital bed density
Health information
•  Birth registration coverage
•  Death registration coverage
•  Completeness of reporting by facilities
Service access and availability
•  Service utilization
•  Service-specific availability and 
readiness
•  Availability of essential medicines and 
commodities
Service quality and safety
•  Perioperative mortality rate 
•  Obstetric and gynaecological 
admissions owing to abortion
•  Institutional maternal mortality ratio
•  Maternal death reviews
•  ART retention rate 
•  TB treatment success rate 
Health security
•  International Health Regulations (IHR) 
core capacity index
Health status
•  Life expectancy at birth
•  Adult mortality rate between  
15 and 60 years of age
•  Under-five mortality rate
•  Infant mortality rate
•  Neonatal mortality rate
•  Stillbirth rate
•  Maternal mortality ratio
•  TB mortality rate
•  AIDS-related mortality rate
•  Malaria mortality rate
•  Mortality between 30 and 70 years 
of age from cardiovascular diseases, 
cancer, diabetes or chronic respiratory 
diseases
•  Suicide rate
•  Mortality rate from road traffic injuries
•  Adolescent fertility rate
•  Total fertility rate
•  New cases of vaccine-preventable 
diseases 
•  New cases of IHR-notifiable diseases 
and other notifiable diseases
•  HIV incidence rate
•  HIV prevalence rate
•  Sexually transmitted infections (STIs) 
incidence rate
•  TB incidence rate
•  TB notification rate
•  TB prevalence rate
•  Malaria parasite prevalence among 
children aged 6–59 months
•  Malaria incidence rate
•  Cancer incidence, by type of cancer
Finanical risk protection
•  Headcount ratio of catastrophic health 
expenditure
•  Headcount ratio of impoverishing 
health expenditure
Coverage of interventions
•  Demand for family planning satisfied with modern methods
•  Contraceptive prevalence rate
•  Antenatal care coverage
•  Births attended by skilled health personnel
•  Postpartum care coverage
•  Care-seeking for symptoms of pneumonia 
•  Children with diarrhoea receiving oral rehydration  
solution (ORS)
•  Vitamin A supplementation coverage
•  Immunization coverage rate by vaccine for each vaccine  
in the national schedule
•  People living with HIV who have been diagnosed
•  Prevention of mother-to-child transmission 
•  HIV care coverage
•  Antiretroviral therapy (ART) coverage
•  HIV viral load suppression 
•  TB preventive therapy for HIV-positive people newly  
enrolled in HIV care
•  HIV test results for registered new and relapse TB patients
•  HIV-positive new and relapse TB patients on ART during  
TB treatment
•  TB patients with results for drug susceptibility testing 
•  TB case detection rate
•  Second-line treatment coverage among multidrug-resistant 
tuberculosis (MDR-TB) cases 
•  Intermittent preventive therapy for malaria during  
pregnancy (IPTp)
•  Use of insecticide treated nets (ITNs)
•  Treatment of confirmed malaria cases
•  Indoor residual spraying (IRS) coverage
•  Coverage of preventive chemotherapy for selected  
neglected tropical diseases 
•  Cervical cancer screening
•  Coverage of services for severe mental health disorders
Risk factors and behaviours
•  Exclusive breastfeeding rate 0–5 months of age
•  Early initiation of breastfeeding
•  Incidence of low birth weight among newborns
•  Children under 5 years who are stunted 
•  Children under 5 years who are wasted 
•  Anaemia prevalence in children
•  Anaemia prevalence in women of reproductive age
•  Condom use at last sex with high-risk partner
•  Population using safely managed drinking-water services
•  Population using safely managed sanitation services
•  Population using modern fuels for cooking/heating/lighting
•  Air pollution level in cities
•  Total alcohol per capita (age 15+ years) consumption
•  Tobacco use among persons aged 18+ years
•  Children aged under 5 years who are overweight
•  Overweight and obesity in adults (Also: adolescents) 
•  Raised blood pressure among adults
•  Raised blood glucose/diabetes among adults 
•  Salt intake 
•  Insufficient physical activity in adults (Also: adolescents)
•  Intimate partner violence prevalence 
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Health status indicators 
Mortality by age and sex
Life expectancy at birth
Adult mortality rate between 15 and 60 years of age
Under-five mortality rate
Infant mortality rate
Neonatal mortality rate
Stillbirth rate
Mortality by cause
Maternal mortality ratio
TB mortality rate
AIDS-related mortality rate
Malaria mortality rate
Mortality between 30 and 70 years of age from cardiovascular diseases,  
 cancer, diabetes or chronic respiratory diseases
Suicide rate
Mortality rate from road traffic injuries
Fertility
Adolescent fertility rate
Total fertility rate
Morbidity
New cases of vaccine-preventable diseases
New cases of IHR-notifiable diseases and other notifiable diseases
HIV incidence rate
HIV prevalence rate
Sexually transmitted infections (STIs) incidence rate
TB incidence rate
TB notification rate
TB prevalence rate
Malaria parasite prevalence among children aged 6–59 months
Malaria incidence rate
Cancer incidence, by type of cancer
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Life expectancy at birth
Abbreviated name Life expectancy at birth
Indicator name Life expectancy at birth
Domain Health status
Subdomain General
Associated terms Mortality by age and sex
Definition The average number of years that a newborn could expect to live if he or she were to pass through life exposed to the sex- and age-specific death 
rates prevailing at the time of his or her birth, for a specific year, in a given country, territory or geographical area.
Numerator (from life tables)
Denominator (from life tables)
Disaggregation/ 
additional dimension
Place of residence, sex, socioeconomic status
Method of measurement Life expectancy at birth is derived from life tables and is based on sex- and age-specific death rates. United Nations values for life expectancy 
at birth correspond to mid-year estimates, consistent with the corresponding United Nations fertility medium-variant quinquennial population 
projections.
Method of estimation Procedures used to estimate WHO life tables for Member States vary according to the data available to assess child and adult mortality.
Three basic methods have been used for this revision. In all three cases, the United Nations Inter-agency Group for Child Mortality Estimation  
(UN-IGME) estimates of neonatal, infant and under-five mortality rates were used. WHO has developed a model life table using a modified logit 
system based on some 1800 life tables from vital registration judged to be of good quality to project life tables and to estimate life tables using a 
limited number of parameters as input. 
1.  When mortality data from civil registration are available, their quality is assessed; they are adjusted for the level of completeness of registration 
if necessary and they are directly used to construct the life tables. 
2.  When mortality data from civil registration for the latest year are not available, the life tables are projected from available years from 1985 
onwards. Estimated under-five mortality rates and adult mortality rates, or under-five mortality rates only, are applied using a modified logit 
model to which a global standard (defined as the average of all the 1800 life tables). 
3.  When no useable data from civil registration are available, the latest life table analyses of the United Nations Population Division were used. 
Predominant type of statistics: predicted.
Measurement frequency Annual if based on preferred data source; otherwise less frequent
Monitoring and 
evaluation framework
Impact
Preferred data sources Civil registration with high coverage
Other possible data sources Household surveys and population census, sample registration system
Further information 
and related links
United Nations demographic yearbook. New York (NY): United Nations; 2013 (http://unstats.un.org/unsd/demographic/products/dyb/dyb2.htm, 
accessed 29 March 2015).
World population prospects. New York (NY): United Nations; 2012 (http://esa.un.org/wpp/, accessed 29 March 2015).
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Adult mortality rate between 15 and 60 years of age
Abbreviated name Adult mortality rate between 15 and 60 years of age
Indicator name Adult mortality rate (probably of dying between 15 and 60 years of age per 1000 population)
Domain Health status
Subdomain General
Associated terms Mortality by age and sex
Definition Probability that a 15-year-old person will die before reaching his or her 60th birthday. The probability of dying between the ages of 15 and 60 
years (per 1000 population) per year among a hypothetical cohort of 100 000 people who would experience the age-specific mortality rate of the 
reporting year.
Numerator Number of deaths at ages 15 to 59 years.
Denominator Number of years of exposure to the risk of death between ages 15 and 59 years.
Disaggregation/ 
additional dimension
Place of residence, sex, socioeconomic status 
Method of measurement Civil or sample registration: Mortality by age and sex are used to calculate age-specific rates. 
Census: Mortality by age and sex is tabulated from questions on recent deaths that occurred in the household during a given period preceding the 
census (usually 12 months). 
Census or surveys: Direct or indirect methods provide adult mortality rates based on information on survival of parents or siblings.
Method of estimation Empirical data from different sources are consolidated to obtain estimates of the level and trend of adult mortality by fitting a curve to the observed 
mortality points. However, to obtain the best possible estimates, judgement needs to be made on data quality and how representative it is of the 
population. Recent statistics based on data availability in most countries are point estimates at least 3–4 years old which need to be projected 
forward in order to obtain estimates of adult mortality for the current year.
In case of inadequate sources of age-specific mortality rates, the latest life table analyses of the United Nations Population Division were used.
Predominant type of statistics: predicted.
Measurement frequency Annual if based on preferred data source; otherwise less frequent
Monitoring and 
evaluation framework
Impact
Preferred data sources Civil registration with high coverage
Other possible data sources Household surveys, population census, sample registration system
Further information 
and related links
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
pdf?ua=1, accessed 29 March 2015).
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Under-five mortality rate
Abbreviated name Under-five mortality rate
Indicator name Under-five mortality rate (probability of dying by age 5 per 1000 live births)
Domain Health status
Subdomain Reproductive, maternal, newborn, child and adolescent health 
Associated terms Mortality by age and sex
Definition The probability of a child born in a specific year or period dying before reaching the age of 5 years, if subject to age-specific mortality rates 
of that period, expressed per 1000 live births.
The under-five mortality rate as defined here is, strictly speaking, not a rate (i.e. the number of deaths divided by the number of population 
at risk during a certain period of time) but a probability of death derived from a life table and expressed as a rate per 1000 live births.
Numerator Number of deaths among children aged 0–4 years (0–59 months of age), broken down by age groups.
Denominator Number of live births (person-years of exposure).
Disaggregation/ 
additional dimension
Place of residence, sex, socioeconomic status  
Also: by cause, including pneumonia or diarrhoea
Method of measurement The most frequently used methods using the above-mentioned data sources are as follows:
 Civil registration: Number of deaths at age 0 and population of the same age are used to calculate death rates which are then converted 
into age-specific probability of dying. 
 Census and surveys: An indirect method is used based on questions to each woman of reproductive age as to how many children she 
has ever given birth to and how many are still alive. The Brass method and model life tables are then used to obtain an estimate of 
infant mortality. 
 Surveys: A direct method is used based on birth history – a series of detailed questions on each child a woman has given birth to 
during her lifetime. To reduce sampling errors, the estimates are often presented as period rates for five years preceding the survey.  
A synthetic cohort method developed by the Demographic and Health Surveys (DHS) is used to compute period rates.
Method of estimation The UN-IGME produces trends of under-five mortality with a standardized methodology by group of countries depending on the type and 
quality of source of data available. For countries with adequate trend of data from civil registration, the calculations of under-five and 
infant mortality rates are derived from a standard period abridged life table. For countries with survey data, under-five mortality rates are 
estimated using the Bayesian B-splines bias-adjusted model. See the UN-IGME link for details. These under-five mortality rates have been 
estimated by applying methods to the available data from all Member States in order to ensure comparability across countries and time; 
hence they are not necessarily the same as the official national data. 
Predominant type of statistics: adjusted and predicted
Measurement frequency Annual if based on registration system; otherwise, less frequent (3–5 years based on surveys)
Monitoring and 
evaluation framework
Impact
Preferred data sources Civil registration with high coverage
Other possible data sources Household surveys, population census
Further information 
and related links
Countdown to 2015. Monitoring maternal, newborn and child health: understanding key progress indicators. Geneva: World Health 
Organization; 2011 (http://apps.who.int/iris/bitstream/10665/44770/1/9789241502818_eng.pdf, accessed 29 March 2015). 
Indicators for monitoring the Millennium Development Goals: definitions, rationale, concepts and sources. New York (NY): United Nations; 
2012 (http://mdgs.un.org/unsd/mi/wiki/MainPage.ashx, accessed 29 March 2015).
UN-IGME estimation method for child mortality. New York (NY): United Nations Inter-agency Group for Child Mortality Estimation; 2014 
(http://www.who.int/entity/gho/child_health/mortality/ChildCME_method.pdf.pdf, accessed 29 March 2015). 
World population prospects. New York (NY): United Nations; 2012 (http://esa.un.org/wpp/, accessed 29 March 2015). 
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Infant mortality rate
Abbreviated name Infant mortality rate
Indicator name Infant mortality rate (probability of dying between birth and age of 1 year per 1000 live births)
Domain Health status
Subdomain Reproductive, maternal, newborn, child and adolescent health 
Associated terms Mortality by age and sex
Definition The probability that a child born in a specific year or period will die before reaching the age of 1 year, if subject to age-specific mortality rates of that 
period, expressed as a rate per 1000 live births.
The infant mortality rate is, strictly speaking, not a rate (i.e. the number of deaths divided by the number of population at risk during a certain 
period of time) but a probability.
Numerator Number of children who died before their first birthday (0−11 months of age).
Denominator Number of live births (years of exposure).
Disaggregation/ 
additional dimension
Age, place of residence, sex, socioeconomic status (neonatal: 0−27 days, postneonatal: 28 days−<1 year)
Method of measurement The most frequently used methods using the above-mentioned data sources are as follows:
 Civil registration: Number of deaths at age 0 and population for the same age are used to calculate the death rate which is then converted into 
the age-specific probability of dying. 
 Census and surveys: An indirect method is used based on questions to each woman of reproductive age as to how many children she has ever 
given birth to and how many are still alive. The Brass method and model life tables are then used to obtain an estimate of infant mortality. 
 Surveys: A direct method is used based on birth history − a series of detailed questions on each child a woman has given birth to during her 
lifetime. To reduce sampling errors, the estimates are often presented as period rates for five years preceding the survey. A synthetic cohort 
method developed by the DHS is used to compute period rates
Method of estimation The UN-IGME produces trends of infant mortality rates with a standardized methodology by group of countries depending on the type and quality 
of source of data available. 
For countries with adequate trend of data from civil registration, the calculations of under-five and infant mortality rates are derived from a 
standard period abridged life table.
For countries with survey data, since infant mortality rates from birth histories of surveys are exposed to recall biases, infant mortality is derived 
from the projection of under-five mortality rates converted into infant mortality rates using the Bayesian B-splines bias-adjusted model. 
These infant mortality rates have been estimated by applying methods to the available data from all Member States in order to ensure 
comparability across countries and time; hence they are not necessarily the same as the official national data.
Predominant type of statistics: adjusted and predicted.
Measurement frequency Annual if based on registration system; otherwise, less frequent (3−5 years based on surveys)
Monitoring and 
evaluation framework
Impact
Preferred data sources Civil registration with high coverage
Other possible data sources Household surveys, population census
Further information 
and related links
Indicators for monitoring the Millennium Development Goals: definitions, rationale, concepts and sources. New York (NY): United Nations; 2012 
(http://mdgs.un.org/unsd/mi/wiki/MainPage.ashx, accessed 29 March 2015).
World population prospects. New York (NY): United Nations; 2012 (http://esa.un.org/wpp/, accessed 29 March 2015). 
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Neonatal mortality rate
Abbreviated name Neonatal mortality rate
Indicator name Neonatal mortality rate (per 1000 live births)
Domain Health status
Subdomain Reproductive, maternal, newborn, child and adolescent health 
Associated terms Mortality by age and sex
Definition Probability that a child born in a specific year or period will die during the first 28 completed days of life if subject to age-specific mortality rates of 
that period, expressed per 1000 live births.
Neonatal deaths (deaths among live births during the first 28 completed days of life) may be subdivided into early neonatal deaths, occurring 
during the first 7 days of life, and late neonatal deaths, occurring after the 7th day but before the 28th completed day of life.
Numerator Number of children who died during the first 28 days of life.
Denominator Number of live births (years of exposure).
Disaggregation/ 
additional dimension
Age in days/weeks, birth weight, place of residence, sex, socioeconomic status 
Method of measurement Data from civil registration: The number of live births and the number of neonatal deaths are used to calculate age-specific rates. This system 
provides annual data.
Data from household surveys: Calculations are based on full birth history, whereby women are asked for the date of birth of each of their children, 
whether each child is still alive and if not the age at death.
Method of estimation To ensure consistency with mortality rates in children younger than 5 years (under-five mortality rate) produced by the UN-IGME and to account for 
variation in survey-to-survey measurement errors, country data points for the under-five and neonatal mortality rates were rescaled for all years 
to match the latest time series estimates of the under-five mortality rate produced by UN-IGME. This rescaling assumes that the proportionate 
measurement error in neonatal and under-five mortality rates is equal for each data point.
The following multilevel statistical model was then applied to estimate neonatal mortality rates: log (neonatal mortality rate/1000) = α0 + 
β1*log(under-five mortality rate/1000) + β2*([log(under-five mortality rate/1000)] 2 ) with random effects parameters or both level and trend 
regression parameters, and random effects parameters influenced by the country itself.
For countries with high-quality civil registration data for neonatal deaths – defined as (i) 100% complete for adults and only civil registration data 
is used for child mortality, (ii) population greater than 800 000, (iii) and with at least three civil registration data points for the periods 1990−1994, 
1995−1999, 2000−2004 and 2005 onwards – we used the same basic equation, but with random effects parameters for both level and trend 
regression parameters, and random effects parameters influenced by the country itself.
Predominant type of statistics: adjusted and predicted.
These neonatal rates are estimates, derived from the estimated UN-IGME neonatal rate infant population for World population prospects to calculate 
the live births; hence they are not necessarily the same as the official national statistics.
Measurement frequency Annual if based on registration system; otherwise, less frequent (3−5 years based on surveys)
Monitoring and 
evaluation framework
Impact
Preferred data sources Civil registration with high coverage
Other possible data sources Household surveys, population census
Further information 
and related links
Every newborn: an action plan to end preventable deaths. Geneva: World Health Organization; 2014 (http://www.everynewborn.org/Documents/
Full-action-plan-EN.pdf, accessed 29 March 2015).
Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development beyond 2014. 
Report of the Secretary-General. New York (NY): United Nations; 2014 (https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/
Framework%20of%20action%20for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf, accessed 19 August 2014).
World population prospects. New York (NY): United Nations; 2012 (http://esa.un.org/wpp/, accessed 29 March 2015).
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Stillbirth rate
Abbreviated name Stillbirth rate 
Indicator name Stillbirth rate (per 1000 total births)
Domain Health status
Subdomain Reproductive, maternal, newborn, child and adolescent health 
Associated terms Mortality by age and sex
Definition Number of stillbirths per 1000 births (live and stillbirths). Stillbirths can occur antepartum or intrapartum. In many cases, stillbirths reflect 
inadequacies in antenatal care coverage or in intrapartum care. For purposes of international comparison, stillbirths are defined as third trimester 
fetal deaths (≥ 1000 g or ≥28 weeks).
Numerator Number of stillbirths.
Denominator Number of births (dead or alive).
Disaggregation/ 
additional dimension
Fresh/macerated
Method of measurement Data from civil registration: the number of stillbirths divided by the number of total births.
Data from surveys: the number of pregnancy losses during or after the seventh month of pregnancy for the 5 years preceding the interview, divided 
by the sum of live births and late pregnancy losses in the same time period. 
Data from administrative reporting systems/registries: the number of stillbirths divided by the number of total births.
Data from health facilities: the number of stillbirths divided by the number of total births documented in the facility.
Method of estimation For data from countries with civil registration and good coverage, data meeting definition criteria of greater than or equal to 1000 g or 28 completed 
weeks gestation are taken directly from civil registration without adjustment. For other countries, stillbirth rates are estimated with a regression 
model.
Measurement frequency Continuous data collection; dissemination every 3−5 years
Monitoring and 
evaluation framework
Impact
Preferred data sources Civil registration and vital statistics system, population-based surveys
Other possible data sources Administrative reporting systems, health facility assessments, special studies
Further information 
and related links
Every newborn: an action plan to end preventable deaths. Geneva: World Health Organization; 2014 (http://www.everynewborn.org/Documents/
Full-action-plan-EN.pdf, accessed 29 March 2015).
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
pdf?ua=1, accessed 29 March 2015).
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Maternal mortality ratio
Abbreviated name Maternal mortality ratio
Indicator name Maternal mortality ratio (per 100 000 live births)
Domain Health status
Subdomain Reproductive, maternal, newborn, child and adolescent health 
Associated terms Mortality by cause
Definition The annual number of female deaths from any cause related to or aggravated by pregnancy or its management (excluding accidental or incidental 
causes) during pregnancy and childbirth or within 42 days of termination of pregnancy, irrespective of the duration and site of the pregnancy, 
expressed per 100 000 live births, for a specified time period.
Numerator Number of maternal deaths.
Denominator Number of live births.
Disaggregation/ 
additional dimension
Age, place of residence
Method of measurement The maternal mortality ratio can be calculated by dividing recorded (or estimated) maternal deaths by total recorded (or estimated) live births in the 
same period and multiplying by 100 000. Measurement requires information on pregnancy status, timing of death (during pregnancy, childbirth, or 
within 42 days of termination of pregnancy), and cause of death.
The maternal mortality ratio can be calculated directly from data collected through vital registration systems, household surveys or other sources. 
There are often data quality problems, particularly related to the underreporting and misclassification of maternal deaths. Therefore, data are often 
adjusted in order to take these data quality issues into account.
Because maternal mortality is a relatively rare event, large sample sizes are needed if household surveys are used to identify recent maternal deaths 
in the household (e.g. last year). This may still result in estimates with large confidence intervals, limiting the usefulness for cross-country or over-
time comparisons.
To reduce sample size requirements, the sisterhood method used in the DHS and multiple indicator surveys (MICS4) measures maternal mortality 
by asking respondents about the survival of sisters. It should be noted that the sisterhood method results in pregnancy-related mortality: regardless 
of the cause of death, all deaths occurring during pregnancy, birth or the six weeks following the termination of the pregnancy are included in the 
numerator of the maternal mortality ratio.
Censuses have also included questions about maternal deaths with variable success.
Reproductive Age Mortality Studies (RAMOS) is a special study that uses varied sources, depending on the context, to identify all deaths of women 
of reproductive age and ascertain which of these deaths are maternal or pregnancy-related.
Method of estimation For facility data-based maternal mortality, the denominator is estimated using population projections.
WHO, UNICEF, UNFPA, the United Nations Population Division and The World Bank have developed a method to adjust existing data in order to 
take into account these data quality issues and ensure the comparability of different data sources. This method involves assessment of data for 
completeness and, where necessary, adjustment for underreporting and misclassification of deaths as well as development of estimates through 
statistical modelling for countries with no reliable national level data.
Data on maternal mortality and other relevant variables are obtained through databases maintained by WHO, the United Nations Population 
Division, UNICEF, and The World Bank. Data available from countries varies in terms of source and methods. Given the variability of the sources of 
data, different methods are used for each data source in order to arrive at country estimates that are comparable and permit regional and global 
aggregation.
Currently, only about one third of all countries/territories have reliable data available and do not need additional estimations. For about half of the 
countries included in the estimation process, country-reported estimates of maternal mortality are adjusted for the purposes of comparability of the 
methodologies. For the remainder of countries/territories – those with no appropriate maternal mortality data – a statistical model is employed to 
predict maternal mortality levels. However, the calculated point estimates with this methodology might not represent the true levels of maternal 
mortality. It is advised to consider the estimates together with the reported uncertainty margins within which the true levels are known to lie.
Predominant type of statistics: predicted.
Measurement frequency For civil registration: annual. For other sources: every 5 years or more
Monitoring and 
evaluation framework
Impact
Preferred data sources Civil registration with high coverage and medical certification of cause of death and regular assessment of misreporting and underreporting
Other possible data sources Household surveys, population census, sample or sentinel registration systems, special studies
Further information 
and related links
Indicators for monitoring the Millennium Development Goals: definitions, rationale, concepts and sources. New York (NY): United Nations; 2012 
(http://mdgs.un.org/unsd/mi/wiki/MainPage.ashx, accessed 29 March 2015).
WHO, UNICEF, UNFPA, The World Bank, United Nations Population Division. Trends in maternal mortality: 1990 to 2013. Geneva: World Health 
Organization; 2014 (http://www.who.int/reproductivehealth/publications/monitoring/maternal-mortality-2013/en/, accessed 29 March 2015). 
World population prospects. New York (NY): United Nations; 2012 (http://esa.un.org/wpp/, accessed 29 March 2015).
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TB mortality rate
Abbreviated name TB mortality rate
Indicator name Tuberculosis (TB) mortality rate (per 100 000 population)
Domain Health status
Subdomain Infectious disease
Associated terms Mortality by cause
Definition Estimated number of deaths attributable to TB in a given year, expressed as a rate per 100 000 population.
Numerator Number of deaths due to TB (all forms), excluding deaths in HIV-positive TB cases.
Denominator Number of years of exposure.
Disaggregation/ 
additional dimension
Age, place of residence, sex, socioeconomic status
Method of measurement Vital registration data based on ICD are used where available (approximately 120 countries). Elsewhere, estimates of mortality are derived from 
estimates of incidence and the case fatality rate.
Method of estimation Estimates of TB mortality are generated through a consultative and analytical process led by WHO and are published annually. Uncertainty bounds 
are provided in addition to best estimates. Published values are rounded to three significant figures. Age standardization is done for comparability 
over time and between populations.
Measurement frequency Annual
Monitoring and 
evaluation framework
Impact
Preferred data sources Civil registration with full coverage and cause of death based on ICD
Other possible data sources Special studies, sample or sentinel registration systems, population surveys with verbal autopsy
Further information 
and related links
Global tuberculosis report 2014. Geneva: World Health Organization; 2014 (http://www.who.int/tb/publications/global_report/en/,  
accessed 29 March 2015).
Indicators for monitoring the Millennium Development Goals: definitions, rationale, concepts and sources. New York (NY): United Nations; 2012 
(http://mdgs.un.org/unsd/mi/wiki/MainPage.ashx, accessed 29 March 2015).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
pdf?ua=1, accessed 29 March 2015).
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AIDS-related mortality rate
Abbreviated name AIDS-related mortality rate
Indicator name AIDS-related mortality rate (per 100 000 population)
Domain Health status
Subdomain Infectious disease
Associated terms Mortality by cause
Definition Estimated number of adults and children who have died due to AIDS-related causes in a specific year, expressed as a rate per 100 000 population.
Numerator Number of deaths due to AIDS x 100 000.
Denominator Estimated population in the reporting year.
Disaggregation/ 
additional dimension
Age (<5, 5–14, 15+), geographic location, sex, TB status
Method of measurement Death registration data using ICD; verbal autopsy-based results are also used. 
The number of AIDs-related deaths can also be modelled using the Spectrum software.
Method of estimation Empirical data from different HIV surveillance sources are consolidated to obtain estimates of the level and trend of HIV infection and of mortality 
in adults and children. Standard methods and tools for HIV estimates that are appropriate to the pattern of the HIV epidemic are used. However, 
to obtain the best possible estimates, judgement must be used as to the quality of the data and how representative it is of the population. 
Adjustments are often needed because of underreporting/misclassification of HIV/AIDS deaths. UNAIDS and WHO produce country-specific 
estimates of mortality due to AIDS every year. 
To calculate mortality rates, the total population is derived from the latest estimates produced by the United Nations Population Division. 
Predominant type of statistics: predicted.
Measurement frequency Annual if based on civil registration data or United Nations estimates
Monitoring and 
evaluation framework
Impact
Preferred data sources Civil registration with full coverage and cause of death based on ICD
Other possible data sources Sample registration systems with causes of death, household surveys with verbal autopsy, modelled estimates
Further information 
and related links
Consolidated Strategic Information Guidelines for HIV in the Health Sector. Geneva: World Health Organization; 2015.
Spectrum software. Glastonbury (CT): Avenir Health. (http://www.avenirhealth.org/software-spectrum.php, accessed 29 March 2015).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
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Malaria mortality rate
Abbreviated name Malaria mortality rate
Indicator name Malaria mortality rate (per 100 000 population)
Domain Health status
Subdomain Infectious disease
Associated terms Mortality by cause
Definition Number of adults and children who have died due to malaria in a specific year, expressed as a rate per 100 000 population.
Numerator Number of deaths due to malaria.
Denominator Number of years of exposure.
Disaggregation/ 
additional dimension
Age, place of residence, sex, socioeconomic status
Method of measurement Death registration data using ICD-10; verbal autopsy-based results are also used.
Method of estimation Modelling, using multiple inputs, is often used to obtain a malaria mortality estimate. 
WHO compiles information supplied by ministries of health (i.e. the agencies responsible for malaria surveillance in endemic countries). The 
procedures for adjusting data to allow for international comparability are as follows: The number of malaria deaths is derived by one of two 
methods: 
1.  by multiplying the estimated number of P. falciparum malaria cases in a country by a fixed case-fatality rate. This method is used for all 
countries outside the WHO African Region and for countries in the African Region where estimates of case incidence are derived from routine 
reporting systems and where malaria accounts for less than 5% of all deaths in children under 5 years, as described in the Global Burden of 
Disease Incremental Revision for 2004. A case fatality rate of 0.45% is applied to the estimated number of P. falciparum cases for countries in 
the African Region and a case fatality rate of 0.3% for P. falciparum cases in other regions. (In situations where the fraction of all deaths due 
to malaria is small, the use of a case fatality rate in conjunction with estimates of case incidence is considered to provide a better guide to the 
levels of malaria mortality than attempts to estimate the fraction of deaths due to malaria.) 
2.  For countries in the African Region where malaria comprises 5% or more of all deaths in children under 5 years, the number of deaths is derived 
from an estimate of the number of people living at high, low or no risk of malaria. Malaria death rates for these populations are inferred from 
longitudinal studies of malaria deaths, as recorded in the published literature.
The malaria death rate is expressed as the number of deaths due to malaria per 100 000 population per year with the population of a country 
derived from projections made by the United Nations Population Division. 
The adjustment procedures described above aim to take into account underreporting of cases if patients do not use public sector facilities or if 
there are gaps in public sector reporting systems. For countries that do not undertake laboratory confirmation of cases, the adjustments also aim 
to correct for over-diagnosis of malaria. Where data from surveillance systems are not available, or are considered to be of insufficient quality, 
incidence is derived from estimated levels of malaria risk and will chiefly be from sources other than locally-available estimates.
Predominant type of statistics: predicted.
Age standardization is done for comparability over time and between populations.
Measurement frequency Annual
Monitoring and 
evaluation framework
Impact
Preferred data sources Civil registration with full coverage and medical certification of cause of death
Other possible data sources Routine facility information systems, household surveys with verbal autopsy, special studies
Further information 
and related links
Household Survey Indicators for Malaria Control. Measure Evaluation/Measure DHS/President’s Malaria Initiative/Roll Back Malaria Partnership/
UNICEF/WHO. 2013 (http://www.malariasurveys.org/documents/Household%20Survey%20Indicators%20for%20Malaria%20Control.pdf,  
accessed 15 April 2015.
Indicators for monitoring the Millennium Development Goals: definitions, rationale, concepts and sources. New York (NY): United Nations; 2012 
(http://mdgs.un.org/unsd/mi/wiki/MainPage.ashx, accessed 29 March 2015).
Roll Back Malaria Partnership/WHO. Disease surveillance for malaria control: an operations manual. Geneva: World Health Organization; 2012 
(http://www.who.int/malaria/publications/atoz/9789241503341/en/, accessed 29 March 2015).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
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Mortality between 30 and 70 years of age from cardiovascular 
diseases, cancer, diabetes or chronic respiratory diseases
Abbreviated name Mortality between 30 and 70 years of age from cardiovascular diseases, cancer, diabetes or chronic respiratory diseases
Indicator name Mortality between ages 30 and 70 years from cardiovascular diseases, cancer, diabetes or chronic respiratory diseases
Domain Health status
Subdomain NCDs 
Associated terms Mortality by cause
Definition Unconditional probability of dying between the exact ages of 30 and 70 years from cardiovascular diseases, cancer, diabetes  
or chronic respiratory diseases.
Numerator Number of deaths between ages 30 and 70 years due to the four causes.
Denominator Number of years of exposure.
Disaggregation/ 
additional dimension
Place of residence, sex, socioeconomic status
Method of measurement Deaths from these four causes will be based on the following ICD codes: 100−I99, COO−C97, E10−E14 and J30−J98.
Method of estimation Modelling, using multiple inputs, is often used if no complete and accurate data are available. 
Age standardization is done for comparability over time and between populations.
Measurement frequency Annual if civil registration data; otherwise every 3−5 years
Monitoring and 
evaluation framework
Impact
Preferred data sources Civil registration and vital statistics systems
Other possible data sources Population-based health surveys with verbal autopsy
Further information 
and related links
Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases, including a set of 
indicators. Agenda item A66/8, Sixty-sixth World Health Assembly, 20–28 May 2013. Geneva: World Health Organization; 2013 (http://apps.who.
int/gb/ebwha/pdf_files/WHA66/A66_8-en.pdf?ua=1, accessed 29 March 2015).
Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development beyond 2014. 
Report of the Secretary-General. New York (NY): United Nations; 2014 (https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/
Framework%20of%20action%20for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf, accessed 19 August 2014).
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
pdf?ua=1, accessed 29 March 2015).
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Suicide rate
Abbreviated name Suicide rate
Indicator name Suicide rate (per 100 000 population)
Domain Health status
Subdomain Injury and violence
Associated terms Mortality by cause
Definition Suicide rate per 100 000 population in a specified period (age-standardized).
Numerator Number of suicides.
Denominator Number of years of exposure.
Disaggregation/ 
additional dimension
Age, place of residence, sex, socioeconomic status 
Method of measurement Death registration data using ICD-10, often with adjustments for underreporting.
Method of estimation Modelling, using multiple inputs, is often used if no complete and accurate data are available.
Measurement frequency Annual if civil registration data are available, otherwise every five years
Monitoring and 
evaluation framework
Impact
Preferred data sources Civil registration and vital statistics systems with full coverage
Other possible data sources Special studies
Further information 
and related links
Mental Health Action Plan, 2013−2020. Geneva: World Health Organization; 2013 
(http://apps.who.int/iris/bitstream/10665/89966/1/9789241506021_eng.pdf?ua=1, accessed 29 March 2015).
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Mortality rate from road traffic injuries
Abbreviated name Mortality rate from road traffic injuries
Indicator name Mortality rate from road traffic injuries (per 100 000 population)
Domain Health status
Subdomain Injury and violence
Associated terms Mortality by cause
Definition Number of road traffic fatal injury deaths per 100 000 population (age-standardized).
Numerator Number of deaths due to road traffic crashes.
Denominator Population.
Disaggregation/ 
additional dimension
Age, per motor vehicle (fatalities per 10 000 motor vehicles), sex, socioeconomic status
Method of measurement Death registration data using ICD-10.
Method of estimation Modelling, using multiple inputs, is often used if no complete and accurate data are available. 
Measurement frequency Annual if civil registration data are available, otherwise every five years
Monitoring and 
evaluation framework
Impact
Preferred data sources Civil registration and vital statistics systems with full coverage
Other possible data sources Population-based health surveys with verbal autopsy, administrative reporting systems (police reports)
Further information 
and related links
ESCAP road safety goals, targets and indicators for the Decade of Action, 2011-2020. In: Road safety: note by the Secretariat. Bangkok: United 
Nations Economic and Social Commission for Asia and the Pacific; 2011: Annex 1 of Document E/ESCAP/MCT.2/8 of United Nations ESCAP Ministerial 
Conference on Transport, Bangkok, 12-16 March 2012 (http://www.unescap.org/ttdw/MCT2011/MCT/MCT2-8E.pdf, accessed 21 April 2015). 
Global status report on road safety: time for action. Geneva: World Health Organization; 2009 (www.who.int/violence_injury_prevention/road_
safety_status/2009, accessed 29 March 2015).
Organisation for Economic Co-operation and Development. Health at a Glance 2013: OECD Indicators, Paris: OECD Publishing; 2013  
(http://dx.doi.org/10.1787/health_glance-2013-en, accessed 29 March 2014).
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Adolescent fertility rate
Abbreviated name Adolescent fertility rate
Indicator name Adolescent fertility rate (per 1000 girls aged 15–19 years)
Domain Health status
Subdomain Reproductive, maternal, newborn, child and adolescent health
Associated terms Fertility
Definition Annual number of births to women aged 15−19 years per 1000 women in that age group.  
It is also referred to as the age-specific fertility rate for women aged 15−19 years.
Numerator Number of live births to women aged 15−19 years.
Denominator Exposure to childbearing by women aged 15−19 years.
Disaggregation/ 
additional dimension
Marital status (when possible, also capture girls < 15 years), place of residence, socioeconomic status
Method of measurement The adolescent birth rate is generally computed as a ratio. The numerator is the number of live births to women aged 15−19 years, and the 
denominator is an estimate of exposure to childbearing by women aged 15−19 years. The numerator and the denominator are calculated 
differently for civil registration and survey and census data.
 Civil registration: In the case of civil registration the numerator is the registered number of live births born to women aged 15−19 years during 
a given year, and the denominator is the estimated or enumerated population of women aged 15−19 years. 
 Survey data: In the case of survey data, the adolescent birth rate is generally computed on the basis of retrospective birth histories. The 
numerator refers to births to women who were 15−19 years of age at the time of the birth during a reference period before the interview, 
and the denominator to person-years lived between the ages of 15 and 19 years by the interviewed women during the same reference period. 
Whenever possible, the reference period corresponds to the five years preceding the survey. The reported observation year corresponds to the 
middle of the reference period. For some surveys, no retrospective birth histories are available and the estimate is based on the date of last birth 
or the number of births in the 12 months preceding the survey. 
 Census data: With census data, the adolescent birth rate is generally computed on the basis of the date of last birth or the number of births in 
the 12 months preceding the enumeration. The census provides both the numerator and the denominator for the rates. In some cases, the rates 
based on censuses are adjusted for under-registration based on indirect methods of estimation. For some countries with no other reliable data, 
the own-children method of indirect estimation provides estimates of the adolescent birth rate for a number of years before the census (See: 
http://mdgs.un.org/unsd/mdg/Metadata.aspx, accessed 19 October 2009.)
If numbers are available, adolescent fertility at ages under 15 years can also be computed.
Method of estimation The United Nations Population Division compiles and updates data on adolescent fertility rates for MDG monitoring. Estimates based on civil 
registration are provided when the country reports at least 90% coverage and there is reasonable agreement between civil registration estimates 
and survey estimates. Survey estimates are provided only when there is no reliable civil registration. Given the restrictions of the United Nations 
MDG database, only one source is provided by year and country. In such cases precedence is given to the survey programme conducted most 
frequently at the country level, with other survey programmes using retrospective birth histories, census and other surveys in that order.  
(See: http://mdgs.un.org/unsd/mdg/Metadata.aspx, accessed 19 October 2009.)
Measurement frequency Annual
Monitoring and 
evaluation framework
Impact
Preferred data sources Civil registration systems with full coverage
Other possible data sources Population census, household surveys
Further information 
and related links
Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development beyond 2014. 
Report of the Secretary-General. New York (NY): United Nations; 2014 (https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/
Framework%20of%20action%20for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf, accessed 19 August 2014).
Monitoring progress in family planning. FP2020 core indicators. Glastonbury (CT): Track20 (http://www.track20.org/pages/data/indicators,  
21 March 2014).
The UNFPA Strategic Plan, 2014−2017. Report of the Executive Director. New York (NY): United Nations Population Fund; 2013.
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Total fertility rate
Abbreviated name Total fertility rate
Indicator name Total fertility rate
Domain Health status
Subdomain Reproductive, maternal, newborn, child and adolescent health
Associated terms Fertility
Definition Average number of children that a hypothetical cohort of women would have at the end of their reproductive period if they were subject during 
their whole lives to the fertility rates of a given period and if they were not subject to mortality. It is expressed as children per woman.
Numerator  
Denominator  
Disaggregation/ 
additional dimension
Place of residence, socioeconomic status
Method of measurement Total fertility rate is directly calculated as the sum of age-specific fertility rates (usually referring to women aged 15−49 years), or five times 
the sum if data are given in five-year age groups. An age-specific or age-group-specific fertility rate is calculated as the ratio of annual births to 
women at a given age or age group to the population of women at the same age or age group, in the same year, for a given country, territory or 
geographical area. Population data from the United Nations correspond to mid-year estimated values, obtained by linear interpolation from the 
corresponding United Nations fertility medium-variant quinquennial population projections.
Method of estimation Population data are taken from the most recent United Nations Population Division's World population prospects.
Measurement frequency Annual if based on civil registration and vital statistics (CRVS); once every 3−5 years if based on surveys and census
Monitoring and 
evaluation framework
Impact
Preferred data sources Civil registration and vital statistics systems
Other possible data sources Population-based health surveys, population census
Further information 
and related links
The UNFPA Strategic Plan, 2014−2017. Report of the Executive Director. New York (NY): United Nations Population Fund; 2013.
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New cases of vaccine-preventable diseases
Abbreviated name New cases of vaccine-preventable diseases
Indicator name New cases of vaccine-preventable diseases 
Domain Health status
Subdomain Infectious disease
Associated terms Morbidity
Definition Number of confirmed new cases of vaccine-preventable diseases that are included in the WHO recommended standards for surveillance of selected 
vaccine-preventable diseases, and vaccine-preventable diseases reported on the WHO-UNICEF reporting form in a specified time period.
Numerator Number of new cases.
Denominator
Disaggregation/ 
additional dimension
Disease (diphtheria, hepatitis B, pertussis, neonatal tetanus, total tetanus, measles, rubella, congenital rubella syndrome, mumps, diarrhoea, 
pneumonia, Japanese encephalitis, yellow fever) 
Age, geographic location (e.g. district) sex, vaccination status
Method of measurement Active surveillance with regular reporting and quality control.
Method of estimation Adjustments for underreporting may be needed.
Measurement frequency Monthly; in some cases more frequently if continuous
Monitoring and 
evaluation framework
Impact
Preferred data sources Active surveillance systems with laboratory confirmation
Other possible data sources
Further information 
and related links
WHO/UNICEF joint reporting form on immunization. Geneva: World Health Organization; 2014 (http://www.who.int/entity/immunization/
monitoring_surveillance/routine/reporting/WHO_UNICEF_JRF_EN.xls?ua=1, accessed 21 March 2014).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
pdf?ua=1, accessed 29 March 2015).
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New cases of IHR-notifiable diseases and other notifiable diseases
Abbreviated name New cases of IHR-notifiable diseases and other notifiable diseases
Indicator name New cases of IHR-notifiable diseases and other notifiable diseases per year
Domain Health status
Subdomain Infectious disease
Associated terms Morbidity
Definition Number of new confirmed cases of IHR-notifiable diseases (immediately notifiable diseases) and other notifiable diseases (diseases that could cause 
serious public health impact and could spread rapidly internationally) per year.
Numerator Number of new cases.
Denominator
Disaggregation/ 
additional dimension
IHR-notifiable diseases: smallpox, poliomyelitis due to wild type poliovirus, human influenza caused by a new subtype, severe acute respiratory 
syndrome (SARS)
Other notifiable diseases: cholera, pneumonic plague, yellow fever, viral haemorrhagic fevers, West Nile fever, other diseases that are of special 
national or regional concern (dengue fever, Rift Valley fever, meningococcal disease)
Age, geographic location, sex, vaccination status
Method of measurement Surveillance with immediate reporting.
Method of estimation
Measurement frequency Continuous
Monitoring and 
evaluation framework
Impact
Preferred data sources Active surveillance systems with laboratory confirmation
Other possible data sources
Further information 
and related links
Decision instrument for the assessment and notification of events that may constitute a public health emergency of international concern. Agenda 
item 2, Intergovernmental Working Group on Revision of the International Health Regulations, 22 February 2005 . Report of the Ad Hoc Expert 
Group on Annex 2. Geneva: World Health Organization; 2005 (http://apps.who.int/gb/ghs/pdf/IHR_IGWG2_ID4-en.pdf, accessed 29 March 2015).
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
pdf?ua=1, accessed 29 March 2015).
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HIV incidence rate
Abbreviated name HIV incidence rate
Indicator name HIV incidence (per 1000 population)
Domain Health status
Subdomain Infectious disease
Associated terms Morbidity
Definition Number of new HIV infections per 1000 uninfected population. The incidence rate is the number of new cases per population at risk in a given time 
period.
Numerator Number of new HIV infections.
Denominator Uninfected population (which is the total population minus people living with HIV).
Disaggregation/ 
additional dimension
General population, Key populations (men who have sex with men, sex workers, people who inject drugs, transgender people, prisoners), Age 
groups (0−14, 15−24, 15−49, 50+ years), for key populations < 25, 25+ years), mode of transmission for children (including mother-to-child 
transmission), geographic location, sex
Method of measurement Longitudinal data on individuals are the best source of data but are rarely available for large populations. Special diagnostic tests in surveys or from 
health facilities can be used to obtain data on HIV incidence.
In generalized epidemics, prevalence among very young age groups can be reviewed as a proxy for or a data source for triangulating incidence.
HIV incidence can also be modelled (e.g. using the Spectrum software).
Method of estimation Modelling is often used to obtain an estimate of new infections. Prevalence data are the main input data.
Measurement frequency Survey schedule; Spectrum model estimates updated every year
Monitoring and 
evaluation framework
Impact
Preferred data sources Household or key population survey with HIV incidence-testing, Spectrum modelling
Other possible data sources Regular surveillance system among key populations
Further information 
and related links
Consolidated Strategic Information Guidelines for HIV in the Health Sector. Geneva: World Health Organization; 2015.
Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development beyond 2014. 
Report of the Secretary-General. New York (NY): United Nations; 2014 (https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/
Framework%20of%20action%20for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf, accessed 19 August 2014).
Global AIDS response progress reporting 2014: construction of core indicators for monitoring the 2011 United Nations political declaration on 
HIV/AIDS. Geneva: Joint United Nations Programme on HIV/AIDS; 2014 (http://www.unaids.org/en/media/unaids/contentassets/documents/
document/2014/GARPR_2014_guidelines_en.pdf, accessed 29 March 2015).
Indicators for monitoring the Millennium Development Goals: definitions, rationale, concepts and sources. New York (NY): United Nations; 2012 
(http://mdgs.un.org/unsd/mi/wiki/MainPage.ashx, accessed 29 March 2015).
Next generation indicators reference guide: planning and reporting. Version 1.2. Washington (DC): The President’s Emergency Plan for AIDS Relief; 
2013 (http://www.pepfar.gov/documents/organization/206097.pdf, accessed 29 March 2014).
Spectrum software. Glastonbury (CT): Avenir Health. (http://www.avenirhealth.org/software-spectrum.php, accessed 29 March 2015).
The UNFPA Strategic Plan, 2014−2017. Report of the Executive Director. New York (NY): United Nations Population Fund; 2013.
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
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HIV prevalence rate
Abbreviated name HIV prevalence rate
Indicator name HIV prevalence (per 1000 population)
Domain Health status
Subdomain Infectious disease
Associated terms Morbidity
Definition Percentage of people living with HIV. Prevalence measures the frequency of existing disease in a defined population at a specific time.
Numerator  Total number of infections.
Denominator Total population.
Disaggregation/ 
additional dimension
General population age groups: 0−14 years (< 1, 1−4, 5−14 years), > 15 years (15−24, 15−49, 50+ years) 
Key population: age groups 15−24 years, 25+ years; men who have sex with men, sex workers, people who inject drugs, transgender people, 
prisoners 
New and relapse TB cases, ART eligibility, location, pregnancy status, sex, socioeconomic status 
HIV prevalence among TB patients
Method of measurement General population surveys with HIV-testing, sample surveys with HIV-testing in key populations, surveillance systems among key populations, key 
population subnational estimates.
HIV prevalence can also be modelled using the Spectrum software.
Method of estimation Modelling is often needed for both numerator and denominator, using data from surveys, surveillance and research studies.
Measurement frequency Survey schedule; Spectrum model estimates updated every year
Monitoring and 
evaluation framework
Impact
Preferred data sources Key population surveys, national population surveys in generalized epidemics, surveillance systems
Other possible data sources Active facility-based surveillance system with key population estimates
Further information 
and related links
Consolidated Strategic Information Guidelines for HIV in the Health Sector. Geneva: World Health Organization; 2015.
Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development beyond 2014. 
Report of the Secretary-General. New York (NY): United Nations; 2014 (https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/
Framework%20of%20action%20for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf, accessed 19 August 2014).
Global AIDS response progress reporting 2014: construction of core indicators for monitoring the 2011 United Nations political declaration on 
HIV/AIDS. Geneva: Joint United Nations Programme on HIV/AIDS; 2014 (http://www.unaids.org/en/media/unaids/contentassets/documents/
document/2014/GARPR_2014_guidelines_en.pdf, accessed 29 March 2015).
Next generation indicators reference guide: planning and reporting. Version 1.2. Washington (DC): The President’s Emergency Plan for AIDS Relief; 
2013 (http://www.pepfar.gov/documents/organization/206097.pdf, accessed 29 March 2014).
Spectrum software. Glastonbury (CT): Avenir Health. (http://www.avenirhealth.org/software-spectrum.php, accessed 29 March 2015).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
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Sexually transmitted infections (STIs) incidence rate
Abbreviated name Sexually transmitted infections (STIs) incidence rate
Indicator name Sexually transmitted infections (STIs) incidence rate
Domain Health status
Subdomain Infectious disease
Associated terms Morbidity
Definition Number of new cases of reported STIs (syndromic or etiological reporting) in a specified time period (year).
Numerator Number of new cases.
Denominator Total population.
Disaggregation/ 
additional dimension
Age, key populations, sex, syndrome/pathogen (gonorrhoea, syphilis [including congenital], urethral discharge, and genital ulcer disease)
Method of measurement Laboratory confirmation is essential. If not available, the syndromic approach is used to estimate incidence, but data are much less reliable.
Method of estimation Annual
Measurement frequency
Monitoring and 
evaluation framework
Impact
Preferred data sources Health facilities
Other possible data sources
Further information 
and related links
Global strategy for the prevention and control of sexually transmitted infections: 2006−2015. Geneva: World Health Organization; 2007  
(http://whqlibdoc.who.int/publications/2007/9789241563475_eng.pdf?ua=1, accessed 29 March 2015).
UN. Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development (ICPD) 
beyond 2014 (Feb 2014). Accessed on 19 August 2014. from https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/Framework%20
of%20action%20for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf
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TB incidence rate
Abbreviated name TB incidence rate
Indicator name Tuberculosis (TB) incidence (per 100 000 population)
Domain Health status
Subdomain Infectious disease
Associated terms Morbidity
Definition Estimated number of new and relapse TB cases (all forms of TB, including cases in people living with HIV) arising in a given year,  
expressed as a rate per 100 000 population.
Numerator Number of new and relapse TB cases arising in a specified time period.
Denominator Number of person-years of exposure.
Disaggregation/ 
additional dimension
Age, HIV status, sex 
Method of measurement Direct measurement requires high-quality surveillance systems in which underreporting is negligible, and strong health systems so that 
underdiagnosis is also negligible; otherwise indirect estimates based on notification data and estimates of levels of underreporting and under-
diagnosis.
Method of estimation Estimates of TB incidence are produced through a consultative and analytical process led by WHO and are published annually. These estimates are 
based on annual case notifications, assessments of the quality and coverage of TB notification data, national surveys of the prevalence of TB disease 
and information from death (vital) registration systems. 
Estimates of incidence for each country are derived, using one or more of the following approaches depending on available data: 
1.  incidence = case notifications/estimated proportion of cases detected; 
2.  incidence = prevalence/duration of condition; 
3.  incidence = deaths/proportion of incident cases that die.
Uncertainty bounds are provided in addition to best estimates.
Details are available from TB impact measurement: policy and recommendations for how to assess the epidemiological burden of TB and the impact of 
TB control and from the online technical appendix to the WHO global tuberculosis report 2014.
Measurement frequency Annual
Monitoring and 
evaluation framework
Impact
Preferred data sources High quality TB surveillance system (linked to routine facility information system)
Other possible data sources Population-based health surveys with TB diagnostic testing
Further information 
and related links
Definitions and reporting framework for tuberculosis – 2013 revision (WHO/HTM/TB/2013.2). Geneva: World Health Organization; 2013  
(http://www.who.int/tb/publications/definitions/en/, accessed 29 March 2015).
Global tuberculosis report 2014. Geneva: World Health Organization; 2014 (http://www.who.int/tb/publications/global_report/en/,  
accessed 29 March 2015).
Indicators for monitoring the Millennium Development Goals: definitions, rationale, concepts and sources. New York (NY): United Nations; 2012 
(http://mdgs.un.org/unsd/mi/wiki/MainPage.ashx, accessed 29 March 2015).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
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TB notification rate
Abbreviated name TB notification rate
Indicator name Tuberculosis (TB) notification rate (per 100 000 population)
Domain Health status
Subdomain Infectious disease
Associated terms Morbidity
Definition Number of new and relapse TB cases notified in a given year, per 100 000 population.
The term “notification” means that TB is diagnosed in a patient and is reported within the national surveillance system, and then on to WHO.
From 2013 onwards, the numbers of cases are reported to WHO in the following categories: New pulmonary bacteriologically confirmed 
TB cases; New pulmonary clinically diagnosed TB cases ; New extrapulmonary TB cases, bacteriologically confirmed or clinically diagnosed; 
Relapse pulmonary bacteriologically confirmed TB cases; Relapse pulmonary clinically diagnosed TB cases; Relapse extrapulmonary TB cases, 
bacteriologically confirmed or clinically diagnosed; Previously treated cases, excluding relapse cases, bacteriologically confirmed or clinically 
diagnosed. Note that “New” in the first three categories above also includes cases with unknown previous TB treatment history.
Prior to 2013, the numbers of cases were reported to WHO in the following categories: New TB case: pulmonary smear-positive; New TB case: 
pulmonary smear-negative; New TB case: pulmonary smear unknown/not done; New TB case: extrapulmonary; New TB case: other; Retreatment TB 
case: relapse (pulmonary smear and/or culture positive); Retreatment TB case: treatment after failure (pulmonary smear and/or culture positive); 
Retreatment TB case: treatment after default (pulmonary smear and/or culture positive); Retreatment TB case: other; Other TB cases (treatment 
history unknown).
Numerator Number of new and relapse cases of TB in a specified time period.
Denominator Number of persons/total population.
Disaggregation/ 
additional dimension
Type of TB (bacteriologically confirmed/clinically diagnosed, pulmonary/extrapulmonary) 
Age, health-care workers, place of residence, prisons, sex, treatment history 
Method of measurement The number of cases detected by national TB control programmes is collected as part of routine surveillance.
Annual case notifications are reported by countries to WHO using a web-based data collection system. See WHO global tuberculosis report. 
The TB case notifications reported by countries follow the WHO recommendations on case definitions and recording and reporting; they are 
internationally comparable and there is no need for any adjustment.
Method of estimation Reported by countries.
Measurement frequency Annual
Monitoring and 
evaluation framework
Impact
Preferred data sources TB surveillance system linked to routine facility information system
Other possible data sources
Further information 
and related links
Definitions and reporting framework for tuberculosis – 2013 revision (WHO/HTM/TB/2013.2). Geneva: World Health Organization; 2013  
(http://www.who.int/tb/publications/definitions/en/, accessed 29 March 2015).
Global tuberculosis report 2014. Geneva: World Health Organization; 2014 (http://www.who.int/tb/publications/global_report/en/,  
accessed 29 March 2015).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
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TB prevalence rate
Abbreviated name TB prevalence rate
Indicator name Tuberculosis (TB) prevalence rate (per 100 000 population)
Domain Health status
Subdomain Infectious disease
Associated terms Morbidity
Definition Number of cases of tuberculosis (all forms) in a population at a given point in time (the middle of the calendar year), expressed as a rate  
per 100 000 population. 
Numerator Number of TB cases.
Denominator Number of persons/population.
Disaggregation/ 
additional dimension
Bacteriologically confirmed TB, all forms of TB 
Age, HIV status, sex
Method of measurement Prevalence can be estimated in national population-based surveys. Where survey data are not available, estimates of prevalence are derived from 
estimates of incidence and the duration of disease.
Method of estimation Estimates of TB prevalence are based on a consultative and analytical process led by WHO and are published annually. Uncertainty bounds are 
provided in addition to best estimates.
Where available, TB prevalence surveys are used to estimate prevalence. In most instances, survey data are not available, and country-specific 
estimates of prevalence are derived from estimates of incidence (for additional details, please refer to the TB incidence indicator metadata), 
combined with assumptions about the duration of disease. The prevalence of TB is calculated from the product of incidence and duration of disease: 
prevalence = incidence x duration of the condition.
The duration of disease is very difficult to measure directly. It is assumed to vary according to whether the individual receives treatment in a 
programme following the internationally recommended TB strategy or not, and whether the individual is infected with HIV. Further, durations are 
assumed to follow distributions with a large variance to account for differences between countries.
Further details are available from Tuberculosis prevalence surveys handbook (2nd edition), TB impact measurement: policy and recommendations 
for how to assess the epidemiological burden of TB and the impact of TB control and in the online technical appendix to the WHO global tuberculosis 
report.
Measurement frequency Annual
Monitoring and 
evaluation framework
Impact
Preferred data sources Population-based TB prevalence surveys/specific population surveys, TB surveillance routine facility information systems
Other possible data sources Special studies
Further information 
and related links
Definitions and reporting framework for tuberculosis – 2013 revision (WHO/HTM/TB/2013.2). Geneva: World Health Organization; 2013  
(http://www.who.int/tb/publications/definitions/en/, accessed 29 March 2015).
Global tuberculosis report 2014. Geneva: World Health Organization; 2014 (http://www.who.int/tb/publications/global_report/en/,  
accessed 29 March 2015).
Indicators for monitoring the Millennium Development Goals: definitions, rationale, concepts and sources. New York (NY): United Nations; 2012 
(http://mdgs.un.org/unsd/mi/wiki/MainPage.ashx, accessed 29 March 2015).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
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Malaria parasite prevalence among children aged 6–59 months
Abbreviated name Malaria parasite prevalence among children aged 6–59 months
Indicator name Malaria parasite prevalence among children aged 6–59 months
Domain Health status
Subdomain Infectious disease
Associated terms Morbidity
Definition Percentage of children aged 6–59 months in the population with malaria parasites in blood.
Numerator Number of children aged 6−59 months in the population with malaria parasites in blood.
Denominator Total number of children aged 6−59 months tested for malaria parasites by rapid diagnostic test or microscopy.
Disaggregation/ 
additional dimension
Age, place of residence, season (year and month), sex
Method of measurement Household survey with rapid diagnostic test or microscopy applied to all children aged 6−59 months.
Method of estimation
Measurement frequency Every 2−5 years depending on epidemiology and intervention intensity
Monitoring and 
evaluation framework
Impact
Preferred data sources Population-based surveys with parasite prevalence testing in blood
Other possible data sources Routine facility information systems with laboratory confirmation
Further information 
and related links
Household Survey Indicators for Malaria Control. Measure Evaluation/Measure DHS/President’s Malaria Initiative/Roll Back Malaria Partnership/
UNICEF/WHO. 2013 (http://www.malariasurveys.org/documents/Household%20Survey%20Indicators%20for%20Malaria%20Control.pdf,  
accessed 15 April 2015.
Roll Back Malaria Partnership/WHO. Disease surveillance for malaria control: an operations manual. Geneva: World Health Organization; 2012 
(http://www.who.int/malaria/publications/atoz/9789241503341/en/, accessed 29 March 2015).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
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Malaria incidence rate
Abbreviated name Malaria incidence rate
Indicator name Malaria incidence rate (per 1000 population)
Domain Health status
Subdomain Infectious disease
Associated terms Morbidity
Definition Number of confirmed reported malaria cases per 1000 persons per year.
Numerator Number of suspected malaria cases confirmed by either microscopy or rapid diagnostic test.
Denominator Population at risk (number of people living in areas where malaria transmission occurs).
Disaggregation/ 
additional dimension
Age, place of residence, season (year and month)
Method of measurement Confirmed by microscopy or rapid diagnostics test.
 Microscopy: The number of cases confirmed by microscopy, including both inpatients and outpatients of all ages. Also includes cases detected 
by both active and passive case detection, but excludes cases detected in the community.
 Rapid diagnostic tests: The number of cases confirmed by rapid diagnostic tests, including both inpatients and outpatients of all ages. Also 
includes cases detected by both active and passive case detection, but excludes cases that are also confirmed by microscopy or that are detected 
and confirmed by community-based programmes.
Method of estimation WHO compiles data on reported confirmed cases of malaria, submitted by the national malaria control programmes. The denominator is estimated, 
using risk mapping and population data.
Measurement frequency Annual
Monitoring and 
evaluation framework
Impact
Preferred data sources Surveillance systems
Other possible data sources
Further information 
and related links
Household Survey Indicators for Malaria Control. Measure Evaluation/Measure DHS/President’s Malaria Initiative/Roll Back Malaria Partnership/
UNICEF/WHO. 2013 (http://www.malariasurveys.org/documents/Household%20Survey%20Indicators%20for%20Malaria%20Control.pdf,  
accessed 15 April 2015.
Indicators for monitoring the Millennium Development Goals: definitions, rationale, concepts and sources. New York (NY): United Nations; 2012 
(http://mdgs.un.org/unsd/mi/wiki/MainPage.ashx, accessed 29 March 2015).
Roll Back Malaria Partnership/WHO. Disease surveillance for malaria control: an operations manual. Geneva: World Health Organization; 2012 
(http://www.who.int/malaria/publications/atoz/9789241503341/en/, accessed 29 March 2015).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
pdf?ua=1, accessed 29 March 2015).
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Cancer incidence, by type of cancer
Abbreviated name Cancer incidence, by type of cancer
Indicator name Cancer incidence rate, by type of cancer (per 100 000 population)
Domain Health status
Subdomain Noncommunicable diseases (NCDs) and Nutrition
Associated terms Morbidity
Definition Number of new cancers of a specific site/type occurring per 100 000 population.
Numerator Number of new cancer cases diagnosed in a specific year. This may include multiple primary cancers occurring in one patient. The primary site 
reported is the site of origin and not the metastatic site. In general, the incidence rate would not include recurrences.
Denominator The at-risk population for the given category of cancer. The population used depends on the rate to be calculated. For cancer sites that occur only in 
one sex, the sex-specific population (e.g. females for cervical cancer) is used.
Disaggregation/ 
additional dimension
Type (leading cancers) – e.g. breast, cervix, colon, liver, lung, prostate, stomach 
Age, place of residence, sex, socioeconomic status
Method of measurement Cancer registries.
Method of estimation (Number of new cancer cases diagnosed in a specific year)/(at-risk population for that category) × 100 000.  
If cancer registries are incomplete, adjustments need to be made.
Measurement frequency Annual
Monitoring and 
evaluation framework
Impact
Preferred data sources Population-based cancer registries which collect and classify information on all new cases of cancer in a defined population
Other possible data sources
Further information 
and related links
Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases, including a set of 
indicators. Agenda item A66/8, Sixty-sixth World Health Assembly, 20–28 May 2013. Geneva: World Health Organization; 2013  
(http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_8-en.pdf?ua=1, accessed 29 March 2015).
WHO guidelines for screening and treatment of precancerous lesions of cervical cancer prevention. Geneva: World Health Organization; 2013.
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
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Risk factors indicators
Nutrition
Exclusive breastfeeding rate 0–5 months of age
Early initiation of breastfeeding
Incidence of low birth weight among newborns
Children under 5 years who are stunted
Children under 5 years who are wasted
Anaemia prevalence in children
Anaemia prevalence in women of reproductive age
Infections
Condom use at last sex with high-risk partner
Environmental risk factors
Population using safely managed drinking-water services
Population using safely managed sanitation services
Population using modern fuels for cooking/heating/lighting
Air pollution level in cities
Noncommunicable diseases
Total alcohol per capita (age 15+ years) consumption
Tobacco use among persons aged 18+ years
Children aged under 5 years who are overweight
Overweight and obesity in adults (Also: adolescents)
Raised blood pressure among adults
Raised blood glucose/diabetes among adults
Salt intake
Insufficient physical activity in adults (Also: adolescents)
Injuries
Intimate partner violence prevalence
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Exclusive breastfeeding rate 0–5 months of age
Abbreviated name Exclusive breastfeeding rate 0–5 months of age
Indicator name Exclusive breastfeeding rate in infants 0–5 months of age 
Domain Risk factors
Subdomain NCDs and nutrition 
Associated terms Nutrition
Definition Percentage of infants 0–5 months of age (<6 months) who are fed exclusively with breast milk.
Numerator Number of infants 0−5 months of age who are exclusively breastfed.
Denominator Total number of infants 0−5 months of age surveyed.
Disaggregation/ 
additional dimension
Place of residence, sex, socio-economic status
Method of measurement Percentage of infants 0–5 months of age who received only breast milk on the previous day = (infants 0–5 months of age who received only breast 
milk during the previous day/infants 0–5 months of age) x 100. Current status data are used. Vitamins and minerals drops or medicines are not 
counted.
DHS and MICS include questions on liquids and foods given the previous day to find out if the child is being exclusively breastfed.
Method of estimation WHO and UNICEF jointly collect data on infant and young child feeding, pooling information from national surveys. The WHO Programme of 
Nutrition, Physical Activity and Obesity, at the Regional Office for Europe compiles country information on exclusive breastfeeding independently. 
Note, many developed country data refer to exclusive breastfeeding at 6 months, which provides lower estimates than the standard measure 
of exclusive breastfeeding averaged over the first six months. The two sources have been combined to display all available data on exclusive 
breastfeeding.
Predominant type of statistics: adjusted.
Measurement frequency Every 3−5 years
Monitoring and 
evaluation framework
Outcome
Preferred data sources Household surveys, specific population based surveys
Other possible data sources
Further information 
and related links
A draft framework for the global monitoring of the Comprehensive Implementation Plan on Maternal, Infant and Young Child Nutrition. Informal 
Consultation with Member States and UN Agencies on a Proposed Set of Indicators for the Global Monitoring Framework for Maternal, Infant and 
Young Child Nutrition, 30 September to 1 October 2013. Geneva: World Health Organization; 2013 (http://www.who.int/nutrition/events/2013_
consultation_indicators_globalmonitoringframework_WHO_MIYCN.pdf, accessed 29 March 2015).
Countdown to 2015. Monitoring maternal, newborn and child health: understanding key progress indicators. Geneva: World Health Organization; 
2011 (http://apps.who.int/iris/bitstream/10665/44770/1/9789241502818_eng.pdf, accessed 29 March 2015).
Every newborn: an action plan to end preventable deaths. Geneva: World Health Organization; 2014 (http://www.everynewborn.org/Documents/
Full-action-plan-EN.pdf, accessed 29 March 2015).
Indicators for assessing infant and young child feeding practices. Geneva: World Health Organization; 2008 (http://whqlibdoc.who.int/
publications/2008/9789241596664_eng.pdf, accessed 29 March 2015).
Keeping promises, measuring results. Commission on information and accountability for Women’s and Children’s Health. Geneva: World Health 
Organization; 2011 (http://www.who.int/topics/millennium_development_goals/accountability_commission/Commission_Report_advance_
copy.pdf, accessed 29 March 2015).
PEPFAR. Next Generation Indicators Reference Guide - Planning and Reporting. Version 1.2. The President’s Emergency Plan for AIDS Relief, Feb. 
2013. (http://www.pepfar.gov/documents/organization/81097.pdf).
Standard foreign assistance indicators/standard foreign assistance master indicator list (MIL). Washington (DC): United States Agency for 
International Development (http://www.state.gov/f/indicators/index.htm, accessed 26 June 2014).
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
pdf?ua=1, accessed 29 March 2015).
53
Early initiation of breastfeeding
Abbreviated name Early initiation of breastfeeding
Indicator name Early initiation of breastfeeding
Domain Risk factors
Subdomain NCDs and nutrition
Associated terms Nutrition
Definition Percentage of infants breastfed within 1 hour of birth in a specified time period.
Numerator Number of newborns breastfed within 1 hour of birth.
Denominator Number of live births in a specified time period.
Disaggregation/ 
additional dimension
Place of residence, sex, socioeconomic status
Method of measurement DHS and MICS include questions on the timing of the initiation of breastfeeding.
Method of estimation UNICEF maintains a global database (http://data.unicef.org/nutrition/iycf).
Measurement frequency Every 3−5 years
Monitoring and 
evaluation framework
Outcome
Preferred data sources Population-based health surveys
Other possible data sources
Further information 
and related links
Indicators for assessing infant and young child feeding practices. Geneva: World Health Organization; 2008  
(http://whqlibdoc.who.int/publications/2008/9789241596664_eng.pdf, accessed 29 March 2015).
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Incidence of low birth weight among newborns
Abbreviated name Incidence of low birth weight among newborns
Indicator name Incidence of low birth weight among newborns
Domain Risk factors
Subdomain Reproductive, maternal, newborn, child and adolescent health
Associated terms Nutrition
Definition Percentage of live births that weigh less than 2500 g.
Numerator Number of live-born neonates with weight less than 2500 g at birth.
Denominator Number of live births.
Disaggregation/ 
additional dimension
Place of residence, preterm status, socioeconomic status 
Method of measurement Delivery registers (hospital management and information systems – HMIS). This method provides data on the incidence of low birth weight among 
newborns delivered in health institutions.
Household surveys which collect data on birth weight (recalled by mother) and relative size of the newborn at birth allow for an adjusted value 
even where many infants are not weighed at birth.
Method of estimation The relative size at birth and recalled birth-weight data are used to estimate incidence. UNICEF maintains a global database in which adjustments 
are made using survey data (mainly DHS and MICS) and administrative estimates are used where the percentage of weighed newborns is high.
Measurement frequency Continuous
Monitoring and 
evaluation framework
Outcome
Preferred data sources Population-based health surveys and data from administrative/information systems
Other possible data sources Routine facility information systems
Further information 
and related links
A draft framework for the global monitoring of the Comprehensive Implementation Plan on Maternal, Infant and Young Child Nutrition. Informal 
Consultation with Member States and UN Agencies on a Proposed Set of Indicators for the Global Monitoring Framework for Maternal, Infant and 
Young Child Nutrition, 30 September to 1 October 2013. Geneva: World Health Organization; 2013 (http://www.who.int/nutrition/events/2013_
consultation_indicators_globalmonitoringframework_WHO_MIYCN.pdf, accessed 29 March 2015).
Countdown to 2015 decade report (2000−2010): taking stock of maternal, newborn and child survival. Geneva and New York (NY): World Health 
Organization/United Nations Children’s Fund; 2010 (http://www.countdown2015mnch.org/reports-and-articles/previous-reports/2010-decade-
report, accessed 29 March 2014).
Organisation for Economic Co-operation and Development. Health at a Glance 2013: OECD Indicators, Paris: OECD Publishing; 2013  
(http://dx.doi.org/10.1787/health_glance-2013-en, accessed 29 March 2014).
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Children under 5 years who are stunted
Abbreviated name Children under 5 years who are stunted
Indicator name Children under 5 years who are stunted (moderate and severe)
Domain Risk factors
Subdomain NCDs and nutrition
Associated terms Nutrition
Definition Percentage of stunted (moderate and severe) children aged 0–59 months (moderate = height-for-age below -2 standard deviations from the WHO 
Child Growth Standards median; severe = height-for-age below -3 standard deviations from the WHO Child Growth Standards median).
Numerator Number of children aged 0–59 months who are stunted.
Denominator Total number of children aged 0–59 months who were measured.
Disaggregation/ 
additional dimension
Age, place of residence, sex, socioeconomic status
Method of measurement Percentage of children aged < 5 years stunted for age = (number of children aged 0–59 months whose z-score falls below -2 standard deviations 
from the median height-for-age of the WHO Child Growth Standards/total number of children aged 0–59 months who were measured) x 100.
Children’s weight and height are measured using standard equipment and methods (e.g. children younger than 24 months are measured lying 
down, while standing height is measured in children aged 24 months and older).
Method of estimation WHO maintains the Global Database on Child Growth and Malnutrition, which includes population-based surveys that fulfil a set of criteria. Data 
are checked for validity and consistency and raw data-sets are analysed according to a standard procedure to obtain comparable results. Prevalence 
below and above defined cut-off points for weight-for-age, height-for-age, weight-for-height and body mass index (BMI)-for-age in pre-school 
children are presented using z-scores based on the WHO Child Growth Standards.
Predominant type of statistics: adjusted.
Measurement frequency Every 3−5 years
Monitoring and 
evaluation framework
Outcome
Preferred data sources Population-based household surveys
Other possible data sources Population-based health surveys with nutrition modules, national surveillance systems
Further information 
and related links
A draft framework for the global monitoring of the Comprehensive Implementation Plan on Maternal, Infant and Young Child Nutrition. Informal 
Consultation with Member States and UN Agencies on a Proposed Set of Indicators for the Global Monitoring Framework for Maternal, Infant and 
Young Child Nutrition, 30 September to 1 October 2013. Geneva: World Health Organization; 2013 (http://www.who.int/nutrition/events/2013_
consultation_indicators_globalmonitoringframework_WHO_MIYCN.pdf, accessed 29 March 2015).
Countdown to 2015 decade report (2000−2010): taking stock of maternal, newborn and child survival. Geneva and New York (NY): World Health 
Organization/United Nations Children’s Fund; 2010 (http://www.countdown2015mnch.org/reports-and-articles/previous-reports/2010-decade-
report, accessed 29 March 2014).
Countdown to 2015. Monitoring maternal, newborn and child health: understanding key progress indicators. Geneva: World Health Organization; 
2011 (http://apps.who.int/iris/bitstream/10665/44770/1/9789241502818_eng.pdf, accessed 29 March 2015).
Decision WHA67(9). Maternal, infant and young child nutrition. In: Sixty-seventh World Health Assembly, Geneva, 19-24 May 2014. Resolutions and 
decisions, annexes. Geneva: World Health Organization; 2014 (http://apps.who.int/gb/ebwha/pdf_files/WHA67-REC1/A67_2014_REC1-en.pdf, 
page 62, accessed 29 March 2015).
Document A67/15. Maternal, infant and young child nutrition. The Global Strategy and the Comprehensive Implementation Plan. Report by the 
Secretariat. Sixty-seventh World Health Assembly, Geneva, 19–24 May 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/gb/
ebwha/pdf_files/WHA67/A67_15-en.pdf, accessed 29 March 2015).
Keeping promises, measuring results. Commission on information and accountability for Women’s and Children’s Health. Geneva: World Health 
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copy.pdf, accessed 29 March 2015).
Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. Geneva: World Health Organization; 1995  
(WHO Technical Report Series, No. 854).
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and development. Geneva: World Health Organization; 2006 (http://www.who.int/childgrowth/standards/technical_report/en/, accessed 29 March 
2015).
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
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Children under 5 years who are wasted
Abbreviated name Children under 5 years who are wasted
Indicator name Children under 5 years who are wasted (moderate and severe)
Domain Risk factors
Subdomain NCDs and nutrition
Associated terms Nutrition
Definition Percentage of wasted (moderate and severe) children aged 0–59 months (moderate = weight-for-height below -2 standard deviations of the WHO 
Child Growth Standards median; severe = weight-for-height below -3 standard deviations of the WHO Child Growth Standards median).
Numerator Number of children aged 0–59 months who are wasted.
Denominator Total number of children aged 0–59 months.
Disaggregation/ 
additional dimension
Age, place of residence, sex, socioeconomic status
Method of measurement Percentage of children aged < 5 years wasted = (number of children aged 0–59 months whose z-score falls below -2 standard deviations from the 
median weight-for-height of the WHO Child Growth Standards/total number of children aged 0–59 months who were measured) x 100.
Children’s weight and height are measured using standard equipment and methods (e.g. children under 24 months are measured lying down, while 
standing height is measured in children aged 24 months and older.
Method of estimation WHO maintains the Global Database on Child Growth and Malnutrition, which includes population-based surveys that fulfil a set of criteria. Data 
are checked for validity and consistency and raw data sets are analysed according to a standard procedure to obtain comparable results. Prevalence 
below and above defined cut-off points for weight-for-age, height-for-age, weight-for-height and BMI-for-age, in pre-school children are 
presented using z-scores based on the WHO Child Growth Standards. 
A detailed description of the methodology and procedures of the database – including data sources, criteria for inclusion, data quality control and 
database workflow – are described in a paper published in 2003 in the International Journal of Epidemiology (de Onis M, Blössner M).
Measurement frequency Every 3−5 years
Monitoring and 
evaluation framework
Outcome
Preferred data sources National nutrition surveys
Other possible data sources Population-based health surveys with nutrition modules, national surveillance systems
Further information 
and related links
A draft framework for the global monitoring of the Comprehensive Implementation Plan on Maternal, Infant and Young Child Nutrition. Informal 
Consultation with Member States and UN Agencies on a Proposed Set of Indicators for the Global Monitoring Framework for Maternal, Infant and 
Young Child Nutrition, 30 September to 1 October 2013. Geneva: World Health Organization; 2013 (http://www.who.int/nutrition/events/2013_
consultation_indicators_globalmonitoringframework_WHO_MIYCN.pdf, accessed 29 March 2015).
Countdown to 2015 decade report (2000−2010): taking stock of maternal, newborn and child survival. Geneva and New York (NY): World Health 
Organization/United Nations Children’s Fund; 2010 (http://www.countdown2015mnch.org/reports-and-articles/previous-reports/2010-decade-
report, accessed 29 March 2014).
de Onis M, Blössner M. The World Health Organization Global Database on Child Growth and Malnutrition: methodology and applications. Int J 
Epidemiol 2003;32(4):518-26.
Decision WHA67(9). Maternal, infant and young child nutrition. In: Sixty-seventh World Health Assembly, Geneva, 19-24 May 2014. Resolutions and 
decisions, annexes. Geneva: World Health Organization; 2014 (http://apps.who.int/gb/ebwha/pdf_files/WHA67-REC1/A67_2014_REC1-en.pdf, 
page 62, accessed 29 March 2015).
Document A67/15. Maternal, infant and young child nutrition. The Global Strategy and the Comprehensive Implementation Plan. Report by the 
Secretariat. Sixty-seventh World Health Assembly, Geneva, 19–24 May 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/gb/
ebwha/pdf_files/WHA67/A67_15-en.pdf, accessed 29 March 2015).
Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. Geneva: World Health Organization; 1995  
(WHO Technical Report Series, No. 854).
WHO child growth standards: Length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: Methods 
and development. Geneva: World Health Organization; 2006 (http://www.who.int/childgrowth/standards/technical_report/en/, accessed 29 March 
2015).
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
pdf?ua=1, accessed 29 March 2015).
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Anaemia prevalence in children
Abbreviated name Anaemia prevalence in children
Indicator name Prevalence of anaemia in children aged 6–59 months 
Domain Risk factors
Subdomain NCDs and nutrition
Associated terms Nutrition
Definition Percentage of children aged 6−59 months with a haemoglobin level of less than 110 g/L, adjusted for altitude.
Numerator Number of children aged 6−59 months with a haemoglobin level of less than 110 g/L, adjusted for altitude.
Denominator Total number of children aged 6−59 months who had haemoglobin levels obtained during the survey.
Disaggregation/ 
additional dimension
Method of measurement Age, place of residence, sex, socioeconomic status 
Also: haemoglobin levels less than 70 g/L (severe anaemia)
Method of estimation
Measurement frequency Every 3−5 years
Monitoring and 
evaluation framework
Outcome
Preferred data sources Population-based health surveys
Other possible data sources
Further information 
and related links
A draft framework for the global monitoring of the Comprehensive Implementation Plan on Maternal, Infant and Young Child Nutrition. Informal 
Consultation with Member States and UN Agencies on a Proposed Set of Indicators for the Global Monitoring Framework for Maternal, Infant and 
Young Child Nutrition, 30 September to 1 October 2013. Geneva: World Health Organization; 2013 (http://www.who.int/nutrition/events/2013_
consultation_indicators_globalmonitoringframework_WHO_MIYCN.pdf, accessed 29 March 2015). 
Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva: 
World Health Organization; 2011 (http://www.who.int/vmnis/indicators/haemoglobin.pdf, accessed 29 March 2015).
Household Survey Indicators for Malaria Control. Measure Evaluation/Measure DHS/President’s Malaria Initiative/Roll Back Malaria Partnership/
UNICEF/WHO. 2013 (http://www.malariasurveys.org/documents/Household%20Survey%20Indicators%20for%20Malaria%20Control.pdf,  
accessed 15 April 2015.
Roll Back Malaria Partnership/WHO. Disease surveillance for malaria control: an operations manual. Geneva: World Health Organization; 2012 
(http://www.who.int/malaria/publications/atoz/9789241503341/en/, accessed 29 March 2015).
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Anaemia prevalence in women of reproductive age
Abbreviated name Anaemia prevalence in women of reproductive age
Indicator name Anaemia prevalence in women of reproductive age
Domain Risk factors
Subdomain NCDs and nutrition
Associated terms Nutrition
Definition Percentage of women aged 15−49 years with a haemoglobin level less than 120 g/L for non-pregnant women and lactating women, and less than 
110 g/L for pregnant women, adjusted for altitude and smoking.
Numerator Number of women aged 15−49 years with haemoglobin levels below the indicated cut-off, adjusted for altitude and smoking.
Denominator Total number of women aged 15−49 years with haemoglobin levels assessed during a specified period.
Disaggregation/ 
additional dimension
Age, place of residence, reproductive status (pregnant, lactating), socioeconomic status 
Also: haemoglobin levels less than 80 g/L for non-pregnant women and lactating women, and less than 70 g/L for pregnant women (severe anaemia)
Method of measurement
Method of estimation
Measurement frequency Every 3−5 years
Monitoring and 
evaluation framework
Outcome
Preferred data sources Population-based health surveys
Other possible data sources
Further information 
and related links
A draft framework for the global monitoring of the Comprehensive Implementation Plan on Maternal, Infant and Young Child Nutrition. Informal 
Consultation with Member States and UN Agencies on a Proposed Set of Indicators for the Global Monitoring Framework for Maternal, Infant and 
Young Child Nutrition, 30 September to 1 October 2013. Geneva: World Health Organization; 2013 (http://www.who.int/nutrition/events/2013_
consultation_indicators_globalmonitoringframework_WHO_MIYCN.pdf, accessed 29 March 2015). 
Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development beyond 2014. 
Report of the Secretary-General. New York (NY): United Nations; 2014 (https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/
Framework%20of%20action%20for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf, accessed 19 August 2014). 
Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva: 
World Health Organization; 2011 (http://www.who.int/vmnis/indicators/haemoglobin.pdf, accessed 29 March 2015).
59
Condom use at last sex with high-risk partner
Abbreviated name Condom use at last sex with high-risk partner
Indicator name Condom use at last sex with high-risk partner
Domain Risk factors
Subdomain Infectious disease
Associated terms Infections
Definition Percentage using a condom during last sexual intercourse with a higher-risk partner (women and men who have more than one sexual partner 
in the past 12 months; sex workers with most recent client; men who have sex with men anal sex with a male partner; people who inject drugs 
condom use at last sex). For people who inject drugs, also measure number of needles per person who injects drugs per year.
Numerator
Denominator
Disaggregation/ 
additional dimension
Age (15−24, 15−49 years), sex  
Sex workers: by sex (F/M/transgender) age (< 25/25+ years)  
Men who have sex with men: age (< 25/25+ years) 
People who inject drugs: sex, age (< 25/25+ years)
Method of measurement Population-based surveys for general population; Surveys targeting key populations such as IBBS.
Method of estimation
Measurement frequency
Monitoring and 
evaluation framework
Outcome
Preferred data sources Surveys
Other possible data sources
Further information 
and related links
The Demographic and Health Surveys Program. Washington (DC): United States Agency for International Development  
(http://www.dhsprogram.com/, accessed 29 March 2015). 
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Population using safely managed drinking-water services
Abbreviated name Population using safely managed drinking-water services
Indicator name Percentage of population using safely managed drinking-water services
Domain Risk factors
Subdomain Environment
Associated terms Environmental risk factors
Definition Population using a basic drinking-water source (piped water into dwelling, yard or plot; public taps or standpipes; boreholes or tubewells; protected dug wells; 
protected springs and rainwater) which is located on premises and available when needed; free of faecal (and priority chemical) contamination and/or regulated 
by a competent authority.
Numerator Population using safely managed drinking-water services
Denominator Total population
Disaggregation/ 
additional dimension
Place of residence (urban/rural), socioeconomic status (wealth, affordability etc.)
Method of measurement The indicator is computed as the ratio of the number of people who use a safely managed drinking-water service, urban and rural, expressed as a percentage. 
Data from household surveys or censuses provide information on the types of basic drinking-water sources listed above. Such data will be combined with water 
quality data from direct testing of water quality at the household level as well as data from administrative records or regulatory frameworks for various aspects of 
safe management. The percentage of the total population using a safely managed drinking-water service is the population-weighted average of the previous two 
numbers. Access to water and sanitation are considered core socioeconomic and health indicators and key determinants of, inter alia, child survival, maternal and 
children’s health, family well-being and economic productivity. Additionally, the use of drinking-water sources and sanitation facilities is part of the wealth index 
used by household surveys to divide the population into wealth quintiles. As a result, most nationally representative household surveys include information about 
basic water and sanitation. The survey questions and response categories pertaining to access to basic drinking-water sources are fully harmonized between 
DHS and MICS and are adopted from the standard questionnaire promoted for inclusion in survey instruments by the WHO/UNICEF Joint Monitoring Programme 
on Water Supply and Sanitation. This can be accessed via www.wssinfo.org. Administrative data on faecal and chemical contamination, and regulation by 
appropriate authorities, will be collected by JMP through consultation with the government departments responsible for drinking-water supply and regulation. 
Method of estimation The Joint Monitoring Programme on Water Supply and Sanitation assembles, reviews and assesses data collected by national statistics offices and other relevant 
institutions through nationally representative household surveys and national censuses. 
For each country, data on use of basic drinking-water sources from surveys and censuses are plotted on a timescale from 1980 to the present. A linear trend line, 
based on the least-squares method, is drawn through these data points to provide estimates of use of basic drinking-water sources for all years between 1990 
and the present year (wherever possible). This is based on the MDG baseline year of 1990, and therefore will be modified based on the agreed baseline for the 
SDGs. Estimates of faecal and chemical contamination, and regulation by appropriate authorities, will be collected from countries and used to adjust the data on 
use of basic drinking-water sources as needed.
Population data used, including the proportion of the population living in urban and rural areas, are those established by the United Nations Population Division.
Predominant type of statistics: adjusted and predicted.
Measurement frequency Biennial
Monitoring and 
evaluation framework
Outcome
Preferred data sources Household surveys, population census, data from administrative sources or regulatory frameworks.
Other possible data sources
Further information 
and related links
A post-2015 Global Goal for Water: synthesis of key findings and recommendations from UN-Water. New York (NY): United Nations; 2014  
(http://www.unwater.org/fileadmin/user_upload/unwater_new/docs/Topics/UN-Water_paper_on_a_Post-2015_Global_Goal_for_Water.pdf,  
accessed 29 March 2015).
A statistical note: proposal for indicator monitoring framework for WaSH, and wastewater targets under the SDGs. Geneva: World Health Organization; 2015 
(http://unstats.un.org/unsd/post-2015/activities/egm-on-indicator-framework/docs/Statistical%20note%20on%20Water%20for%20UNSC%20final%20
25Feb2015.pdf, accessed 23 April 2015).
Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development beyond 2014. Report of the 
Secretary-General. New York (NY): United Nations; 2014 (https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/Framework%20of%20action%20
for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf, accessed 19 August 2014).
Guidelines for drinking-water quality, fourth edition. Geneva: World Health Organization; 2011
(http://www.who.int/water_sanitation_health/publications/2011/dwq_guidelines/en/, accessed 29 March 2015).
WASH targets and indicators post-2015: recommendations from international consultations. Geneva: Water Supply and Sanitation Collaborative Council;  
2014 (http://www.wssinfo.org/fileadmin/user_upload/resources/post-2015-WASH-targets-factsheet-12pp.pdf, accessed 29 March 2015).
WHO/UNICEF. Progress on drinking-water and sanitation − 2014 update. Geneva: World Health Organization; 2014 (http://www.wssinfo.org/fileadmin/user_
upload/resources/JMP_report_2014_webEng.pdf, accessed 29 March 2015).
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Population using safely managed sanitation services
Abbreviated name Population using safely managed sanitation services
Indicator name Percentage of population using safely managed sanitation services
Domain Risk factors
Subdomain Environment
Associated terms Environmental risk factors
Definition Population using a basic sanitation facility (flush or pour-flush toilets to sewer systems, septic tanks or pit latrines, ventilated improved pit latrines, pit latrines 
with a slab, and composting toilets) which is not shared with other households and where excreta are safely disposed in situ (e.g. in a sealed latrine pit until 
they are safe to handle and re-use, such as an agricultural input ) or transported to a designated place for safe disposal or treatment (e.g. treatment facility 
or hygienically collected from septic tanks or pit latrines by a suction truck or similar equipment that limits human contact and thereafter transported to a 
designated location such as a treatment facility or solid waste collection site). 
Numerator Population using safely managed sanitation services
Denominator Total population
Disaggregation/ 
additional dimension
Place of residence (urban/rural), socioeconomic status (wealth, affordability etc.)
Method of measurement The percentage of the population using basic sanitation facilities is computed as the ratio of the number of people who use a basic sanitation facility, urban 
and rural, expressed as a percentage. Data from household surveys or censuses provide information on types of basic sanitation facilities listed above. Such 
data will be combined with data from administrative records or regulatory frameworks for various aspects of safe management. The percentage of the 
total population using an improved sanitation facility is the population weighted average of the previous two numbers. Access to water and sanitation are 
considered core socioeconomic and health indicators and key determinants of, inter alia, child survival, maternal and children’s health, family well-being and 
economic productivity. Additionally the use of drinking-water sources and sanitation facilities is part of the wealth index used by household surveys to divide 
the population into wealth quintiles. As a result, most nationally representative household surveys include information about basic water and sanitation. The 
survey questions and response categories pertaining to access to basic sanitation facilities are fully harmonized between DHS and MICS and are adopted from 
the standard questionnaire promoted for inclusion in survey instruments by the WHO/UNICEF Joint Monitoring Programme on Water Supply and Sanitation. This 
can be accessed via www.vwssinfo.org. The percentage of the population using different types of basic sanitation facilities will be adjusted with estimates of the 
proportion of faecal waste which is safely disposed in situ or transported to a designated place for safe disposal or treatment.
Method of estimation The Joint Monitoring Programme on Water Supply and Sanitation assembles, reviews and assesses data collected by national statistics offices and other relevant 
institutions through nationally representative household surveys and national censuses. 
For each country, survey and census data are plotted on a timescale from 1980 to the present. A linear trend line, based on the least-squares method, is drawn 
through these data points to provide estimates for all years between 1990 and the present year (wherever possible). This is based on the MDG baseline year of 
1990, and therefore will be modified based on the agreed baseline for the SDGs. Estimates of excreta management, and regulation by appropriate authorities, 
will be collected from countries and used to adjust the data on use of basic sanitation facilities as needed. Administrative, population (including population 
density) and environmental data can be combined to estimate safe disposal or transport of excreta, when no country data are available. Excreta management 
will initially be estimated globally and regionally, and progressively at country level.
Population data used, including the proportion of the population living in urban and rural areas, are those established by the United Nations Population Division. 
Predominant type of statistics: estimated and predicted.
Measurement frequency Biennial
Monitoring and 
evaluation framework
Outcome
Preferred data sources Household surveys, population census, data from administrative sources or regulatory frameworks.
Other possible data sources
Further information 
and related links
A post-2015 Global Goal for Water: synthesis of key findings and recommendations from UN-Water. New York (NY): United Nations; 2014 (http://www.unwater.
org/fileadmin/user_upload/unwater_new/docs/Topics/UN-Water_paper_on_a_Post-2015_Global_Goal_for_Water.pdf, accessed 29 March 2015).
A statistical note: proposal for indicator monitoring framework for WaSH, and wastewater targets under the SDGs. Geneva: World Health Organization; 2015 
(http://unstats.un.org/unsd/post-2015/activities/egm-on-indicator-framework/docs/Statistical%20note%20on%20Water%20for%20UNSC%20final%20
25Feb2015.pdf, accessed 23 April 2015).
Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development beyond 2014. Report of 
the Secretary-General. New York (NY): United Nations; 2014 (https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/Framework%20of%20
action%20for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf, accessed 19 August 2014).
WASH targets and indicators post-2015: recommendations from international consultations. Geneva: Water Supply and Sanitation Collaborative Council; 2014 
(http://www.wssinfo.org/fileadmin/user_upload/resources/post-2015-WASH-targets-factsheet-12pp.pdf, accessed 29 March 2015).
WHO/UNICEF. Progress on drinking-water and sanitation − 2014 update. Geneva: World Health Organization; 2014 (http://www.wssinfo.org/fileadmin/
user_upload/resources/JMP_report_2014_webEng.pdf, accessed 29 March 2015).
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Population using modern fuels for cooking/heating/lighting
Abbreviated name Population using modern fuels for cooking/heating/lighting
Indicator name Population using modern fuels and technologies for cooking/heating/lighting (indoor air)
Domain Risk factors
Subdomain Environment
Associated terms Environmental risk factors
Definition Percentage of households/population using modern fuels and technologies for cooking/heating/lighting as defined by the recommendations set 
forth in the WHO guidelines for indoor air quality: household fuel combustion. 
Numerator Number of households (population) using modern fuels and technologies for cooking/heating/lighting.
Denominator Total number of households (population).
Disaggregation/ 
additional dimension
Place of residence, sex, socioeconomic status  
Fuel type, end use (i.e. cooking, heating, lighting)
Method of measurement The indicator is calculated as the number of people using modern fuels and technologies divided by the total population, expressed as a percentage. 
Data on the use of fuels and technologies for different end uses (e.g. cooking, heating, lighting) are routinely collected at national and subnational 
levels in most countries using censuses and surveys. Currently, modern fuels exclude solid fuels and kerosene. For the purpose of estimating the 
health impacts, it is recommended to monitor the use of kerosene also as a separate category.
Method of estimation The indicator is modelled with household survey data compiled by WHO. The information on cooking fuel use and cooking practices from more than 
700 nationally representative data sources, such as those listed above, is used in combination with the most recent survey data available on heating 
and lighting fuels and technologies. 
Unless stated otherwise, estimates for cooking using modern fuels and technologies for the total (urban and rural) population for a given year were 
obtained separately using a multilevel model. The model accounts only for regions, countries and time as a spline function, and estimates were 
restricted to values ranging from zero to one. All analyses were conducted using STATA software (version 12, StataCorp LP, College Station, TX, USA). 
Estimates for countries with no available surveys were obtained as follows: When no information on the fuels and technologies use in the home 
was available for the country, the regional population-weighted mean was used. Note that this approach was also applied to Equatorial Guinea 
instead of the one used for high-income countries (see below); Countries classified as high-income with a Gross National Income (GNI) of more than 
US$ 12 616 per capita (The World Bank, http://data.worldbank.org/about/country-classifications, accessed July 2013) are assumed to have made a 
complete transition to using modern fuels and technologies as the primary source of domestic energy for cooking and heating, and solid fuel use is 
reported to be less than 5%.
Measurement frequency Every 3−5 years
Monitoring and 
evaluation framework
Outcome
Preferred data sources Household surveys, population census
Other possible data sources Other sources, including estimation and modelling
Further information 
and related links
Bonjour S, Adair-Rohani H, Wolf J, Bruce NG, Mehta S, Prüss-Ustün A et al. Solid fuel use for household cooking: country and regional estimates for 
1980–2010. Environ Health Perspect. 2013;121(7):784–90).
Indoor air quality guidelines: household fuel combustion. Geneva: World Health Organization; 2014 [in press] (http://www.who.int/indoorair/
publications/household-fuel-combustion/en/, accessed 29 March 2015).
Rehfuess E, Mehta S, Prüss-Üstün A. Assessing household solid fuel use: multiple implications for the Millennium Development Goals. Environ 
Health Perspect. 2006;114(3):373−8).
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
pdf?ua=1, accessed 29 March 2015).
63
Air pollution level in cities
Abbreviated name Air pollution level in cities
Indicator name Air pollution level in cities (particulate matter [PM])
Domain Risk factors
Subdomain Environment
Associated terms Environmental risk factors
Definition Annual mean concentration of particulate matter of less than 2.5 microns of diameter (PM2.5) [ug/m3] (or of less than 10 microns [PM10]  
if PM2.5 is not available) in cities
Numerator
Denominator
Disaggregation/ 
additional dimension
Method of measurement The mean annual concentration of fine suspended particles of less than 10 or 2.5 microns in diameters is a common measure of air pollution. The 
mean city concentration is based on daily measurements, or data which could be aggregated into annual means. In the absence of annual means, 
measurements covering a more limited period of the year can exceptionally be used (provided that data are largely representative for the annual 
mean exposure). 
Method of estimation Annual means represent an average of the cities’ monitoring stations. The average can be population-weighted if stations are representative for 
certain parts of the city. In order to present air quality that is largely representative for human exposure, urban measurement characterized as 
urban background, residential areas, commercial and mixed areas should be used. Stations characterized as particular “hot spots” or exclusively 
industrial areas are generally not included, unless their levels are representative for people’s exposures. This selection should be in line with the aim 
of capturing representative values for human exposure. The location of hot spots, often measured for the purpose of capturing the cities’ maximum 
values and industrial areas, are often deemed less likely to be representative for the mean exposure of a significant part of a city’s population. “Hot 
spots” are either designated as such by the original reports, or are qualified as such due to their exceptional nature (e.g. exceptionally busy roads 
etc.). Omitting them may also lead to an underestimation of the mean air pollution levels of a city.
Annual mean PM2.5 data can be estimated, when not available, on the basis of PM10. Conversion factors PM2.5/PM10 may vary according to 
location, and should, if possible, be taken from other stations which measure both PM2.5 and PM10 in the city or country, or by default from the 
region. They should be considered as approximate only. The converted value for individual cities may deviate from the actual value (generally 
between 0.3 and 0.8).
Measurement frequency
Monitoring and 
evaluation framework
Outcome
Preferred data sources National/subnational/monitoring reports and web sites containing measurements of PM10 or PM2.5 and relevant national agencies
Other possible data sources Data from research projects/articles from peer reviewed journals, Development agencies, UN Agencies
Further information 
and related links
WHO Air quality guidelines for particulate matter, ozone, nitrogen dioxide and sulfur dioxide: Global update 2005. Geneva: World Health 
Organization; 2014 (http://www.who.int/phe/health_topics/outdoorair/outdoorair_aqg/en/, accessed 06 May 2015).
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Total alcohol per capita (age 15+ years) consumption
Abbreviated name Total alcohol per capita (age 15+ years) consumption
Indicator name Total alcohol per capita (age 15+ years) consumption 
Domain Risk factors
Subdomain NCDs and nutrition
Associated terms Noncommunicable diseases
Definition Total alcohol per capita is the total amount (sum of recorded alcohol per capita three-year average and unrecorded alcohol per capita) of alcohol 
consumed per adult (15+ years) in a calendar year, in litres of pure alcohol. Recorded alcohol consumption refers to official statistics (production, 
import, export, and sales or taxation data), while unrecorded alcohol consumption refers to alcohol which is not taxed and is outside the usual 
system of government control. In circumstances in which the number of tourists per year is at least the number of inhabitants, tourist consumption 
is also taken into account and is deducted from a country's recorded alcohol per capita.
Numerator Sum of recorded and unrecorded alcohol consumed in a population during a calendar year, in litres.
Denominator Mid-year resident population aged 15+ for the same calendar year.
Disaggregation/ 
additional dimension
Age, sex, other relevant sociodemographic stratifiers where available
Method of measurement Recorded consumption: Recorded alcohol per capita (15+ years) consumption of pure alcohol is calculated as the sum of beverage-specific alcohol 
consumption of pure alcohol (beer, wine, spirits, other) from different sources. The first priority in the decision tree is given to government statistics, 
the second are country-specific alcohol industry statistics in the public domain (Canadian, IWSR-International Wine and Spirit Research, OIV-
International Organisation of Vine and Wine, Wine Institute, historically World Drink Trends), and third is the Food and Agriculture Organization of 
the United Nations’ statistical database (FAOSTAT). For countries where the data source is FAOSTAT, unrecorded consumption may be included in the 
recorded consumption.
Unrecorded consumption: The first priority in the decision tree is given to nationally representative empirical data, often from general population 
surveys in countries where alcohol is legal. The second priority are specific other empirical investigations, while the third is expert opinion.
Method of estimation Sum of recorded and unrecorded alcohol consumed in a population during a calendar year.
Measurement frequency Annual
Monitoring and 
evaluation framework
Outcome
Preferred data sources Administrative reporting systems for recorded alcohol per capita, and survey data for unrecorded alcohol per capita. The priority of data sources for 
recorded alcohol per capita consumption should be given to government statistics on sales of alcoholic beverages during a calendar year or data 
on production, export and import of alcohol in different beverage categories. For countries where government data on sales or production are not 
available, the preferred data source would be country-specific and publicly available data from the private sector, including alcohol producers, 
or country-specific data from FAOSTAT which may also include estimates of unrecorded alcohol consumption. For main categories of alcoholic 
beverages, “beer” includes malt beers, “wine” includes wine made from grapes, “spirits” include all distilled beverages, and “other” includes one or 
several other alcoholic beverages – such as fermented beverages made from sorghum, maize, millet, rice, or cider, fruit wine, fortified wine, etc. 
Data sources for unrecorded alcohol consumption include survey data, FAOSTAT data, other data sources such as customs or police data, and expert 
opinion.
Other possible data sources Data sets of FAO and United Nations Statistics Division
Further information 
and related links
Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases, including  
a set of indicators. Agenda item A66/8, Sixty-sixth World Health Assembly, 20–28 May 2013. Geneva: World Health Organization; 2013  
(http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_8-en.pdf?ua=1, accessed 29 March 2015).
Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization; 2009  
(http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf, accessed 29 March 2015).
Global strategy to reduce the harmful use of alcohol. Geneva: World Health Organization; 2010 (http://www.who.int/substance_abuse/
alcstratenglishfinal.pdf?ua=1, accessed 29 March 2015).
Rehm J, Baliunas D, Borges GL, Graham K, Irving H, Kehoe T et al. The relation between different dimensions of alcohol consumption and  
burden of disease - an overview. Addiction. 2010;105(5):817−43.
65
Tobacco use among persons aged 18+ years
Abbreviated name Tobacco use among persons aged 18+ years
Indicator name Age-standardized prevalence of current tobacco use among persons aged 18+ years
Domain Risk factors
Subdomain NCDs and nutrition
Associated terms Noncommunicable diseases
Definition Age-standardized prevalence of current tobacco use among persons aged 18+ years. “Smoked tobacco products” include the consumption of 
cigarettes, bidis, cigars, cheroots, pipes, shisha (water pipes), fine-cut smoking articles (roll-your-own), krekets, and any other form of smoked 
tobacco.
“Smokeless tobacco” includes moist snuff, plug, creamy snuff, dissolvables, dry snuff, gul, loose leaf, red tooth powder, snus, chimo, gutkha, khaini, 
gudakhu, zarda, quiwam, dohra, tuibur, nasway, naas/naswar, shammah, betel quid, toombak, pan (betel quid), iq’mik, mishri, tapkeer, tombol and 
any other tobacco product that is sniffed, held in the mouth, or chewed.
Numerator Number of current tobacco users aged 18+ years. “Current users” include both daily and non-daily users of smoked or smokeless tobacco.
Denominator All respondents of the survey aged 18+ years.
Disaggregation/ 
additional dimension
Age, sex, other relevant sociodemographic stratifiers where available
Method of measurement
Method of estimation Number of respondents aged 18+ years currently using any tobacco product (smoked or smokeless)/(number of survey respondents aged  
18+ years) x 100.
Measurement frequency At least every 5 years
Monitoring and 
evaluation framework
Outcome
Preferred data sources Population-based (preferably nationally representative) survey
Other possible data sources
Further information 
and related links
Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases, including a  
set of indicators. Agenda item A66/8, Sixty-sixth World Health Assembly, 20–28 May 2013. Geneva: World Health Organization; 2013  
(http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_8-en.pdf?ua=1, accessed 29 March 2015).
Global estimate of the burden of disease from second-hand smoke. Geneva: World Health Organization; 2010.
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Children aged under 5 years who are overweight
Abbreviated name Children aged under 5 years who are overweight
Indicator name Children aged under 5 years who are overweight
Domain Risk factors
Subdomain NCDs and nutrition
Associated terms Noncommunicable diseases
Definition Prevalence of weight-for-height in children aged 0–59 months defined as above +2 standard deviations of the WHO Child Growth Standards median 
Numerator Number of children aged 0–59 months who are overweight.
Denominator Total number of children aged 0–59 months who were measured.
Disaggregation/ 
additional dimension
Age, place of residence, sex, socioeconomic status
Method of measurement Percentage of children aged < 5 years who are overweight for age = (number of children aged 0–59 months whose z-score is over two standard 
deviations above the median weight-for-height of the WHO Child Growth Standards/total number of children aged 0–59 months who were measured) x 
100. 
Children’s weight and height are measured using standard technology (e.g. children under 24 months are measured lying down, while standing height is 
measured in children 24 months and older.
The data sources include national nutrition surveys, any other nationally representative population-based surveys with nutrition modules, and national 
surveillance systems.
Method of estimation WHO maintains the Global Database on Child Growth and Malnutrition, which includes population-based surveys that fulfil a set of criteria. Data are 
checked for validity and consistency and raw data-sets are analysed according to a standard procedure to obtain comparable results. Prevalence below 
and above defined cut-off points for weight-for-age, height-for-age, weight-for-height and BMI-for-age in pre-school children are presented using 
z-scores based on the WHO Child Growth Standards. 
A detailed description of the methodology and procedures of the database – including data sources, criteria for inclusion, data quality control and 
database workflow – are described in a paper published in 2003 in the International Journal of Epidemiology (de Onis M, Blössner M).
Predominant type of statistics: adjusted.
Measurement frequency Every 3−5 years
Monitoring and 
evaluation framework
Outcome
Preferred data sources National nutrition surveys
Other possible data sources Population-based health surveys with nutrition modules, national surveillance systems
Further information 
and related links
A draft framework for the global monitoring of the Comprehensive Implementation Plan on Maternal, Infant and Young Child Nutrition. Informal 
Consultation with Member States and UN Agencies on a Proposed Set of Indicators for the Global Monitoring Framework for Maternal, Infant and Young 
Child Nutrition, 30 September to 1 October 2013. Geneva: World Health Organization; 2013 (http://www.who.int/nutrition/events/2013_consultation_
indicators_globalmonitoringframework_WHO_MIYCN.pdf, accessed 29 March 2015).
de Onis M, Blössner M. The World Health Organization Global Database on Child Growth and Malnutrition: methodology and applications. Int J Epidemiol 
2003;32(4):518-26.
Decision WHA67(9). Maternal, infant and young child nutrition. In: Sixty-seventh World Health Assembly, Geneva, 19-24 May 2014. Resolutions and 
decisions, annexes. Geneva: World Health Organization; 2014 (http://apps.who.int/gb/ebwha/pdf_files/WHA67-REC1/A67_2014_REC1-en.pdf, page 
62, accessed 29 March 2015).
Document A67/15. Maternal, infant and young child nutrition. The Global Strategy and the Comprehensive Implementation Plan. Report by the 
Secretariat. Sixty-seventh World Health Assembly, Geneva, 19–24 May 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/gb/ebwha/
pdf_files/WHA67/A67_15-en.pdf, accessed 29 March 2015).
Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases, including a set of indicators. 
Agenda item A66/8, Sixty-sixth World Health Assembly, 20–28 May 2013. Geneva: World Health Organization; 2013 (http://apps.who.int/gb/ebwha/
pdf_files/WHA66/A66_8-en.pdf?ua=1, accessed 29 March 2015).
Organisation for Economic Co-operation and Development. Health at a Glance 2013: OECD Indicators, Paris: OECD Publishing; 2013 (http://dx.doi.
org/10.1787/health_glance-2013-en, accessed 29 March 2014).
WHO child growth standards: Length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: Methods and 
development. Geneva: World Health Organization; 2006 (http://www.who.int/childgrowth/standards/technical_report/en/, accessed 29 March 2015).
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
pdf?ua=1, accessed 29 March 2015).
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Overweight and obesity in adults
Overweight and obesity in adults (Also: adolescents)
Abbreviated name Overweight and obesity in adults (Also: adolescents)
Indicator name Age-standardized prevalence of overweight and obesity in persons aged 18+ years
Domain Risk factors
Subdomain NCDs and nutrition
Associated terms Noncommunicable diseases
Definition Percentage of adults (18+ years) who are overweight (defined as having a BMI ≥ 25 kg/m²) and obese (defined as having a BMI ≥ 30 kg/m²).
Numerator Number of respondents aged 18+ years who are overweight. Number of respondents aged 18+ years who are obese.
BMI is calculated by dividing weight in kilograms by height in meters squared. Overweight is defined as having a BMI ≥ 25 kg/m² and obesity is 
defined as having a BMI ≥ 30 kg/m².
Denominator All respondents of the survey aged 18+ years.
Disaggregation/ 
additional dimension
Age, sex, other relevant sociodemographic stratifiers where available 
Also: Overweight and obesity in adolescents.  
Note: In adolescents the definitions of overweight and obesity vary by age and gender. The prevalence of overweight is defined as the percentage 
of adolescents with sex-specific BMI-for-age above +1 SD from the WHO 2007 growth reference median, and the prevalence of obesity as the 
percentage of adolescents with sex-specific BMI-for-age above +2 SD from the WHO 2007 growth reference median.
Method of measurement
Method of estimation (Number of survey respondents aged 18+ years who are overweight)/(number of survey respondents aged 18+ years) x 100. 
(Number of survey respondents aged 18+ years who are obese)/(number of survey respondents aged 18+ years) x 100.
Measurement frequency At least every five years
Monitoring and 
evaluation framework
Outcome
Preferred data sources Population-based (preferably nationally representative) survey in which height and weight were measured
Other possible data sources
Further information 
and related links
de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and 
adolescents. Bull World Health Organ. 2007;85:660−7 (http://www.who.int/growthref/growthref_who_bull/en/, accessed 29 March 2015).
Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases, including a set of 
indicators. Agenda item A66/8, Sixty-sixth World Health Assembly, 20–28 May 2013. Geneva: World Health Organization; 2013  
(http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_8-en.pdf?ua=1, accessed 29 March 2015).
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Raised blood pressure among adults
Abbreviated name Raised blood pressure among adults
Indicator name Age-standardized prevalence of raised blood pressure among persons aged 18+ years 
Domain Risk factors
Subdomain NCDs and nutrition
Associated terms Noncommunicable diseases
Definition Age-standardized prevalence of raised blood pressure among persons aged 18+ years (defined as systolic blood pressure ≥ 140 mmHg and/or 
diastolic blood pressure ≥ 90 mmHg), and mean systolic blood pressure. 
Numerator Number of respondents with systolic blood pressure ≥ 140mmHg or diastolic blood pressure ≥ 90mmHg. Ideally three blood pressure 
measurements should be taken and the average systolic and diastolic readings of the second and third measures should be used in this calculation.
Denominator All respondents of the survey aged 18+ years.
Disaggregation/ 
additional dimension
Age, sex, other relevant sociodemographic stratifiers where available
Method of measurement  
Method of estimation (Number of respondents aged 18+years with systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg)/(number of survey 
respondents aged 18+ years) x 100.
Measurement frequency At least every five years
Monitoring and 
evaluation framework
Outcome
Preferred data sources Population-based (preferably nationally representative) survey in which blood pressure was measured, not self-reported
Other possible data sources
Further information 
and related links
Diet, nutrition and the prevention of chronic diseases: report of a Joint WHO/FAO Expert Consultation. Geneva: World Health Organization; 2003 
(WHO Technical Report Series, No. 916; http://whqlibdoc.who.int/trs/WHO_TRS_916.pdf, accessed 29 March 2015).
Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases, including a set of 
indicators. Agenda item A66/8, Sixty-sixth World Health Assembly, 20–28 May 2013. Geneva: World Health Organization; 2013  
(http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_8-en.pdf?ua=1, accessed 29 March 2015).
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Raised blood glucose/diabetes among adults
Abbreviated name Raised blood glucose/diabetes among adults
Indicator name Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose
Domain Risk factors
Subdomain NCDs and nutrition
Associated terms Noncommunicable diseases
Definition Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years or on medication for raised blood glucose (defined as 
fasting plasma glucose value ≥ 7.0 mmol/L (126 mg/dL) or on medication for raised blood glucose among adults aged 18+ years).
Numerator Number of respondents aged 18+ years with fasting plasma glucose value ≥7.0 mmol/L (126 mg/dL) or on medication for raised blood glucose. 
Fasting blood glucose must be measured, not self-reported, and measurements must be taken after the person has fasted for at least eight hours. 
Denominator All respondents of the survey aged 18+ years.
Disaggregation/ 
additional dimension
Age, sex, other relevant sociodemographic stratifiers where available
Method of measurement
Method of estimation (Number of respondents aged 18+ years with fasting plasma glucose value ≥ 7.0 mmol/L [126 mg/dL] or on medication for raised blood glucose)/
(number of survey respondents aged 18+ years) x 100.
Measurement frequency At least every 5 years
Monitoring and 
evaluation framework
Outcome
Preferred data sources Population-based (preferably nationally representative) survey. There are two main blood chemistry screening methods – dry and wet chemistry. 
Dry chemistry uses capillary blood taken from a finger and is used in a rapid diagnostic test. Wet chemistry uses a venous blood sample with a 
laboratory-based test. Either method is acceptable.
Other possible data sources
Further information 
and related links
Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases, including a set of 
indicators. Agenda item A66/8, Sixty-sixth World Health Assembly, 20–28 May 2013. Geneva: World Health Organization; 2013  
(http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_8-en.pdf?ua=1, accessed 29 March 2015).
Levitan EB, Song Y, Ford ES, Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies.  
Arch Intern Med. 2004;164(19):2147−55.
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Salt intake
Abbreviated name Salt intake
Indicator name Age-standardized mean population intake of salt (sodium chloride) per day in grams in persons aged 18+ years
Domain Risk factors
Subdomain NCDs and nutrition
Associated terms Noncommunicable diseases
Definition Age-standardized mean population intake of salt (sodium chloride) per day in grams in persons aged 18+ years. 
Numerator The sum of sodium excretion in urine samples from all respondents aged 18+ years. The gold standard for estimating salt intake is through 24-hour 
urine collection. However, other methods such as spot urine and food frequency surveys may be more feasible to administer at the population level.
Denominator All respondents of the survey aged 18+ years.
Disaggregation/ 
additional dimension
Age, sex, other relevant sociodemographic stratifiers where available
Method of measurement  
Method of estimation Sum of sodium excretion in urine samples from all respondents aged 18+ years/number of survey respondents aged 18+ years.
Measurement frequency At least every 5 years
Monitoring and 
evaluation framework
Outcome
Preferred data sources Population-based (preferably nationally representative) survey
Other possible data sources
Further information 
and related links
Brown IJ, Tzoulaki I, Candelas V, Elliott P. Salt intakes around the world: implications for public health. Int J Epidemiol. 2009;38:791–813. 
Cappuccio F, Capewell S, Lincoln P, McPherson K. Policy options to reduce population salt intake. BMJ. 2011;343:d4995.
Creating an enabling environment for population-based salt reduction strategies: report of a joint technical meeting held by WHO and the Food 
Standards Agency, United Kingdom, July 2010. Geneva: World Health Organization; 2010. 
Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases, including a set of 
indicators. Agenda item A66/8, Sixty-sixth World Health Assembly, 20–28 May 2013. Geneva: World Health Organization; 2013  
(http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_8-en.pdf?ua=1, accessed 29 March 2015).
Prevention of cardiovascular disease: pocket guidelines for assessment and management of cardiovascular risk. Geneva: World Health Organization; 
2007.
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Insufficient physical activity in adults
Insufficient physical activity in adults (Also: adolescents)
Abbreviated name Insufficient physical activity in adults (Also: adolescents)
Indicator name Age-standardized prevalence of insufficiently physically active persons aged 18+ years
Domain Risk factors
Subdomain NCDs and nutrition
Associated terms Noncommunicable diseases
Definition Age-standardized prevalence of insufficiently physically active persons aged 18+ years (percentage of adults aged 18+ years not meeting any of 
the following criteria: 150 minutes of moderate-intensity physical activity per week; 75 minutes of vigorous-intensity physical activity per week; 
an equivalent combination of moderate- and vigorous-intensity physical activity accumulating at least 600 metabolic equivalent minutes per week 
(minutes of physical activity can be accumulated over the course of a week but must be of a duration of at least 10 minutes).
*Metabolic equivalent (MET) is the ratio of a person’s working metabolic rate relative to the resting metabolic rate. One metabolic equivalent 
is defined as the energy cost of sitting quietly and is equivalent to a caloric consumption of 1 kcal/kg per hour. Physical activities are frequently 
classified by their intensity, using the metabolic equivalent as a reference.
Numerator Number of respondents where all three of the following criteria are true:  
weekly minutes* of vigorous activity < 75 minutes;  
weekly minutes* of moderate activity < 150 minutes; 
weekly metabolic equivalent minutes** < 600. 
* Weekly minutes are calculated by multiplying the number of days on which vigorous/moderate activity is done by the number of minutes of 
vigorous/moderate activity per day. 
** Weekly metabolic equivalent minutes are calculated by multiplying the weekly minutes of vigorous activity by 8 and the number of weekly 
minutes of moderate activity by 4 and then adding these two results together.
Denominator All respondents of the survey aged 18+ years.
Disaggregation/ 
additional dimension
Age, sex, other relevant sociodemographic stratifiers where available 
Also: Prevalence of insufficiently physically active adolescents (defined as less than 60 minutes of moderate to vigorous intensity activity daily)
Method of measurement
Method of estimation (Number of respondents aged 18+ years not meeting the aforementioned criteria for physical activity)/(number of survey respondents aged  
18+ years) x 100.
Measurement frequency At least every 5 years
Monitoring and 
evaluation framework
Outcome
Preferred data sources Population-based (preferably nationally representative) survey
Other possible data sources
Further information 
and related links
Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases, including a set of 
indicators. Agenda item A66/8, Sixty-sixth World Health Assembly, 20–28 May 2013. Geneva: World Health Organization; 2013  
(http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_8-en.pdf?ua=1, accessed 29 March 2015).
Global recommendations on physical activity for health. Geneva: World Health Organization; 2010.
Physical Activity Guidelines Advisory Committee (PAGAC). Physical Activity Guidelines Advisory Committee Report, 2008. Washington (DC): 
Department of Health and Human Services; 2008.
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Intimate partner violence prevalence
Abbreviated name Intimate partner violence prevalence
Indicator name Intimate partner violence prevalence
Domain Risk factors
Subdomain Injury and violence
Associated terms Injuries
Definition Percentage of currently partnered girls and women aged 15−49 years who have experienced physical and/or sexual violence by their current 
intimate partner in the last 12 months.
Numerator Number of girls and women who currently have an intimate partner, and who report experiencing physical or sexual violence by their current 
intimate partner in the past 12 months. 
Denominator Total number of girls and women aged 15−49 years surveyed who currently have or had an intimate partner.
Disaggregation/ 
additional dimension
Age (15−19, 20−24 and 25−49 years), HIV status
Method of measurement Household surveys with a special module on violence.
Method of estimation
Measurement frequency 5 years
Monitoring and 
evaluation framework
Outcome
Preferred data sources Household surveys
Other possible data sources
Further information 
and related links
Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development beyond 2014. 
Report of the Secretary-General. New York (NY): United Nations; 2014 (https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/
Framework%20of%20action%20for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf, accessed 19 August 2014). 
Global AIDS response progress reporting 2014: construction of core indicators for monitoring the 2011 United Nations political declaration on 
HIV/AIDS. Geneva: Joint United Nations Programme on HIV/AIDS; 2014 (http://www.unaids.org/en/media/unaids/contentassets/documents/
document/2014/GARPR_2014_guidelines_en.pdf, accessed 29 March 2015).
Global and regional estimates of violence against women: prevalence and health effects of intimate partner violence and non-partner sexual 
violence. Geneva: World Health Organization; 2013.
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Service coverage indicators
Reproductive, maternal, newborn, child and adolescent
Demand for family planning satisfied with modern methods
Contraceptive prevalence rate
Antenatal care coverage
Births attended by skilled health personnel 
Postpartum care coverage
Care-seeking for symptoms of pneumonia 
Children with diarrhoea receiving oral rehydration solution (ORS) 
Vitamin A supplementation coverage
Immunization
Immunization coverage rate by vaccine for each vaccine in the national schedule
HIV 
People living with HIV who have been diagnosed
Prevention of mother-to-child transmission 
HIV care coverage
Antiretroviral therapy (ART) coverage
HIV viral load suppression 
HIV/TB
TB preventive therapy for HIV-positive people newly enrolled in HIV care
HIV test results for registered new and relapse TB patients
HIV-positive new and relapse TB patients on ART during TB treatment
Tuberculosis
TB patients with results for drug susceptibility testing
TB case detection rate 
Second-line treatment coverage among multidrug-resistant tuberculosis (MDR-TB) cases
Malaria
Intermittent preventive therapy for malaria during pregnancy (IPTp)
Use of insecticide treated nets (ITNs)
Treatment of confirmed malaria cases 
Indoor residual spraying (IRS) coverage
Neglected tropical diseases 
Coverage of preventive chemotherapy for selected neglected tropical diseases 
Screening and preventive care 
Cervical cancer screening
Mental Health
Coverage of services for severe mental health disorders
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Demand for family planning satisfied with modern methods
Abbreviated name Demand for family planning satisfied with modern methods
Indicator name Demand for family planning satisfied with modern methods
Domain Service coverage
Subdomain Reproductive, maternal, newborn, child and adolescent health
Associated terms Reproductive, maternal, newborn, child and adolescent
Definition Percentage of women of reproductive age (15−49 years) who are sexually active and who have their need for family planning satisfied with 
modern methods.
Numerator Number of women with family planning demand who use modern methods
Denominator Total number of women in need of family planning.
Disaggregation/ 
additional dimension
Age, marital status, place of residence, socioeconomic status
Method of measurement Household surveys include a series of questions to measure modern contraceptive prevalence rate and demand for family planning. 
Total demand for family planning is defined as the sum of the number of women of reproductive age (15–49 years) who are married or in a union 
and who are currently using, or whose sexual partner is currently using, at least one contraceptive method, and the unmet need for family planning. 
Unmet need for family planning is the proportion of women of reproductive age (15–49 years) either married or in a consensual union, who are 
fecund and sexually active but who are not using any method of contraception (modern or traditional), and report not wanting any more children or 
wanting to delay the birth of their next child for at least two years. Included are: 
1.  all pregnant women (married or in a consensual union) whose pregnancies were unwanted or mistimed at the time of conception; 
2.  all postpartum amenorrhoeic women (married or in consensual union) who are not using family planning and whose last birth was unwanted 
or mistimed; 
3.  all fecund women (married or in consensual union) who are neither pregnant nor postpartum amenorrhoeic, and who either do not want any 
more children (want to limit family size), or who wish to postpone the birth of a child for at least two years or do not know when or if they want 
another child (want to space births), but are not using any contraceptive method.
Method of estimation
Measurement frequency Every 3−5 years
Monitoring and 
evaluation framework
Outcome
Preferred data sources Population-based health surveys
Other possible data sources
Further information 
and related links
Countdown to 2015. Monitoring maternal, newborn and child health: understanding key progress indicators. Geneva: World Health Organization; 
2011 (http://apps.who.int/iris/bitstream/10665/44770/1/9789241502818_eng.pdf, accessed 29 March 2015).
Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development beyond 2014. 
Report of the Secretary-General. New York (NY): United Nations; 2014 (https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/
Framework%20of%20action%20for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf, accessed 19 August 2014). 
Keeping promises, measuring results. Commission on information and accountability for Women’s and Children’s Health. Geneva: World Health 
Organization; 2011 (http://www.who.int/topics/millennium_development_goals/accountability_commission/Commission_Report_advance_
copy.pdf, accessed 29 March 2015).
Monitoring progress in family planning. FP2020 core indicators. Glastonbury (CT): Track20 (http://www.track20.org/pages/data/indicators,  
21 March 2014).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
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Contraceptive prevalence rate
Abbreviated name Contraceptive prevalence rate
Indicator name Contraceptive prevalence rate
Domain Service coverage
Subdomain Reproductive, maternal, newborn, child and adolescent health
Associated terms Reproductive, maternal, newborn, child and adolescent
Definition Percentage of women aged 15−49 years, married or in union, who are currently using, or whose sexual partner is using, at least one method of 
contraception, regardless of the method used.
Numerator Number of women using or partner using a contraceptive method.
Denominator Number of women married or in a union.
Disaggregation/ 
additional dimension
Age, method (short, long, permanent), place of residence, sexually active (irrespective of marital status or whether in a union), socioeconomic 
status
Method of measurement Contraceptive prevalence = (women of reproductive age [15−49 years] who are married or in a union and who are currently using any method of 
contraception)/(total number of women of reproductive age [15−49 years] who are married or in a union) x 100.
Household surveys that can generate this indicator include DHS, MICS, Fertility and Family Surveys (FFS), Reproductive Health Surveys (RHS) and 
other surveys based on similar methodologies.
Method of estimation The United Nations Population Division compiles data from nationally representative surveys, including the DHS, MICS, FFS, the CDC-assisted RHS 
and national family planning, or health, or household, or socioeconomic surveys. 
In general, all nationally representative surveys with comparable questions on current use of contraception are included. There is no attempt to 
provide estimates when country data are not available. The results are published regularly in the World Contraceptive Use report.
Predominant type of statistics: adjusted.
Measurement frequency Biennial
Monitoring and 
evaluation framework
Outcome
Preferred data sources Household surveys
Other possible data sources Routine facility information systems/health facility assessments and surveys
Further information 
and related links
Countdown to 2015 decade report (2000−2010): taking stock of maternal, newborn and child survival. Geneva and New York (NY): World Health 
Organization/United Nations Children’s Fund; 2010 (http://www.countdown2015mnch.org/reports-and-articles/previous-reports/2010-decade-
report, accessed 29 March 2014).
Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development beyond 2014. 
Report of the Secretary-General. New York (NY): United Nations; 2014 (https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/
Framework%20of%20action%20for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf, accessed 19 August 2014).
Indicators for monitoring the Millennium Development Goals: definitions, rationale, concepts and sources. New York (NY): United Nations; 2012 
(http://mdgs.un.org/unsd/mi/wiki/MainPage.ashx, accessed 29 March 2015).
Keeping promises, measuring results. Commission on information and accountability for Women’s and Children’s Health. Geneva: World Health 
Organization; 2011 (http://www.who.int/topics/millennium_development_goals/accountability_commission/Commission_Report_advance_
copy.pdf, accessed 29 March 2015).
Monitoring progress in family planning. FP2020 core indicators. Glastonbury (CT): Track20 (http://www.track20.org/pages/data/indicators,  
21 March 2014).
Standard foreign assistance indicators/standard foreign assistance master indicator list (MIL). Washington (DC): United States Agency for 
International Development (http://www.state.gov/f/indicators/index.htm, accessed 26 June 2014).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
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Antenatal care coverage
Abbreviated name Antenatal care coverage
Indicator name Antenatal care coverage − at least four visits (%)
Domain Service coverage
Subdomain Reproductive, maternal, newborn, child and adolescent health 
Associated terms Reproductive, maternal, newborn, child and adolescent
Definition Percentage of women aged 15−49 years with a live birth in a given time period who received antenatal care, four times or more.
Numerator Number of women aged 15−49 years with a live birth in a given time period who received antenatal care four or more times.
Denominator Total number of women aged 15−49 years with a live birth in the same period.
Disaggregation/ 
additional dimension
Age, place of residence, socioeconomic status, type of provider 
Also: at least one visit
Method of measurement The number of women aged 15−49 years with a live birth in a given time period who received antenatal care four or more times during pregnancy 
is expressed as a percentage of women aged 15−49 with a live birth in the same period. 
(Number of women aged 15−49 years attended at least four times during pregnancy by any provider for reasons related to the pregnancy/total 
number of women aged 15−49 years with a live birth) x 100.
The indicators of antenatal care (at least one visit and at least four visits) are based on standard questions that ask if and how many times the 
health of the woman was checked during pregnancy. This is because the key national-level household surveys do not collect information on type 
of provider for each visit. The indicators of antenatal care (at least one visit and at least four visits) are based on standard questions that ask if, how 
many times, and by whom the health of the woman was checked during pregnancy. Household surveys that can generate this indicator include 
DHS, MICS, FFS, RHS and other surveys based on similar methodologies. Service/facility reporting systems can be used where the coverage is high, 
usually in industrialized countries.
Method of estimation
Measurement frequency Annual from routine facility reports; every 3−5 years from survey
Monitoring and 
evaluation framework
Outcome
Preferred data sources Household surveys
Other possible data sources Routine facility information systems
Further information 
and related links
Countdown to 2015 decade report (2000−2010): taking stock of maternal, newborn and child survival. Geneva and New York (NY): World Health 
Organization/United Nations Children’s Fund; 2010 (http://www.countdown2015mnch.org/reports-and-articles/previous-reports/2010-decade-
report, accessed 29 March 2014).
Indicators for monitoring the Millennium Development Goals: definitions, rationale, concepts and sources. New York (NY): United Nations; 2012 
(http://mdgs.un.org/unsd/mi/wiki/MainPage.ashx, accessed 29 March 2015).
Keeping promises, measuring results. Commission on information and accountability for Women’s and Children’s Health. Geneva: World Health 
Organization; 2011 (http://www.who.int/topics/millennium_development_goals/accountability_commission/Commission_Report_advance_
copy.pdf, accessed 29 March 2015).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
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Births attended by skilled health personnel
Abbreviated name Births attended by skilled health personnel
Indicator name Births attended by skilled health personnel (%)
Domain Service coverage
Subdomain Reproductive, maternal, newborn, child and adolescent health
Associated terms Reproductive, maternal, newborn, child and adolescent
Definition Percentage of live births attended by skilled health personnel during a specified time period.
Numerator Number of births attended by skilled health personnel (doctors, nurses or midwives) trained in providing life-saving obstetric care, including giving 
the necessary supervision, care and advice to women during pregnancy, childbirth and the postpartum period, to conduct deliveries on their own, 
and to care for newborns.
Denominator The total number of live births in the same period.
Disaggregation/ 
additional dimension
Age, parity, place of residence, socioeconomic status, type of provider 
Also: Institutional delivery coverage (women giving birth in a health institution) among all births in the population
Method of measurement Definition of skilled birth attendant varies between countries. The percentage of births attended by skilled health personnel is calculated as the 
number of births attended by skilled health personnel (doctors, nurses or midwives) expressed as a percentage of the total number of births in the 
same period.  
Births attended by skilled health personnel = (number of births attended by skilled health personnel)/(total number of live births) x 100.
In household surveys, such as DHS, MICS and RHS, the respondent is asked about each live birth and who helped during delivery for a period up to 
five years before the interview. 
Service/facility records could be used where a high proportion of births occur in health facilities and are therefore recorded.
Method of estimation Data for global monitoring are reported by UNICEF and WHO. These agencies obtain the data − both survey and registry data – from national 
sources. Before data can be included in the global databases, UNICEF and WHO undertake a process of data verification that includes correspondence 
with field offices to clarify any questions.
In terms of survey data, some survey reports may present a total percentage of births attended by a type of provider that does not conform to 
the MDG definition (e.g. total includes providers who are not considered skilled, such as community health workers). In this case, the percentage 
delivered by a physician, nurse or midwife are totalled and entered into the global database as the MDG estimate. 
Predominant type of statistics: adjusted.
Measurement frequency Biennial 
Monitoring and 
evaluation framework
Outcome
Preferred data sources Household surveys
Other possible data sources Routine facility information systems
Further information 
and related links
Countdown to 2015 decade report (2000−2010): taking stock of maternal, newborn and child survival. Geneva and New York (NY): World Health 
Organization/United Nations Children’s Fund; 2010 (http://www.countdown2015mnch.org/reports-and-articles/previous-reports/2010-decade-
report, accessed 29 March 2014).
Countdown to 2015. Monitoring maternal, newborn and child health: understanding key progress indicators. Geneva: World Health Organization; 
2011 (http://apps.who.int/iris/bitstream/10665/44770/1/9789241502818_eng.pdf, accessed 29 March 2015).
Every newborn: an action plan to end preventable deaths. Geneva: World Health Organization; 2014 (http://www.everynewborn.org/Documents/
Full-action-plan-EN.pdf, accessed 29 March 2015).
Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development beyond 2014. 
Report of the Secretary-General. New York (NY): United Nations; 2014 (https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/
Framework%20of%20action%20for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf, accessed 19 August 2014).
Indicators for monitoring the Millennium Development Goals: definitions, rationale, concepts and sources. New York (NY): United Nations; 2012 
(http://mdgs.un.org/unsd/mi/wiki/MainPage.ashx, accessed 29 March 2015).
Keeping promises, measuring results. Commission on information and accountability for Women’s and Children’s Health. Geneva: World Health 
Organization; 2011 (http://www.who.int/topics/millennium_development_goals/accountability_commission/Commission_Report_advance_
copy.pdf, accessed 29 March 2015).
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Postpartum care coverage
Abbreviated name Postpartum care coverage
Indicator name Postpartum care coverage
Domain Service coverage
Subdomain Reproductive, maternal, newborn, child and adolescent health
Associated terms Reproductive, maternal, newborn, child and adolescent
Definition Percentage of mothers and babies who received postpartum care within two days of childbirth (regardless of place of delivery).
Numerator Number of women and babies who received postpartum care within two days of childbirth.
Denominator Total number of women age 15−49 years with a live birth in the specified time period.
Disaggregation/ 
additional dimension
Age, facility ownership, marital status, parity, place of residence, socioeconomic status
Method of measurement  
Method of estimation
Measurement frequency Annual from routine facility reports; every 3−5 years from survey
Monitoring and 
evaluation framework
Outcome
Preferred data sources Population-based health surveys
Other possible data sources Routine facility information systems/health facility assessments and surveys
Further information 
and related links
Countdown to 2015 decade report (2000−2010): taking stock of maternal, newborn and child survival. Geneva and New York (NY): World Health 
Organization/United Nations Children’s Fund; 2010 (http://www.countdown2015mnch.org/reports-and-articles/previous-reports/2010-decade-
report, accessed 29 March 2014).
Countdown to 2015. Monitoring maternal, newborn and child health: understanding key progress indicators. Geneva: World Health Organization; 
2011 (http://apps.who.int/iris/bitstream/10665/44770/1/9789241502818_eng.pdf, accessed 29 March 2015).
Every newborn: an action plan to end preventable deaths. Geneva: World Health Organization; 2014 (http://www.everynewborn.org/Documents/
Full-action-plan-EN.pdf, accessed 29 March 2015).
Keeping promises, measuring results. Commission on information and accountability for Women’s and Children’s Health. Geneva: World Health 
Organization; 2011 (http://www.who.int/topics/millennium_development_goals/accountability_commission/Commission_Report_advance_
copy.pdf, accessed 29 March 2015).
Standard foreign assistance indicators/standard foreign assistance master indicator list (MIL). Washington (DC): United States Agency for 
International Development (http://www.state.gov/f/indicators/index.htm, accessed 26 June 2014).
79
Care-seeking for symptoms of pneumonia
Abbreviated name Care-seeking for symptoms of pneumonia
Indicator name Percentage of children under 5 years of age with suspected pneumonia taken to a health facility
Domain Service coverage
Subdomain Reproductive, maternal, newborn, child and adolescent health
Associated terms Reproductive, maternal, newborn, child and adolescent 
Definition Percentage of children under 5 years of age with suspected pneumonia (cough and difficult breathing NOT due to a problem in the chest and a 
blocked nose) in the two weeks preceding the survey taken to an appropriate health facility or provider.
Numerator Number of children with suspected pneumonia in the two weeks preceding the survey taken to an appropriate health provider.
Denominator Number of children with suspected pneumonia in the two weeks preceding the survey.
Disaggregation/ 
additional dimension
Place of residence, provider, sex, socioeconomic status,  
Also: with “receiving appropriate antibiotics”
Method of measurement During the UNICEF/WHO Meeting on Child Survival Survey-based Indicators, held in New York, USA, on 17–18 June 2004, it was recommended 
that suspected Acute Respiratory Infection (ARI) be described as “presumed pneumonia” to better reflect the probable cause and the recommended 
interventions. The definition of ARI used in the DHS and MICS was chosen by the group and is based on the mother’s perceptions of a child who has a 
cough, is breathing faster than usual with short, quick breaths or is having difficulty breathing, excluding children who had only a blocked nose.
Method of estimation
Measurement frequency Every 3−5 years
Monitoring and 
evaluation framework
Outcome
Preferred data sources Household surveys
Other possible data sources
Further information 
and related links
Countdown to 2015. Monitoring maternal, newborn and child health: understanding key progress indicators. Geneva: World Health Organization; 
2011 (http://apps.who.int/iris/bitstream/10665/44770/1/9789241502818_eng.pdf, accessed 29 March 2015).
Ending preventable child deaths from pneumonia and diarrhoea by 2025. The integrated Global Action Plan for Pneumonia and Diarrhoea (GAPPD). 
Geneva: World Health Organization/United Nations Children’s Fund; 2013 (http://apps.who.int/iris/bitstream/10665/79200/1/9789241505239_
eng.pdf?ua=1, accessed 29 March 2015).
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
pdf?ua=1, accessed 29 March 2015).
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Children with diarrhoea receiving oral rehydration solution (ORS)
Abbreviated name Children with diarrhoea receiving oral rehydration solution (ORS)
Indicator name Children with diarrhoea receiving oral rehydration solution (ORS)
Domain Service coverage
Subdomain Reproductive, maternal, newborn, child and adolescent health
Associated terms Reproductive, maternal, newborn, child and adolescent
Definition Percentage of children under 5 years of age with diarrhoea in the last two weeks receiving ORS (fluids made from ORS packets or pre-packaged ORS 
fluids). 
Numerator Number of children under 5 years of age with diarrhoea in the two weeks preceding the survey given fluid from ORS packets or pre-packaged ORS 
fluids.
Denominator Number of children with diarrhoea in the two weeks preceding the survey.
Disaggregation/ 
additional dimension
Place of residence, sex, socioeconomic status 
Also: with continued feeding, oral rehydration therapy (ORT)
Method of measurement According to the DHS, the term(s) used for diarrhoea should encompass the expressions used for all forms of diarrhoea, including bloody stools 
(consistent with dysentery), watery stools, etc. The term encompasses the mother’s definition as well as locally-used term(s).
Method of estimation
Measurement frequency
Monitoring and 
evaluation framework
Outcome
Preferred data sources Household surveys
Other possible data sources  Routine facility information systems
Further information 
and related links
Ending preventable child deaths from pneumonia and diarrhoea by 2025. The integrated Global Action Plan for Pneumonia and Diarrhoea (GAPPD). 
Geneva: World Health Organization/United Nations Children’s Fund; 2013 (http://apps.who.int/iris/bitstream/10665/79200/1/9789241505239_
eng.pdf?ua=1, accessed 29 March 2015).
Standard foreign assistance indicators/standard foreign assistance master indicator list (MIL). Washington (DC): United States Agency for 
International Development (http://www.state.gov/f/indicators/index.htm, accessed 26 June 2014).
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
pdf?ua=1, accessed 29 March 2015).
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Vitamin A supplementation coverage
Abbreviated name Vitamin A supplementation coverage
Indicator name Children aged 6−59 months who received vitamin A supplementation (% of doses)
Domain Service coverage
Subdomain Reproductive, maternal, newborn, child and adolescent health
Associated terms Reproductive, maternal, newborn, child and adolescent 
Definition Percentage of children aged 6–59 months who received two age-appropriate doses of vitamin A in the past 12 months. 
Numerator Number of children who received two age-appropriate doses of vitamin A supplements in the last 12 months.
Denominator Number of children aged 6−59 months in the survey.
Disaggregation/ 
additional dimension
Age, place of residence, sex, socioeconomic status 
Method of measurement In accordance with WHO’s 2011 guidelines on vitamin A supplementation in infants and children aged 6–59 months. 
Method of estimation
Measurement frequency Annual from routine facility reports; every 3−5 years from survey
Monitoring and 
evaluation framework
Outcome
Preferred data sources Household surveys
Other possible data sources Routine facility information systems
Further information 
and related links
Countdown to 2015 decade report (2000−2010): taking stock of maternal, newborn and child survival. Geneva and New York (NY): World Health 
Organization/United Nations Children’s Fund; 2010 (http://www.countdown2015mnch.org/reports-and-articles/previous-reports/2010-decade-
report, accessed 29 March 2014).
Ending preventable child deaths from pneumonia and diarrhoea by 2025. The integrated Global Action Plan for Pneumonia and Diarrhoea (GAPPD). 
Geneva: World Health Organization/United Nations Children’s Fund; 2013 (http://apps.who.int/iris/bitstream/10665/79200/1/9789241505239_
eng.pdf?ua=1, accessed 29 March 2015).
Guideline: Vitamin A supplementation in infants and children 6–59 months of age. Geneva: World Health Organization; 2011 (http://apps.who.int/
iris/bitstream/10665/44664/1/9789241501767_eng.pdf?ua=1&ua=1, accessed 24 April 2015).
Standard foreign assistance indicators/standard foreign assistance master indicator list (MIL). Washington (DC): United States Agency for 
International Development (http://www.state.gov/f/indicators/index.htm, accessed 26 June 2014).
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
pdf?ua=1, accessed 29 March 2015).
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Immunization coverage rate by vaccine for each vaccine in the national schedule
Abbreviated name Immunization coverage rate by vaccine for each vaccine in the national schedule
Indicator name Immunization coverage rate by vaccine for each vaccine in the national schedule
Domain Service coverage
Subdomain Reproductive, maternal, newborn, child and adolescent health
Associated terms Immunization
Definition Percentage of the target population that has received the last recommended dose for each vaccine recommended in the national schedule 
by vaccine. This should include all vaccines within a country’s routine immunization schedule (e.g., Bacillus Calmette–Guérin (BCG); polio; 
pneumococcal conjugate vaccine (PCV); rotavirus; diphtheria, tetanus, pertussis-Hepatitis B-Haemophilus influenzae type B vaccine (DTP-HepB-
Hib); measles (MCV); rubella; human papilloma virus (HPV); tetanus toxoid (TT); influenza; and others as determined by the national schedule).
Numerator The number of individuals in the target group for each vaccine that has received the last recommended dose in the series. For vaccines in the infant 
immunization schedule, this would be the number of children aged 12–23 months who have received the specified vaccinations before their first 
birthday.
Denominator The total number of individuals in the target group for each vaccine. For vaccines in the infant immunization schedule, this would be the total 
number of infants surviving to age one.
Disaggregation/ 
additional dimension
Age, place of residence, sex, socioeconomic status 
DTP1-DTP3 dropout rate, MCV1-MCV2 dropout, full immunization coverage where possible
Method of measurement Example of a national schedule is:
At birth: BCG, HepB, oral polio vaccine  
At 6, 10 and 14 weeks: DTP-HepB-Hib, PCV, rotavirus, oral polio vaccine (with one dose of inactivated polio vaccine) 
At 9 months: measles 
At 18 months measles 
For adolescents: HPV 
TT: multiple 
For persons aged over 60 years: influenza.
Method of estimation For survey data, the vaccination status of children aged 12–23 months is used for vaccines included in the infant immunization schedule, collected 
from child health cards or, if there is no card, from recall by the care-taker.
Measurement frequency Annual tracking through facility information systems, supplemented by periodic estimation through household surveys
Monitoring and 
evaluation framework
Outcome
Preferred data sources Household surveys, facility information systems
Other possible data sources
Further information 
and related links
Countdown to 2015. Monitoring maternal, newborn and child health: understanding key progress indicators. Geneva: World Health Organization; 
2011 (http://apps.who.int/iris/bitstream/10665/44770/1/9789241502818_eng.pdf, accessed 29 March 2015).
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People living with HIV who have been diagnosed
Abbreviated name People living with HIV who have been diagnosed
Indicator name People living with HIV who have been diagnosed (%)
Domain Service coverage
Subdomain Infectious disease
Associated terms HIV
Definition Percentage of people living with HIV who have been diagnosed.
Numerator Number of people living with HIV who have been diagnosed.
Denominator Estimated number of people living with HIV.
Disaggregation/ 
additional dimension
Age (<1, 1–4, 5–9, 10–19, 20–24, 25–49, 50+ years), sex, key populations, other target populations
Method of measurement The denominator is the estimated total number of people living with HIV based on HIV estimation models, such as Spectrum. If an HIV case 
report registry that is regularly updated is available, the numerator can be calculated by taking the number of cases reported in the registry and 
subtracting any deaths that may have occurred. Case report data can provide cumulative information on the overall number of people living with 
HIV who have been diagnosed since the beginning of record-keeping. 
Household surveys with HIV testing and questions to assess whether respondents know their positive status is another means of measurement.
Method of estimation If death records are not widely available for counting the number of people living with HIV who know their HIV status and are alive, other proxy 
data could be reviewed in order to estimate the indicator value. For example, the number of HIV-related deaths may be estimated from other 
sources (e.g. cause-specific death registries, modelling). Survey data on the percentage of people living with HIV who know their HIV status (ever, 
and in the past 12 months) can also be used to triangulate estimates.
Measurement frequency
Monitoring and 
evaluation framework
Outcome
Preferred data sources Case registry
Other possible data sources Surveys and models for estimates
Further information 
and related links
Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development beyond 2014. 
Report of the Secretary-General. New York (NY): United Nations; 2014 (https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/
Framework%20of%20action%20for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf, accessed 19 August 2014). 
Next generation indicators reference guide: planning and reporting. Version 1.2. Washington (DC): The President’s Emergency Plan for AIDS Relief; 
2013 (http://www.pepfar.gov/documents/organization/206097.pdf, accessed 29 March 2014).
84
Prevention of mother-to-child transmission
Abbreviated name Prevention of mother-to-child transmission
Indicator name Prevention of mother-to-child transmission
Domain Service coverage
Subdomain Infectious disease
Associated terms HIV
Definition Percentage of HIV-positive pregnant women provided with ART to reduce the risk of mother-to-child transmission during pregnancy. 
Numerator Number of HIV-positive pregnant women who received ART as recommended by WHO.
Denominator Estimated number of HIV-positive pregnant women.
Disaggregation/ 
additional dimension
Already on ART Newly on ART 
Other regimen categories specific to setting
Method of measurement Numerator: national programme records aggregated from programme monitoring tools, such as patient registers and summary reporting forms.
Denominator: estimation models such as Spectrum or antenatal clinic surveillance surveys, in combination with demographic data and appropriate 
adjustments related to coverage of antenatal care surveys.
Method of estimation
Measurement frequency Annual
Monitoring and 
evaluation framework
Outcome
Preferred data sources Routine facility information systems
Other possible data sources
Further information 
and related links
Consolidated Strategic Information Guidelines for HIV in the Health Sector. Geneva: World Health Organization; 2015.
Countdown to 2015. Monitoring maternal, newborn and child health: understanding key progress indicators. Geneva: World Health Organization; 
2011 (http://apps.who.int/iris/bitstream/10665/44770/1/9789241502818_eng.pdf, accessed 29 March 2015).
Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development beyond 2014. 
Report of the Secretary-General. New York (NY): United Nations; 2014 (https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/
Framework%20of%20action%20for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf, accessed 19 August 2014).
Global AIDS response progress reporting 2014: construction of core indicators for monitoring the 2011 United Nations political declaration on 
HIV/AIDS. Geneva: Joint United Nations Programme on HIV/AIDS; 2014 (http://www.unaids.org/en/media/unaids/contentassets/documents/
document/2014/GARPR_2014_guidelines_en.pdf, accessed 29 March 2015).
Keeping promises, measuring results. Commission on information and accountability for Women’s and Children’s Health. Geneva: World Health 
Organization; 2011 (http://www.who.int/topics/millennium_development_goals/accountability_commission/Commission_Report_advance_
copy.pdf, accessed 29 March 2015).
Next generation indicators reference guide: planning and reporting. Version 1.2. Washington (DC): The President’s Emergency Plan for AIDS Relief; 
2013 (http://www.pepfar.gov/documents/organization/206097.pdf, accessed 29 March 2014).
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HIV care coverage
Abbreviated name HIV care coverage
Indicator name HIV care coverage
Domain Service coverage
Subdomain Infectious disease
Associated terms HIV
Definition Number and percentage of people living with HIV who are receiving HIV care, as proxied by receipt of at least one of the following during the 
reporting period: clinical assessment (WHO staging) or CD4 count or viral load or on ART.
Numerator Number of HIV-positive adults and children who received HIV care (as proxied by receipt of at least one of the following during the reporting period: 
clinical assessment (WHO staging) or CD4 count or viral load).
Denominator Estimated number of people living with HIV.
Disaggregation/ 
additional dimension
Age (< 5, 5−14, 15−19, 20−49, 50+ years), key populations,8 treatment status (i.e. pre-ART or ART), pregnancy status, sex
Method of measurement General populations: for the numerator, national programme records aggregated from programme monitoring tools, such as patient registers and 
summary reporting forms; for the denominator, estimation models such as Spectrum. 
Key populations: surveys.
Method of estimation
Measurement frequency Annual, or more frequently depending on frequency of data use at various levels
Monitoring and 
evaluation framework
Outcome
Preferred data sources
Other possible data sources
Further information 
and related links
Consolidated Strategic Information Guidelines for HIV in the Health Sector. Geneva: World Health Organization; 2015.
Spectrum software. Glastonbury (CT): Avenir Health. (http://www.avenirhealth.org/software-spectrum.php, accessed 29 March 2015).
8 In many settings data on key populations cannot be collected from routine programme monitoring and require surveys.
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Antiretroviral therapy (ART) coverage
Abbreviated name Antiretroviral therapy (ART) coverage
Indicator name Antiretroviral therapy (ART) coverage (%)
Domain Service coverage
Subdomain Infectious disease
Associated terms HIV
Definition Percentage of people living with HIV currently receiving ART among the estimated number of adults and children living with HIV. 
Numerator Number of adults and children who are currently receiving ART at the end of the reporting period.
Denominator Estimated number of adults and children living with HIV. 
Disaggregation/ 
additional dimension
Age: 
1. Minimum for paper-based (routine): <15, 15+; 
2. Annual data extraction of disaggregated data if not reported routinely: <5, 5–9, 10–14, 15–19, 20–24, 25–49, 50+; 
3. Electronic system: 5-year age groups
Key populations9, provider type (public/private), regimen type (e.g. first line, second line), sex
Method of measurement Numerator: The numerator can be generated by counting the number of adults and children who received antiretroviral combination therapy at the 
end of the reporting period. Data can be collected from facility-based ART registers or drug supply management systems. These are then tallied and 
transferred to cross-sectional monthly or quarterly reports which can then be aggregated for national totals. Patients receiving ART in the private 
sector and public sector should be included in the numerator where data are available.
Denominator: The denominator is generated by estimating the number of people with advanced HIV infection requiring (in need of/eligible for) 
ART. This estimation must take into consideration a variety of factors, including, but not limited to, the current number of people with HIV, the 
current number of patients on ART and the natural history of HIV from infection to enrolment on ART. A standard modelling HIV estimation method, 
such as in the Spectrum model, is recommended.
Method of estimation
Measurement frequency Annual
Monitoring and 
evaluation framework
Outcome
Preferred data sources Facility reporting system
Other possible data sources
Further information 
and related links
Consolidated Strategic Information Guidelines for HIV in the Health Sector. Geneva: World Health Organization; 2015.
Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development beyond 2014. 
Report of the Secretary-General. New York (NY): United Nations; 2014 (https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/
Framework%20of%20action%20for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf, accessed 19 August 2014).
Global AIDS response progress reporting 2014: construction of core indicators for monitoring the 2011 United Nations political declaration on 
HIV/AIDS. Geneva: Joint United Nations Programme on HIV/AIDS; 2014 (http://www.unaids.org/en/media/unaids/contentassets/documents/
document/2014/GARPR_2014_guidelines_en.pdf, accessed 29 March 2015).
Indicators for monitoring the Millennium Development Goals: definitions, rationale, concepts and sources. New York (NY): United Nations; 2012 
(http://mdgs.un.org/unsd/mi/wiki/MainPage.ashx, accessed 29 March 2015).
Next generation indicators reference guide: planning and reporting. Version 1.2. Washington (DC): The President’s Emergency Plan for AIDS Relief; 
2013 (http://www.pepfar.gov/documents/organization/206097.pdf, accessed 29 March 2014).
Spectrum software. Glastonbury (CT): Avenir Health. (http://www.avenirhealth.org/software-spectrum.php, accessed 29 March 2015).
9 In many settings data on key populations cannot be collected from routine programme monitoring and require surveys.
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HIV viral load suppression
Abbreviated name HIV viral load suppression
Indicator name HIV viral load suppression
Domain Service coverage
Subdomain Infectious disease
Associated terms HIV
Definition Percentage of people on ART who are virologically suppressed (VL level ≤ 1000 copies/mL).
Numerator Number of adults and children living with HIV and on ART who have a suppressed viral load (< 1000 copies/mL).
Denominator Total number of adults on ART in the past 12 months.
Disaggregation/ 
additional dimension
Age: 
1. Minimum for paper-based (routine): <15, 15+; 
2. Annual data extraction of disaggregated data if not reported routinely: <5, 5–9, 10–14, 15–19, 20–24, 25–49, 50+; 
3. Electronic system: 5-year age groups
Sex
Method of measurement Viral load data recorded in patient records and reported through facilities. If there are representative surveys collecting viral load data among 
people living with HIV and those on ART, the survey values can be used. Nationally representative surveys of acquired drug resistance also provide 
information on viral suppression.10 
Method of estimation If a viral load measure is not available from a sufficiently representative sample of people living with HIV who are on ART, the level of viral load 
suppression among those on ART but without a viral load measurement in the past 12 months needs to be estimated. Estimates can be derived on 
the basis of characteristics among those without a viral load measure and their expected viral load suppression. 
Measurement frequency Annual
Monitoring and 
evaluation framework
Outcome
Preferred data sources Routine facility information systems
Other possible data sources Cross-sectional population-based survey
Further information 
and related links
Consolidated Strategic Information Guidelines for HIV in the Health Sector. Geneva: World Health Organization; 2015.
Global AIDS response progress reporting 2014: construction of core indicators for monitoring the 2011 United Nations political declaration on 
HIV/AIDS. Geneva: Joint United Nations Programme on HIV/AIDS; 2014 (http://www.unaids.org/en/media/unaids/contentassets/documents/
document/2014/GARPR_2014_guidelines_en.pdf, accessed 29 March 2015).
10  Acquired HIVDR Survey (http://www.who.int/hiv/pub/drugresistance/acquired_drugresistance/en/).
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TB preventive therapy for HIV-positive people newly enrolled in HIV care
Abbreviated name TB preventive therapy for HIV-positive people newly enrolled in HIV care
Indicator name TB preventive therapy for HIV-positive people newly enrolled in HIV care
Domain Service coverage
Subdomain Infectious disease
Associated terms HIV/TB
Definition Number of patients who are started on treatment for latent TB infection expressed as a percentage of the total number newly enrolled in HIV care in 
a specified time period.
Numerator Total number of people living with HIV newly enrolled in HIV care who are started on treatment for latent TB infection in a specified time period.
Denominator Total number of persons newly enrolled in HIV care – i.e. registered in the pre-ART or ART register during the specified time period.
Disaggregation/ 
additional dimension
Adults (aged ≥ 15 years) and children (aged 0–4 and 5–14 years), sex
Method of measurement TB preventive therapy should be started in all eligible persons, and the date of starting treatment should be recorded on an HIV care/ART card 
(encounter section). Those who accept treatment and receive at least the first dose should then be recorded in pre-ART and ART registers (INH start 
month/year column).
 Numerator: Count the total number of people living with HIV newly enrolled in HIV care during the reporting period who are started on 
treatment for latent TB infection – i.e. who are given at least one dose of anti-TB drugs (e.g. isoniazid).
 Denominator: Count the total number of people living with HIV newly registered in the pre-ART register plus those registered in the ART register 
during the reporting period.
For accurate planning and drug management, additional information should be collected. A pharmacy-based register may be used to record 
attendance of clients and collection of drugs. Alternatively, the ART facility may maintain a latent TB infection treatment register in parallel with the 
ART register. Such a record may facilitate understanding of the number of new and continuing patients on latent TB infection treatment, as well as 
the treatment completion rate and the frequency and type of adverse events.
Method of estimation
Measurement frequency Annual
Monitoring and 
evaluation framework
Outcome
Preferred data sources Routine facility information systems
Other possible data sources
Further information 
and related links
A guide to monitoring and evaluation for collaborative TB/HIV activities (2015 revision). WHO, 2015 (WHO/HTM/TB/2015.2).
Global AIDS response progress reporting 2014: construction of core indicators for monitoring the 2011 United Nations political declaration on 
HIV/AIDS. Geneva: Joint United Nations Programme on HIV/AIDS; 2014 (http://www.unaids.org/en/media/unaids/contentassets/documents/
document/2014/GARPR_2014_guidelines_en.pdf, accessed 29 March 2015).
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HIV test results for registered new and relapse TB patients
Abbreviated name HIV test results for registered new and relapse TB patients
Indicator name HIV test results for registered new and relapse TB patients
Domain Service coverage
Subdomain Infectious disease
Associated terms HIV/TB
Definition Number of new and relapse TB patients who had an HIV test result recorded in the TB register, expressed as a percentage of the number registered in 
a specified time period.
Numerator Number of new and relapse TB patients registered during the specified time period who had an HIV test result recorded in the TB register.
Denominator Total number of new and relapse TB patients registered in the TB register in the specified time period.
Disaggregation/ 
additional dimension
Adults (aged ≥ 15 years) and children (aged 0−4 and 5−14 years), HIV status (positive, negative, unknown), sex
Method of measurement TB treatment cards and TB registers at the basic management unit should document the HIV status of TB patients. The history of previous TB 
treatment should also be documented systematically to identify new and relapse TB patients.
 Numerator: Count the total number of new and relapse TB patients registered in a specified time period who had their HIV status documented 
as positive or negative, including those previously documented to be HIV-positive (e.g. documented evidence of enrolment in HIV care). HIV-
negative TB patients are those who had a negative HIV test result at the time of current TB diagnosis.
 Denominator: Count the total number of new and relapse TB patients registered during the specified time period. 
Disaggregation of HIV status is documented using HIV test results. This may include TB patients previously documented to be HIV-positive 
(documented evidence of enrolment in HIV care), those newly detected positive or those having a negative HIV test result at the time of TB 
diagnosis. The HIV status of all TB patients should be recorded in TB registers at the basic management unit as soon as possible and preferably at 
the time of TB diagnosis, along with information on past history of TB treatment. This information should be accessible only to the staff directly 
responsible for the health care of the individual. Maintaining confidentiality is their prime responsibility.
 Numerator: The total number of new and relapse TB patients registered in a specified time period who had their HIV status documented as 
positive, including those previously documented to be HIV-positive (e.g. documented evidence of enrolment in HIV care). 
 Denominator: The total number of new and relapse TB patients added to the TB register during the specified time period who had their HIV 
status documented as positive or negative, including those previously documented to be HIV-positive (e.g. documented evidence of enrolment 
in HIV care). HIV-negative TB patients include those having a negative test result at the time of TB diagnosis.
Method of estimation
Measurement frequency Annual
Monitoring and 
evaluation framework
Outcome
Preferred data sources Routine facility information systems
Other possible data sources
Further information 
and related links
A guide to monitoring and evaluation for collaborative TB/HIV activities (2015 revision). Geneva: World Health Organization; 2015.
Definitions and reporting framework for tuberculosis – 2013 revision (WHO/HTM/TB/2013.2). Geneva: World Health Organization; 2013  
(http://www.who.int/tb/publications/definitions/en/, accessed 29 March 2015).
Global AIDS response progress reporting 2014: construction of core indicators for monitoring the 2011 United Nations political declaration on 
HIV/AIDS. Geneva: Joint United Nations Programme on HIV/AIDS; 2014 (http://www.unaids.org/en/media/unaids/contentassets/documents/
document/2014/GARPR_2014_guidelines_en.pdf, accessed 29 March 2015).
Global tuberculosis report 2014. Geneva: World Health Organization; 2014 (http://www.who.int/tb/publications/global_report/en/, accessed 29 
March 2015).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/, accessed 
29 March 2015).
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HIV-positive new and relapse TB patients on ART during TB treatment
Abbreviated name HIV-positive new and relapse TB patients on ART during TB treatment
Indicator name HIV-positive new and relapse TB patients on antiretroviral therapy (ART) during TB treatment
Domain Service coverage
Subdomain Infectious disease
Associated terms HIV/TB
Definition Number of HIV-positive new and relapse TB patients who received ART during TB treatment, expressed as a percentage of those registered in a 
specified time period.
Numerator Total number of HIV-positive new and relapse TB patients started on TB treatment during the specified time period who are already on ART or 
started on ART during TB treatment.
Denominator Total number of HIV-positive new and relapse TB patients registered during the specified time period.
Disaggregation/ 
additional dimension
Adults (aged ≥ 15 years) and children (aged 0–4 and 5–14 years), sex
Method of measurement All HIV-positive new and relapse TB patients detected in a specified time period should be counted for measurement of the proportion receiving ART 
during TB treatment.
 Numerator: Count the total number of HIV-positive new and relapse TB patients who were started on TB treatment (as recorded in the TB 
register) and ART, or who were already on ART (as recorded in the ART register).
 Denominator: In countries with national web-based data systems with individual case records routinely updated by health facilities, the total 
number of HIV-positive new and relapse TB patients detected during a specified reporting period can be easily computed. With paper-based 
systems, the National Tuberculosis Control Programme and National AIDS Control Programme should refer to both the TB and HIV registers to 
obtain the complete number of patients detected. This can be done by counting the total number of new and relapse TB patients added to the 
TB register during in a specified time period who had their HIV status documented as positive, including patients previously known to be HIV-
positive (e.g. documented evidence of enrolment in HIV care). Cases with undocumented TB treatment history should be counted as new cases.
The National Tuberculosis Control Programme and National AIDS Control Programme should ensure that the TB register is updated and that all 
people living with HIV in pre-ART care or on ART who have a recorded TB diagnosis during the reporting period are also registered. Information in 
the TB and ART registers at facility level should be reconciled monthly or quarterly, taking into account the possibility of time lags in updating TB 
information in the ART register and ART information in the TB register. Efforts should be made to update such missing data so that both registers are 
consistent. Care should be taken to avoid double counting of patients across these registers.
Method of estimation
Measurement frequency Annual
Monitoring and 
evaluation framework
Outcome
Preferred data sources Routine facility information systems
Other possible data sources
Further information 
and related links
A guide to monitoring and evaluation for collaborative TB/HIV activities (2015 revision). Geneva: World Health Organization; 2015.
Global AIDS response progress reporting 2014: construction of core indicators for monitoring the 2011 United Nations political declaration on 
HIV/AIDS. Geneva: Joint United Nations Programme on HIV/AIDS; 2014 (http://www.unaids.org/en/media/unaids/contentassets/documents/
document/2014/GARPR_2014_guidelines_en.pdf, accessed 29 March 2015).
Global tuberculosis report 2014. Geneva: World Health Organization; 2014 (http://www.who.int/tb/publications/global_report/en/,  
accessed 29 March 2015).
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TB patients with results for drug susceptibility testing
Abbreviated name TB patients with results for drug susceptibility testing
Indicator name Percentage of TB patients with test results for isoniazid and rifampicin drug susceptibility
Domain Service coverage
Subdomain Infectious disease
Associated terms Tuberculosis
Definition Percentage of TB cases with results for diagnostic drug susceptibility testing for resistance to isoniazid and rifampicinin a specified time period.
Numerator Number of TB cases with drug susceptibility testing results for both isoniazid and rifampicin resistance in a specified time period.
Denominator Number of TB cases identified during the specified time period.
Disaggregation/ 
additional dimension
Risk factors specified in the national policy, treatment history (new, previously treated)
Method of measurement Numerator: Laboratory register.
Denominator: Basic TB register and treatment card. For some risk categories (e.g. contacts of MDR-TB) the information may have to be traced from 
elsewhere in the medical records.
Method of estimation
Measurement frequency Annual
Monitoring and 
evaluation framework
Outcome
Preferred data sources Routine facility information systems
Other possible data sources
Further information 
and related links
Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization; 
2014 (http://www.who.int/tb/publications/pmdt_companionhandbook/en/, accessed 29 March 2015).
Definitions and reporting framework for tuberculosis – 2013 revision (WHO/HTM/TB/2013.2). Geneva: World Health Organization; 2013  
(http://www.who.int/tb/publications/definitions/en/, accessed 29 March 2015).
Global tuberculosis report 2014. Geneva: World Health Organization; 2014 (http://www.who.int/tb/publications/global_report/en/,  
accessed 29 March 2015).
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TB case detection rate
Abbreviated name TB case detection rate
Indicator name Case detection rate for all forms of tuberculosis
Domain Service coverage
Subdomain Infectious disease
Associated terms Tuberculosis
Definition Percentage of estimated new and relapse TB cases detected in a given year under the internationally recommended tuberculosis control strategy. 
The term “case detection”, as used here, means that TB is diagnosed in a patient and is reported within the national surveillance system and then to 
WHO. 
The term “rate” is used for historical reasons. The indicator is actually a ratio (expressed as a percentage) and not a rate.
Numerator Number of new and relapse cases notified in a given year.
Denominator Number of estimated incident cases in the same year.
Disaggregation/ 
additional dimension
Method of measurement Notification data reported by national TB programmes or national surveillance systems (TB notification rate indicator). For methods used for TB 
incidence, see methods described for that indicator.
Method of estimation The number of new and relapse TB cases diagnosed and treated in national TB control programmes and notified to WHO, divided by WHO's estimate 
of the number of incident TB cases for the same year, expressed as a percentage. Uncertainty bounds are provided in addition to best estimates. For 
more information, see Chapter 4 of WHO’s Global tuberculosis report 2014 and the online technical appendix.
Measurement frequency Annual
Monitoring and 
evaluation framework
Outcome
Preferred data sources Facility information systems, surveillance systems
Other possible data sources Routine facility information systems/health facility assessments and surveys
Further information 
and related links
Global tuberculosis report 2014. Geneva: World Health Organization; 2014 (http://www.who.int/tb/publications/global_report/en/,  
accessed 29 March 2015).
Indicators for monitoring the Millennium Development Goals: definitions, rationale, concepts and sources. New York (NY): United Nations; 2012 
(http://mdgs.un.org/unsd/mi/wiki/MainPage.ashx, accessed 29 March 2015).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
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Second-line treatment coverage among multidrug-resistant tuberculosis (MDR-TB) cases
Abbreviated name Second-line treatment coverage among multidrug-resistant tuberculosis (MDR-TB) cases
Indicator name Second-line treatment coverage among multidrug-resistant tuberculosis (MDR-TB) cases 
Domain Service coverage
Subdomain Infectious disease
Associated terms Tuberculosis
Definition Percentage of notified TB patients estimated to have MDR-TB who were detected with MDR-TB and enrolled on second-line anti-TB treatment in a 
specified time period.
Numerator Number of rifampicin-resistant MDR-TB cases (presumptive or confirmed) registered and started on a prescribed MDR-TB treatment regimen in a 
specified time period.
Denominator Estimated number of notified TB patients with MDR-TB.
Disaggregation/ 
additional dimension
Treatment history (new, previously treated)
Method of measurement Number of cases started on treatment is counted from the second-line TB treatment register. Number of notified TB patients with MDR-TB is 
estimated by combining the number of notifications with evidence about the proportion of cases that have MDR-TB from drug resistance surveys or 
continuous surveillance systems with high coverage of diagnostic testing for drug resistance.
Method of estimation
Measurement frequency Annual
Monitoring and 
evaluation framework
Outcome
Preferred data sources Continuous surveillance systems with drug resistance surveys
Other possible data sources
Further information 
and related links
Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization; 
2014 (http://www.who.int/tb/publications/pmdt_companionhandbook/en/, accessed 29 March 2015).
Definitions and reporting framework for tuberculosis – 2013 revision (WHO/HTM/TB/2013.2). Geneva: World Health Organization; 2013  
(http://www.who.int/tb/publications/definitions/en/, accessed 29 March 2015).
Global tuberculosis report 2014. Geneva: World Health Organization; 2014 (http://www.who.int/tb/publications/global_report/en/,  
accessed 29 March 2015).
Standard foreign assistance indicators/standard foreign assistance master indicator list (MIL). Washington (DC): United States Agency for 
International Development (http://www.state.gov/f/indicators/index.htm, accessed 26 June 2014).
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Intermittent preventive therapy for malaria during pregnancy (IPTp)
Abbreviated name Intermittent preventive therapy for malaria during pregnancy (IPTp)
Indicator name Intermittent preventive therapy for malaria during pregnancy (IPTp)
Domain Service coverage
Subdomain Infectious disease
Associated terms Malaria
Definition Percentage of women who received three or more doses of intermittent preventive treatment during antenatal care visits during their last 
pregnancy.
Numerator Number of women receiving three or more doses of recommended treatment.
Denominator Total number of pregnant women/surveyed with a live birth in the last 2 years.
Disaggregation/ 
additional dimension
Age, place of residence, socioeconomic status
Method of measurement  
Method of estimation
Measurement frequency
Monitoring and 
evaluation framework
Outcome
Preferred data sources Household surveys, facility information systems
Other possible data sources
Further information 
and related links
Countdown to 2015 decade report (2000−2010): taking stock of maternal, newborn and child survival. Geneva and New York (NY): World Health 
Organization/United Nations Children’s Fund; 2010 (http://www.countdown2015mnch.org/reports-and-articles/previous-reports/2010-decade-
report, accessed 29 March 2014).
Household Survey Indicators for Malaria Control. Measure Evaluation/Measure DHS/President’s Malaria Initiative/Roll Back Malaria Partnership/
UNICEF/WHO. 2013 (http://www.malariasurveys.org/documents/Household%20Survey%20Indicators%20for%20Malaria%20Control.pdf,  
accessed 15 April 2015.
Roll Back Malaria Partnership/WHO. Disease surveillance for malaria control: an operations manual. Geneva: World Health Organization; 2012 
(http://www.who.int/malaria/publications/atoz/9789241503341/en/, accessed 29 March 2015).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
95
Use of insecticide treated nets (ITNs)
Abbreviated name Use of insecticide treated nets (ITNs)
Indicator name Percentage of population sleeping under insecticide-treated nets (%)
Domain Service coverage
Subdomain Infectious disease
Associated terms Malaria
Definition Percentage population in malaria-endemic areas who slept under an ITN the previous night.
Numerator Number of people in malaria endemic areas who slept under an ITN.
Denominator Total number of people in malaria endemic areas.
Disaggregation/ 
additional dimension
Age (children under 5 years), place of residence, pregnant women, socioeconomic status
Method of measurement Data are principally derived from nationally representative household surveys such as Demographic and Health Surveys, Multiple Indicator Surveys, 
Malaria Indicator Surveys and other representative population based surveys.
Method of estimation Household survey results may be supplemented with information on ITN deliveries from manufacturers and distribution by malaria programmes to 
model annual estimates of this indicator.
Measurement frequency Surveys: every 3−5 years; modelled estimates: annually
Monitoring and 
evaluation framework
Outcome
Preferred data sources
Other possible data sources
Further information 
and related links
Global technical strategy for malaria. Geneva: World Health Organization (http://www.who.int/malaria/areas/global_technical_strategy/draft_
strategy/en/, accessed 21 May 2015)
Household Survey Indicators for Malaria Control. Measure Evaluation/Measure DHS/President’s Malaria Initiative/Roll Back Malaria Partnership/
UNICEF/WHO; 2013 (http://www.rollbackmalaria.org/files/files/toolbox/docs/rbmtoolbox/tool_HouseholdSurveyIndicatorsForMalariaControl.pdf, 
accessed 15 April 2015.
World Malaria Report 2014. Geneva: World Health Organization; 2014 (http://www.who.int/malaria/publications/world_malaria_report_2014/
en/, accessed 21 May 2015).
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Treatment of confirmed malaria cases 
Abbreviated name Treatment of confirmed malaria cases 
Indicator name Treatment of confirmed malaria cases (%)
Domain Service coverage
Subdomain Infectious disease
Associated terms Malaria
Definition Percentage of confirmed malaria cases that receive first-line antimalarial treatment
Numerator Number of confirmed malaria cases that receive first line antimalarial treatment
Denominator Number of confirmed malaria cases
Disaggregation/ 
additional dimension
Age (children under 5 years), place of residence, socioeconomic status
Method of measurement Data may be obtained through routine facility reports, health facility-based surveys and nationally representative household surveys.
Method of estimation Survey results, information from manufacturers on number of treatment courses sold and from malaria programmes on number of treatment 
courses distributed can be combined to model annual estimates of this indicator.
Measurement frequency Routine facility reports and modelled estimates: annually; surveys: every 3–5 years
Monitoring and 
evaluation framework
Outcome
Preferred data sources
Other possible data sources
Further information 
and related links
Global technical strategy for malaria. Geneva: World Health Organization (http://www.who.int/malaria/areas/global_technical_strategy/draft_
strategy/en/, accessed 21 May 2015)
Household Survey Indicators for Malaria Control. Measure Evaluation/Measure DHS/President’s Malaria Initiative/Roll Back Malaria Partnership/
UNICEF/WHO; 2013 (http://www.rollbackmalaria.org/files/files/toolbox/docs/rbmtoolbox/tool_HouseholdSurveyIndicatorsForMalariaControl.pdf, 
accessed 15 April 2015.
World Malaria Report 2014. Geneva: World Health Organization; 2014 (http://www.who.int/malaria/publications/world_malaria_report_2014/
en/, accessed 21 May 2015).
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Indoor residual spraying (IRS) coverage
Abbreviated name Indoor residual spraying (IRS) coverage
Indicator name Indoor residual spraying (IRS) coverage (%)
Domain Service coverage
Subdomain Infectious disease
Associated terms Malaria
Definition Percentage of population at risk protected by IRS during a specified time period.
Numerator Number of persons protected by IRS.
Denominator Population at risk.
Disaggregation/ 
additional dimension
 
Method of measurement Often targeted districts
Method of estimation
Measurement frequency
Monitoring and 
evaluation framework
Outcome
Preferred data sources Population-based health surveys
Other possible data sources Administrative reporting systems
Further information 
and related links
Countdown to 2015 decade report (2000−2010): taking stock of maternal, newborn and child survival. Geneva and New York (NY): World Health 
Organization/United Nations Children’s Fund; 2010 (http://www.countdown2015mnch.org/reports-and-articles/previous-reports/2010-decade-
report, accessed 29 March 2014).
Household Survey Indicators for Malaria Control. Measure Evaluation/Measure DHS/President’s Malaria Initiative/Roll Back Malaria Partnership/
UNICEF/WHO. 2013 (http://www.malariasurveys.org/documents/Household%20Survey%20Indicators%20for%20Malaria%20Control.pdf,  
accessed 15 April 2015.
Roll Back Malaria Partnership/WHO. Disease surveillance for malaria control: an operations manual. Geneva: World Health Organization; 2012 
(http://www.who.int/malaria/publications/atoz/9789241503341/en/, accessed 29 March 2015).
Standard foreign assistance indicators/standard foreign assistance master indicator list (MIL). Washington (DC): United States Agency for 
International Development (http://www.state.gov/f/indicators/index.htm, accessed 26 June 2014).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
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Coverage of preventive chemotherapy for selected neglected tropical diseases
Abbreviated name Coverage of preventive chemotherapy for selected neglected tropical diseases
Indicator name Coverage of preventive chemotherapy for selected neglected tropical diseases
Domain Service coverage
Subdomain Infectious disease
Associated terms Neglected tropical diseases 
Definition Proportion of the population living in endemic areas requiring preventive chemotherapy that received treatment for at least one of the selected 
neglected tropical diseases (schistosomiasis, soil-transmitted helminthiases, lymphatic filariasis , onchocerciasis).
Numerator Number of people requiring and receiving preventive chemotherapy for at least one of the selected neglected tropical diseases (schistosomiasis, 
soil-transmitted helminthiases, lymphatic filariasis , onchocerciasis).
Denominator Number of people requiring preventive chemotherapy for at least one of the selected neglected tropical diseases (schistosomiasis, soil-transmitted 
helminthiases, lymphatic filariasis , onchocerciasis).
Disaggregation/ 
additional dimension
Age (pre-school-aged children [1−4 years], school-aged [5−14 years] and adults [> 15 years]) 
Disaggregation by sex and district is optional or depends on which diseases are co-endemic
Method of measurement Country reporting systems
Method of estimation The number of people requiring/receiving preventive chemotherapy through each disease-specific control or elimination programme is reported by 
national programme managers from ministries of health to WHO. The number of people requiring preventive chemotherapy for each disease was 
compared among the different age groups in each country, and the largest population in each age group for any of the diseases was selected as 
the conservative estimate of the number of people requiring preventive chemotherapy for at least one disease in that particular age group. Finally, 
the largest populations requiring preventive chemotherapy in each age group were summed, and this total was considered to be a conservative 
estimate of the number of individuals needing preventive chemotherapy for at least one disease. The same principle was used to estimate the 
number of people who had received integrated preventive chemotherapy. When subnational data on treatment coverage were available, the 
analysis was conducted at the subnational level.
Measurement frequency Annual
Monitoring and 
evaluation framework
Outcome
Preferred data sources Administrative reporting systems, in particular the Joint Application Package for donated medicines. 
Other possible data sources Other sources, including estimation and modelling
Further information 
and related links
Global plan to combat neglected tropical diseases, 2008–2015. Geneva: World Health Organization; 2007 (http://whqlibdoc.who.int/hq/2007/
who_cds_ntd_2007.3_eng.pdf, accessed 29 March 2015).
Integrated preventive chemotherapy for neglected tropical diseases: estimation of the number of interventions required and delivered, 2009–2010. 
Wkly Epidemiol Rec. 2012;87:17-28 (http://www.who.int/wer/2012/wer8702.pdf, accessed 28 April 2015).
Neglected tropical diseases: planning, requesting medicines and reporting (WHO webpage). Geneva: World Health Organization; 2015  
(http://www.who.int/neglected_diseases/preventive_chemotherapy/reporting/en/, accessed 28 April 2015).
Standard foreign assistance indicators/standard foreign assistance master indicator list (MIL). Washington (DC): United States Agency for 
International Development (http://www.state.gov/f/indicators/index.htm, accessed 26 June 2014).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
pdf?ua=1, accessed 29 March 2015).
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Cervical cancer screening
Abbreviated name Cervical cancer screening
Indicator name Cervical cancer screening
Domain Service coverage
Subdomain Reproductive, maternal, newborn, child and adolescent health
Associated terms Screening and preventive care
Definition Proportion of women aged 30−49 years who report they were screened for cervical cancer using any of the following methods: visual Inspection 
with acetic acid/vinegar (VIA), pap smear, human papilloma virus (HPV) test.
Numerator Number of women aged 30−49 years who report ever having had a screening test for cervical cancer using any of these methods: VIA, pap smear 
and HPV test.
Denominator All female respondents aged 30−49 years.
Disaggregation/ 
additional dimension
Age, sex, other relevant sociodemographic stratifiers where available
Method of measurement
Method of estimation (Number of female respondents aged 30−49 years who report ever having had a screening test for cervical cancer)/(number of female respondents 
aged 30−49 years) x 100.
Measurement frequency At least every 5 years
Monitoring and 
evaluation framework
Outcome
Preferred data sources Population-based (preferably nationally representative) surveys
Other possible data sources Facility-based data
Further information 
and related links
Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases, including a set of 
indicators. Agenda item A66/8, Sixty-sixth World Health Assembly, 20–28 May 2013. Geneva: World Health Organization; 2013 (http://apps.who.
int/gb/ebwha/pdf_files/WHA66/A66_8-en.pdf?ua=1, accessed 29 March 2015).
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al. Globocan 2012. Estimated cancer incidence, mortality and prevalence 
worldwide in 2012. Lyon: International Agency for Research on Cancer; IARC CancerBase No. 11 (http://globocan.iarc.fr, accessed 29 March 2015).
WHO guidelines for screening and treatment of precancerous lesions of cervical cancer prevention. Geneva: World Health Organization; 2013.
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Coverage of services for severe mental health disorders
Abbreviated name Coverage of services for severe mental health disorders
Indicator name Coverage of services for severe mental health disorders
Domain Service coverage
Subdomain NCDs and nutrition
Associated terms Mental health
Definition Percentage of persons with a severe mental disorder (psychosis, bipolar affective disorder, moderate-severe depression) who are using services.
Numerator Number of people receiving services.
Denominator Total number of people in need.
Disaggregation/ 
additional dimension
Age, sex
Method of measurement  
Method of estimation
Measurement frequency
Monitoring and 
evaluation framework
Outcome
Preferred data sources Household surveys
Other possible data sources Facility information systems
Further information 
and related links
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
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Health systems indicators
Quality and safety of care
Perioperative mortality rate 
Obstetric and gynaecological admissions owing to abortion
Institutional maternal mortality ratio
Maternal death reviews
ART retention rate 
TB treatment success rate 
Service-specific availability and readiness
Access
Service utilization
Health service access
Hospital bed density
Availability of essential medicines and commodities
Health workforce
Health worker density and distribution
Output training institutions
Health information
Birth registration coverage
Death registration coverage
Completeness of reporting by facilities
Health financing
Total current expenditure on health (% of gross domestic product)
Current expenditure on health by general government and compulsory schemes  
 (% of current expenditure on health)
Out-of-pocket payment for health (% of current expenditure on health)
Externally sourced funding (% of current expenditure on health)
Total capital expenditure on health (% current + capital expenditure on health)
Headcount ratio of catastrophic health expenditure
Headcount ratio of impoverishing health expenditure
Health security
International Health Regulations (IHR) core capacity index 
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Perioperative mortality rate
Abbreviated name Perioperative mortality rate
Indicator name Perioperative mortality rate
Domain Health systems
Subdomain Health system strengthening (HSS)
Associated terms Quality and safety of care 
Definition All-cause death rate prior to discharge among patients having one or more procedures in an operating theatre during the relevant admission.
Numerator Number of deaths among patients having one or more procedures in an operating theatre during the relevant admission. 
Denominator Total number of surgical procedures.
Disaggregation/ 
additional dimension
By region/health facility, age, emergency and elective surgery 
Also: surgical volume per 100 000 population
Method of measurement Requires a register of operations (major surgery only) in hospitals and of survival status at discharge after operation. The indicator also generates 
information on the surgical volume (procedures performed in an operating theatre per 100 000 population per year). This is a rough indicator of 
access.
Method of estimation
Measurement frequency Annual
Monitoring and 
evaluation framework
Output
Preferred data sources Hospital registers linked to routine facility information systems
Other possible data sources
Further information 
and related links
Organisation for Economic Co-operation and Development. Health at a Glance 2013: OECD Indicators, Paris: OECD Publishing; 2013  
(http://dx.doi.org/10.1787/health_glance-2013-en, accessed 29 March 2014).
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Obstetric and gynaecological admissions owing to abortion
Abbreviated name Obstetric and gynaecological admissions owing to abortion
Indicator name Obstetric and gynaecological admissions owing to abortion
Domain Health systems
Subdomain Health system strengthening (HSS)
Associated terms Quality and safety of care 
Definition Percentage of admissions for (spontaneous or induced) abortion-related complications to service delivery points providing inpatient obstetric and 
gynaecological services, among all admissions (except those for planned termination of pregnancy).
Abortion is the termination of a pregnancy before the fetus has attained viability – i.e. become capable of independent extra-uterine life. Induced 
abortion is the deliberate termination of a pregnancy before the fetus has attained viability – i.e. become capable of independent extra-uterine life. 
Spontaneous abortion is the spontaneous termination of a pregnancy before the fetus has attained viability – i.e. become capable of independent 
extra-uterine life – and is often referred to as a miscarriage.
Numerator Admissions for abortion-related complications.
Denominator All admissions, except those for planned termination of pregnancy.
Disaggregation/ 
additional dimension
Method of measurement
Method of estimation
Measurement frequency No specific frequency is recommended
Monitoring and 
evaluation framework
Output
Preferred data sources Hospital registers linked to routine facility information systems
Other possible data sources
Further information 
and related links
Reproductive health indicators. Guidelines for their generation, interpretation and analysis for global monitoring. Geneva: World Health 
Organization; 2006 (http://www.who.int/reproductivehealth/publications/monitoring/924156315x/en/, accessed 29 March 2015). 
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Institutional maternal mortality ratio
Abbreviated name Institutional maternal mortality ratio
Indicator name Institutional maternal mortality ratio (per 100 000 deliveries)
Domain Health systems
Subdomain Reproductive, maternal, newborn, child and adolescent health 
Associated terms Quality and safety of care 
Definition Number of maternal deaths among 100 000 deliveries in health facilities/institutions.
Numerator Number of maternal deaths in institutions.
Denominator Total number of deliveries in institutions.
Disaggregation/ 
additional dimension
Age, cause of death, geographic location, parity
Method of measurement Labour ward registers, emergency admission registers, specialist ward registers. 
Regular quality control for completeness, assessment and misclassification.
Method of estimation Number of maternal deaths among 100 000 deliveries in health facilities/institutions.
Measurement frequency Annual
Monitoring and 
evaluation framework
Output
Preferred data sources Routine facility information systems, maternal deaths surveillance and response systems
Other possible data sources
Further information 
and related links
Indicators for monitoring the Millennium Development Goals: definitions, rationale, concepts and sources. New York (NY): United Nations; 2012 
(http://mdgs.un.org/unsd/mi/wiki/MainPage.ashx, accessed 29 March 2015).
Keeping promises, measuring results. Commission on information and accountability for Women’s and Children’s Health. Geneva: World Health 
Organization; 2011 (http://www.who.int/topics/millennium_development_goals/accountability_commission/Commission_Report_advance_
copy.pdf, accessed 29 March 2015).
Next generation indicators reference guide: planning and reporting. Version 1.2. Washington (DC): The President’s Emergency Plan for AIDS Relief; 
2013 (http://www.pepfar.gov/documents/organization/206097.pdf, accessed 29 March 2014).
Next generation indicators reference guide: planning and reporting. Version 1.2. Washington (DC): The President’s Emergency Plan for AIDS Relief; 
2013 (http://www.pepfar.gov/documents/organization/206097.pdf, accessed 29 March 2014).
The UNFPA Strategic Plan, 2014−2017. Report of the Executive Director. New York (NY): United Nations Population Fund; 2013.Countdown to 2015 
decade report (2000−2010): taking stock of maternal, newborn and child survival. Geneva and New York (NY): World Health Organization/United 
Nations Children’s Fund; 2010 (http://www.countdown2015mnch.org/reports-and-articles/previous-reports/2010-decade-report,  
accessed 29 March 2014).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
pdf?ua=1, accessed 29 March 2015).
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Maternal death reviews
Abbreviated name Maternal death reviews
Indicator name Maternal death review coverage (%)
Domain Health systems 
Subdomain Health system strengthening (HSS)
Associated terms Quality and safety of care 
Definition Percentage of maternal deaths occurring in the facility that were audited.
Numerator Number of health facility maternal deaths reviewed.
Denominator All maternal deaths in facilities.
Disaggregation/ 
additional dimension
Community deaths, facilities, major administrative regions
Method of measurement Need for a clear definition of what qualifies as a “review”. This may or may not include actions taken, if these can be measured objectively.
Method of estimation
Measurement frequency Annual (or more frequently)
Monitoring and 
evaluation framework
Output
Preferred data sources Specific monitoring with routine facility information systems
Other possible data sources
Further information 
and related links
Consultation on Improving measurement of the quality of maternal, newborn and child care in health facilities. Geneva: World Health Organization/
Partnership for Maternal, Newborn and Child Health; 2013.
WHO. Keeping promises, measuring results: Commission on information and accountability for Women’s and Children’s Health. Geneva, WHO, 2011 
(http://www.who.int/topics/millennium_development_goals/accountability_commission/Commission_Report_advance_copy.pdf,  
accessed 29 March 2015).
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ART retention rate
Abbreviated name ART retention rate
Indicator name ART retention rate
Domain Health systems
Subdomain Infectious disease
Associated terms Quality and safety of care 
Definition Percentage of adults and children with HIV alive and on ART 12, 24, 36 (etc.) months after initiating treatment among patients initiating ART during 
a specified time period.
Numerator Number of people on ART at 12, 24 and 60 months.
Denominator Total number of people who initiated treatment and should have completed 12, 24, 36 (etc.) months.
Disaggregation/ 
additional dimension
Age: 
1. Minimum for paper-based (routine): <15, 15+; 
2. Annual data extraction of disaggregated data if not reported routinely: <5, 5–9, 10–14, 15–19, 20–24, 25–49, 50+; 
3. Electronic system: 5-year age groups
Breastfeeding, pregnancy, sex
Method of measurement A cohort analysis can be used to estimate ART retention at specific points in time after initiation of treatment. 
Method of estimation
Measurement frequency Annual (or more frequently)
Monitoring and 
evaluation framework
Output
Preferred data sources ART register 
Other possible data sources
Further information 
and related links
Consolidated Strategic Information Guidelines for HIV in the Health Sector. Geneva: World Health Organization; 2015.
Indicators for monitoring the Millennium Development Goals: definitions, rationale, concepts and sources. New York (NY): United Nations; 2012 
(http://mdgs.un.org/unsd/mi/wiki/MainPage.ashx, accessed 29 March 2015).
PEPFAR. Next Generation Indicators Reference Guide - Planning and Reporting. Version 1.2. The President’s Emergency Plan for AIDS Relief, Feb. 
2013. (http://www.pepfar.gov/documents/organization/81097.pdf).
UNAIDS. Global AIDS Response Progress Reporting 2014: construction of core indicators for monitoring the 2011 UN political declaration on HIV/
AIDS. Geneva, UNAIDS, 2014. (http://www.unaids.org/en/media/unaids/contentassets/documents/document/2014/GARPR_2014_guidelines_
en.pdf).
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TB treatment success rate
Abbreviated name TB treatment success rate
Indicator name TB treatment success rate
Domain Health systems
Subdomain Infectious disease
Associated terms Quality and safety of care 
Definition Percentage of TB cases successfully treated (cured plus treatment completed) among TB cases notified to the national health authorities during a 
specified period.
Numerator Number of TB cases registered in a specified period which were successfully treated.
Denominator Total number of TB cases registered in the same period.
Disaggregation/ 
additional dimension
Age, bacteriological confirmation status, drug resistance status (drug-susceptible and treated with first-line drugs, drug-resistant and treated with a 
second-line regimen), HIV-status, previous treatment history (new and relapse, previously treated excluding relapse), sex
Method of measurement
Method of estimation
Measurement frequency Annual
Monitoring and 
evaluation framework
Output
Preferred data sources TB register and related quarterly reporting system (or electronic TB registers)
Other possible data sources
Further information 
and related links
Definitions and reporting framework for tuberculosis – 2013 revision (WHO/HTM/TB/2013.2). Geneva: World Health Organization; 2013  
(http://www.who.int/tb/publications/definitions/en/, accessed 29 March 2015).
Global tuberculosis report 2014. Geneva: World Health Organization; 2014 (http://www.who.int/tb/publications/global_report/en/,  
accessed 29 March 2015).
Indicators for monitoring the Millennium Development Goals: definitions, rationale, concepts and sources. New York (NY): United Nations; 2012 
(http://mdgs.un.org/unsd/mi/wiki/MainPage.ashx, accessed 29 March 2015).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
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Service-specific availability and readiness
Abbreviated name Service-specific availability and readiness
Indicator name Service-specific availability and readiness
Domain Health systems
Subdomain HSS
Associated terms Quality and safety of care 
Definition Number of health facilities offering specific services per 10 000 population and meeting minimum service standards on the basis of a set of tracer 
criteria for specific services, etc.
Numerator Number of facilities that offer and meet tracer criteria for specific services: 
 Family planning
 Antenatal care
 Basic emergency obstetric and neonatal care (BEmONC)
 Comprehensive emergency obstetric and neonatal care (CEmONC), post-abortion care
 Essential newborn care
 Immunization
 Child health preventative and curative care
 Adolescent health services
 Life-saving commodities for women and children
 Malaria diagnosis or treatment
 Tuberculosis services
 HIV counselling and testing
 HIV/AIDS care and support services
 Antiretroviral prescription and client management
 Prevention of mother-to-child transmission of HIV
 Sexually transmitted infections diagnosis or treatment
 NCDs diagnosis or management: diabetes, cardiovascular disease, chronic respiratory disease, cervical cancer screening
 Basic and comprehensive surgical care, including caesarean section, laparotomy and open fracture 
 Blood transfusion
 Laboratory capacity.
Denominator Total number of health facilities and total number of facilities offering specific services.
Disaggregation/ 
additional dimension
Facility type, managing authority  
Also: general service availability and readiness
Method of measurement Facility assessment.
Method of estimation
Measurement frequency Annual or biannual
Monitoring and 
evaluation framework
Output
Preferred data sources Health facility assessments
Other possible data sources
Further information 
and related links
Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development beyond 2014. 
Report of the Secretary-General. New York (NY): United Nations; 2014 (https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/
Framework%20of%20action%20for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf, accessed 19 August 2014). 
Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies. Geneva: World Health Organization; 
2010 (http://www.who.int/healthinfo/systems/WHO_MBHSS_2010_full_web.pdf?ua=1, accessed 29 March 2015).
PEPFAR. Next Generation Indicators Reference Guide - Planning and Reporting. Version 1.2. The President’s Emergency Plan for AIDS Relief, Feb. 
2013. (http://www.pepfar.gov/documents/organization/81097.pdf).
109
Service utilization
Abbreviated name Service utilization
Indicator name Service utilization
Domain Health systems 
Subdomain HSS
Associated terms Access
Definition Number of outpatient department visits per person per year.
Numerator Total number of outpatient department visits per year.
Denominator Total population.
Disaggregation/ 
additional dimension
Age, place of residence, sex 
Also: hospital (inpatient) admissions per 100 population per year 
Method of measurement
Method of estimation Requires complete and reliable recording and reporting of the number of outpatient department visits by public and private facilities. Recall in 
population surveys can also be used.
Measurement frequency
Monitoring and 
evaluation framework
Output
Preferred data sources Routine facility information systems, population-based health surveys
Other possible data sources
Further information 
and related links
Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies. Geneva: World Health Organization; 
2010 (http://www.who.int/healthinfo/systems/WHO_MBHSS_2010_full_web.pdf?ua=1, accessed 29 March 2015).
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Health service access
Abbreviated name Health service access
Indicator name Health service access
Domain Health systems 
Subdomain HSS
Associated terms Access
Definition Percentage of population living within 5 km of a health facility (total number of health facilities per 10 000 population).
Numerator Number of facilities in public and private sectors.
Denominator Total population.
Disaggregation/ 
additional dimension
Access to emergency surgery (% of the population that can access, within 2 hours, a facility that can perform emergency caesarean section, 
laparotomy and open fracture fixation), density of specific services, facility ownership, location (district, province, national), type
Method of measurement Availability (health facility assessment, census, master facility list).
Geographical accessibility is the preferred indicator and is often measured by distance or travel time to a static health facility. A more objective and 
easier indicator uses facility databases to assess density and distribution.
Method of estimation
Measurement frequency Annual
Monitoring and 
evaluation framework
Input
Preferred data sources Facility database, geospatial modelling
Other possible data sources Surveys
Further information 
and related links
Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies. Geneva: World Health Organization; 
2010 (http://www.who.int/healthinfo/systems/WHO_MBHSS_2010_full_web.pdf?ua=1, accessed 29 March 2015).
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
pdf?ua=1, accessed 29 March 2015).
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Hospital bed density
Abbreviated name Hospital bed density
Indicator name Hospital bed density (per 10 000 population)
Domain Health systems
Subdomain Health system strengthening (HSS)
Associated terms Access
Definition Total number of hospital beds per 10 000 population.
Numerator Number of hospital beds (excluding labour and delivery beds).
Denominator Total population.
Disaggregation/ 
additional dimension
Distribution (by province/district), ownership (public/private), type of bed
Method of measurement A national database is usually maintained. Regular updates through surveys or facility censuses are needed.
Method of estimation
Measurement frequency Annual or biannual
Monitoring and 
evaluation framework
Input
Preferred data sources Routine facility information systems/national database
Other possible data sources Health facility census.
Further information 
and related links
Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies. Geneva: World Health Organization; 
2010 (http://www.who.int/healthinfo/systems/WHO_MBHSS_2010_full_web.pdf?ua=1, accessed 29 March 2015). 
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
pdf?ua=1, accessed 29 March 2015).
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Availability of essential medicines and commodities
Abbreviated name Availability of essential medicines and commodities
Indicator name Availability of essential medicines and commodities
Domain Health systems 
Subdomain HSS
Associated terms Access
Definition Percentage of health facilities with essential medicines and life-saving commodities
Numerator Number of facilities with essential medicines in stock.
Denominator Total number of health facilities.
Disaggregation/ 
additional dimension
Facility type, facility managing authority (public/private), specific type of medicine/commodity (e.g. priority medicines for women and children, 
vaccines, ART, family planning, essential NCD medicines) 
WHO-recommended essential core list of medicines: bronchodilator inhaler, steroid inhaler, glibenclamide, metformin, insulin, angiotensin-
converting-enzyme (ACE) inhibitor, calcium channel blocker, statin, aspirin, thiazide diuretic, beta-blocker, omeprazole tablet, diazepam injection, 
fluoxetine tablet, haloperidol tablet, carbamazepine tablet, amoxicillin tablet/capsule, amoxicillin suspension, ampicillin injection, ceftriaxone 
injection, gentamicin injection, oral rehydration salts, zinc sulfate. 
Essential NCD medicines: at least aspirin, a statin, an ACE inhibitor, thiazide diuretic, a long-acting calcium channel blocker, metformin, insulin, a 
bronchodilator and a steroid inhalant.
Priority medicines for women and children: amoxicillin tablet/capsule, amoxicillin suspension, ampicillin injection, ceftriaxone injection, gentamicin 
injection, oral rehydration salts, zinc sulphate, oxytocin injection, magnesium sulphate injection.
Suggested core list of medicines for pricing/affordability surveys: Salbutamol inhaler 100 mcg per dose (200 doses); beclometasone inhaler 
100 mcg/dose (200 doses); glibenclamide 5 mg tablet; metformin 500 mg tablet; insulin regular 100 IU/ml, 10 ml vial; enalapril 5 mg tablet; 
amlodipine 5 mg tablet; simvastatin 20 mg tablet; aspirin 100 mg tablet; hydrochlorothiazide 25 mg tablet; carvedilol 12.5 mg tablet; omeprazole 
20 mg tablet; diazepam 10 mg/2 ml injection; fluoxetine 20 mg tablet; haloperidol 5 mg tablet; carbamazepine 200 mg tablet; amoxicillin 500 
mg capsule/tablet; amoxicillin 250 mg/5 ml suspension; ampicillin 500 mg injection; ceftriaxone 1 G vial; gentamicin 80 mg/2 ml injection; oral 
rehydration salts (sachet for 1 litre); zinc sulfate 2 0mg tablet; oxytocin injection (5 or 10 iu); magnesium sulfate 50% injection 10 ml vial.
Method of measurement Stock out data may also refer to specific time period (1 month, 3 months).
Data on the availability of a specific list of medicines are collected from a survey of a sample of facilities. Availability is reported as the percentage of 
medicine outlets where a particular medicine was found on the day of the survey. Health facility reports may also include stockouts indicators but 
require regular independent verification.
Method of estimation
Measurement frequency Annual or biannual
Monitoring and 
evaluation framework
Output
Preferred data sources Special facility surveys
Other possible data sources Routine facility information systems
Further information 
and related links
Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases, including a set of 
indicators. Agenda item A66/8, Sixty-sixth World Health Assembly, 20–28 May 2013. Geneva: World Health Organization; 2013  
(http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_8-en.pdf?ua=1, accessed 29 March 2015).
Indicators for monitoring the Millennium Development Goals: definitions, rationale, concepts and sources. New York (NY): United Nations; 2012 
(http://mdgs.un.org/unsd/mi/wiki/MainPage.ashx, accessed 29 March 2015).
Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies. Geneva: World Health Organization; 
2010 (http://www.who.int/healthinfo/systems/WHO_MBHSS_2010_full_web.pdf?ua=1, accessed 29 March 2015).
Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development beyond 2014. 
Report of the Secretary-General. New York (NY): United Nations; 2014 (https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/
Framework%20of%20action%20for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf, accessed 19 August 2014).
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Health worker density and distribution
Abbreviated name Health worker density and distribution
Indicator name Health worker density and distribution (per 1000 population)
Domain Health systems 
Subdomain HSS
Associated terms Health workforce
Definition Number of health workers per 1000 population. 
Numerator Number of health workers by cadre.
Denominator Total population.
Disaggregation/ 
additional dimension
By cadre, including generalist medical practitioners, specialist medical practitioners (surgeons, anaesthetists, obstetricians, emergency medicine 
specialists, cardiologists, paediatricians, psychiatrists, ophthalmologists, gynaecologists, etc.), nursing and midwifery professionals, traditional and 
complementary medicine professionals, among others.
Distribution: place of employment (urban/rural), subnational (district)
Method of measurement National database or registry of health workers, preferably at individual level.
Method of estimation If there is a national database or registry, there should be regular assessment of completeness using census data, professional association registers, 
facility censuses, etc.
Health worker concentration: percentage of all health workers working in urban areas divided by percentage of total population in urban areas.
Measurement frequency Annual
Monitoring and 
evaluation framework
Input
Preferred data sources Health worker registry
Other possible data sources National health workforce database (aggregate)
Further information 
and related links
Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development beyond 2014. 
Report of the Secretary-General. New York (NY): United Nations; 2014 (https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/
Framework%20of%20action%20for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf, accessed 19 August 2014). 
Handbook on monitoring and evaluation of human resources for health with special focus on low- and middle-income countries. Geneva:  
World Health Organization; 2009.
Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies. Geneva: World Health Organization; 
2010 (http://www.who.int/healthinfo/systems/WHO_MBHSS_2010_full_web.pdf?ua=1, accessed 29 March 2015).
World health statistics 2014. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.
pdf?ua=1, accessed 29 March 2015).
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Output training institutions
Abbreviated name Output training institutions
Indicator name Output training institutions
Domain Health systems 
Subdomain Health system strengthening (HSS)
Associated terms Health workforce
Definition Number of graduates from health workforce educational institutions (including schools of dentistry, medicine, midwifery, nursing, pharmacy) 
during the last academic year per 1000 population.
Numerator Number of graduates of health professions educational institutions in the past academic year.
Denominator Total population.
Disaggregation/ 
additional dimension
Level and field of education 
Also: age at graduation, home postcode on entry to educational institution, sex
Method of measurement Database with training school data.
Method of estimation
Measurement frequency Annual
Monitoring and 
evaluation framework
Input
Preferred data sources Administrative reporting systems
Other possible data sources
Further information 
and related links
Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies. Geneva: World Health Organization; 
2010 (http://www.who.int/healthinfo/systems/WHO_MBHSS_2010_full_web.pdf?ua=1, accessed 29 March 2015).
Standard foreign assistance indicators/standard foreign assistance master indicator list (MIL). Washington (DC): United States Agency for 
International Development (http://www.state.gov/f/indicators/index.htm, accessed 26 June 2014).
WHO. Handbook on monitoring and Evaluation of Human Resources for Health with special focus on low and middle income countries.
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Birth registration coverage
Abbreviated name Birth registration coverage
Indicator name Birth registration coverage
Domain Health systems 
Subdomain HSS
Associated terms Health information
Definition Percentage of births that are registered within one month of age in a civil registration system.
Numerator Number of births registered.
Denominator Total number of births.
Disaggregation/ 
additional dimension
Place of residence, sex, socioeconomic status
Method of measurement Questions are asked about registration status in household surveys. The numerator of this indicator includes children whose birth certificate was 
seen by the interviewer or whose mother or care-taker says the birth has been registered. Data are also often presented for other age groups such 
as infants or children under 5 years of age. Civil registration administrative data are another source of data that could be linked to estimates of the 
expected number of newborns.
Method of estimation Estimates of coverage are taken from two sources: (i) the United Nations Demographic Yearbook and (ii) United Nations statistics and UNICEF.
Measurement frequency Annual
Monitoring and 
evaluation framework
Input
Preferred data sources Household surveys
Other possible data sources Civil registration and vital statistics systems
Further information 
and related links
Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies. Geneva: World Health Organization; 
2010 (http://www.who.int/healthinfo/systems/WHO_MBHSS_2010_full_web.pdf?ua=1, accessed 29 March 2015).
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Death registration coverage
Abbreviated name Death registration coverage
Indicator name Death registration coverage
Domain Health systems 
Subdomain HSS
Associated terms Health information
Definition Percentage of deaths that are registered (with age and sex).
Numerator Number of deaths registered.
Denominator Total number of deaths.
Disaggregation/ 
additional dimension
Place of residence 
Also: registered with cause (ICD)
Method of measurement Questions about presence of a death certificate are asked for all recent deaths (e.g. in the last year).
Method of estimation WHO estimates coverage by taking the total number of deaths that have been registered with cause-of-death information in the vital registration 
system for a country and year and then dividing it by the total estimated deaths for that year for the national population. Administrative data 
sources could be used to obtain the number of death certificates issued and link those to the estimated number of deaths in a given time period.
Measurement frequency
Monitoring and 
evaluation framework
Input
Preferred data sources Household surveys
Other possible data sources Civil registration and vital statistics systems
Further information 
and related links
Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies. Geneva: World Health Organization; 
2010 (http://www.who.int/healthinfo/systems/WHO_MBHSS_2010_full_web.pdf?ua=1, accessed 29 March 2015).
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Completeness of reporting by facilities
Abbreviated name Completeness of reporting by facilities
Indicator name Completeness of reporting by facilities
Domain Health systems
Subdomain HSS
Associated terms Health information
Definition Percentage of facilities that submit reports within the required deadline.
Numerator Number of facilities reporting monthly within a given time period.
Denominator Total facilities.
Disaggregation/ 
additional dimension
Facility type, geographic location, managing authority, programme
Method of measurement The number of reports received from facilities (usually monthly) is divided by the expected number of reports from facilities. Districts also report 
on a monthly or quarterly basis to national levels, and the received number of reports can be related to the expected number in order to assess 
completeness.
Method of estimation
Measurement frequency Annual (monthly)
Monitoring and 
evaluation framework
Input
Preferred data sources Routine facility information systems
Other possible data sources
Further information 
and related links
Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies. Geneva: World Health Organization; 
2010 (http://www.who.int/healthinfo/systems/WHO_MBHSS_2010_full_web.pdf?ua=1, accessed 29 March 2015).
Standard foreign assistance indicators/standard foreign assistance master indicator list (MIL). Washington (DC): United States Agency for 
International Development (http://www.state.gov/f/indicators/index.htm, accessed 26 June 2014).
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Total current expenditure on health (% of gross domestic product)
Abbreviated name Total current expenditure on health (% of gross domestic product)
Indicator name Total current expenditure on health as percentage of gross domestic product 
Domain Health systems
Subdomain HSS
Associated terms Health financing
Definition Total current expenditure on health as a percentage of gross domestic product.
Numerator Sum of all current expenditure on health (12-month period).
Denominator Gross domestic product.
Disaggregation/ 
additional dimension
Financing source institutional unit, disease, main type of care, main type of provider, socioeconomic status, subnational level 
Method of measurement This includes all current expenditure, regardless of the source (domestic and donor funding).
Method of estimation
Measurement frequency Annual
Monitoring and 
evaluation framework
Input
Preferred data sources Administrative reporting systems
Other possible data sources Other sources, including estimation and modelling
Further information 
and related links
A system of health accounts − 2011 edition. Geneva: Organisation for Economic Co-operation and Development/Eurostat/World Health 
Organization; 2011 (http://who.int/health-accounts/methodology/sha2011.pdf?ua=1, accessed 29 March 2015).
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Current expenditure on health by general government and compulsory schemes  
(% of current expenditure on health)
Abbreviated name Current expenditure on health by general government and compulsory schemes (% of current expenditure on health)
Indicator name Current expenditure on health by general government and compulsory schemes as a percentage of current expenditure on health
Domain Health systems
Subdomain HSS
Associated terms Health financing
Definition Current expenditure on health by general government and compulsory schemes as a share of total current expenditure on health (expressed as 
a % of total current expenditure on health). This is the sum of current health outlays paid for in cash or supplied in kind by government entities 
such as the Ministry of Health, other ministries, parastatal organizations or social security agencies, or by entities running health schemes that are 
compulsory by law.
Numerator Sum of all current expenditure on health by the government sector and compulsory schemes by law (12-month period).
Denominator Total current expenditure on health.
Disaggregation/ 
additional dimension
Financing source institutional unit, disease, main type of care, main type of provider, socioeconomic status, subnational level
Method of measurement Includes any donor funding passing through government and compulsory entities.
Method of estimation
Measurement frequency Annual
Monitoring and 
evaluation framework
Input
Preferred data sources Administrative reporting systems
Other possible data sources Other sources, including estimation and modelling
Further information 
and related links
A system of health accounts − 2011 edition. Geneva: Organisation for Economic Co-operation and Development/Eurostat/World Health 
Organization; 2011 (http://who.int/health-accounts/methodology/sha2011.pdf?ua=1, accessed 29 March 2015).
Framework of actions for the follow-up to the Programme of Action of the International Conference on Population and Development beyond 2014. 
Report of the Secretary-General. New York (NY): United Nations; 2014 (https://www.unfpa.org/webdav/site/global/shared/documents/ICPD/
Framework%20of%20action%20for%20the%20follow-up%20to%20the%20PoA%20of%20the%20ICPD.pdf, accessed 19 August 2014). 
120
Out-of-pocket payment for health (% of current expenditure on health)
Abbreviated name Out-of-pocket payment for health (% of current expenditure on health)
Indicator name Out-of-pocket payment on health as a percentage of current expenditure on health
Domain Health systems
Subdomain HSS
Associated terms Health financing
Definition Share of total current expenditure on health paid by households out-of-pocket, expressed as a percentage of total current expenditure on health 
(this is the households’ out-of-pocket expenditure).
Numerator Total household out-of-pocket expenditure for health (12-month period).
Denominator Total current expenditure on health.
Disaggregation/ 
additional dimension
Financing source institutional unit, disease, main type of care, main type of provider, socioeconomic status, subnational level
Method of measurement
Method of estimation
Measurement frequency Annual
Monitoring and 
evaluation framework
Input
Preferred data sources Administrative reporting systems
Other possible data sources Households consumption survey and National Accounts
Further information 
and related links
A system of health accounts − 2011 edition. Geneva: Organisation for Economic Co-operation and Development/Eurostat/World Health 
Organization; 2011 (http://who.int/health-accounts/methodology/sha2011.pdf?ua=1, accessed 29 March 2015).
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Externally sourced funding (% of current expenditure on health)
Abbreviated name Externally sourced funding (% of current expenditure on health)
Indicator name Externally sourced funding as a percentage of current expenditure on health
Domain Health systems
Subdomain HSS
Associated terms Health financing
Definition Share of total current expenditure on health funded by external (rest of the world) institutional units providing revenues to financing schemes.
Numerator Total external (rest of the world) funding (12-month period).
Denominator Total current expenditure on health.
Disaggregation/ 
additional dimension
Disease, main type of care, main type of provider, socioeconomic status, subnational level
Method of measurement This indicator traces the financing flows from external sources that provide the funds to public and private financing schemes. It includes resources 
in cash and in kind provided as loans and grants. Health accounts track records of transactions without double counting in order to reach a 
comprehensive coverage. Resources are accounted for in the same period as when they are used by financing schemes.
Method of estimation
Measurement frequency Annual
Monitoring and 
evaluation framework
Input
Preferred data sources Survey and administrative reporting systems
Other possible data sources Other sources, including estimation and modelling
Further information 
and related links
A system of health accounts − 2011 edition. Geneva: Organisation for Economic Co-operation and Development/Eurostat/World Health 
Organization; 2011 (http://who.int/health-accounts/methodology/sha2011.pdf?ua=1, accessed 29 March 2015).
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Total capital expenditure on health (% current + capital expenditure on health)
Abbreviated name Total capital expenditure on health (% current + capital expenditure on health)
Indicator name Total capital expenditure on health as a share of current + capital expenditure on health
Domain Health systems
Subdomain HSS
Associated terms Health financing
Definition Total capital expenditure on health as a percentage of current + capital expenditure on health.
Numerator Sum of all capital expenditure on health (HK) – (12-month period).
Denominator Current + capital expenditure on health (12 month).
Disaggregation/ 
additional dimension
Disease, financing source institutional unit, financing agent, provider
Method of measurement Includes capital expenditures funded by donor (in kind or cash).
Method of estimation
Measurement frequency Annual
Monitoring and 
evaluation framework
Input
Preferred data sources Administrative reporting systems
Other possible data sources Other sources, including estimation and modelling
Further information 
and related links
A system of health accounts − 2011 edition. Geneva: Organisation for Economic Co-operation and Development/Eurostat/World Health 
Organization; 2011 (http://who.int/health-accounts/methodology/sha2011.pdf?ua=1, accessed 29 March 2015).
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Headcount ratio of catastrophic health expenditure
Abbreviated name Headcount ratio of catastrophic health expenditure
Indicator name Headcount ratio of catastrophic health expenditure
Domain Health systems
Subdomain HSS
Associated terms Health financing
Definition Proportion of the population (or sub-population) facing catastrophic health expenditures.
Numerator Total number of households with catastrophic health expenditure.
Denominator Total number of households.
Disaggregation/ 
additional dimension
Subnational variables available in survey data
Method of measurement Financial protection indicators are based on information collected from population-based household expenditure surveys implemented by or in 
close collaboration with national statistical bureaus. Datasets from these surveys are typically obtained through technical contacts in-country 
but may also be available publically or for direct purchase. The two most common surveys are Household Budget Surveys and Living Standards 
Measurement Surveys.
Such surveys include questions that elicit information on a household’s total consumption expenditure (i.e. monetary and in-kind payments on all 
goods and services, plus the monetary value of the consumption of home-made products). The main components of the consumption aggregate 
include expenses on food, non-food (clothing, household articles etc.), utilities (gas, telephone, electricity, etc.), education, health, and housing. 
Survey data allows for construction of the three key variables (i.e. total expenditure, food expenditure and out-of-pocket health expenditure) 
needed for the calculation of the headcount ratio of catastrophic health expenditure.
Method of estimation Headcount ratios are the estimated total number of households facing catastrophic health expenditures over the total number of households. 
A household is identified as facing catastrophic health expenditures when its out-of-pocket health expenditures represent 40% or more of its 
capacity-to-pay. Capacity-to-pay is estimated as total expenditure net of a subsistence level of food expenditure. The latter is calculated as the 
average food expenditure per equivalent adults of households in the 45th−55th food budget share distribution. When actual food spending falls 
below this amount, capacity-to-pay is defined as total expenditures net of actual food spending.
Measurement frequency Every 1–5 years depending on implementation of population-based household expenditure surveys led by national statistics offices
Monitoring and 
evaluation framework
Impact
Preferred data sources Population-based household expenditure surveys
Other possible data sources Health surveys with a module collecting expenditure data
Further information 
and related links
Analyzing health equity using household survey data. Washington, DC: World Bank Group; 2008 (http://www.worldbank.org/en/topic/health/
publication/analyzing-health-equity-using-household-survey-data, accessed 06 May 2015).
Ke Xu, David B Evans, Kei Kawabata, Riadh Zeramdini, Jan Klavus, Christopher J L Murray. Household catastrophic health expenditure: a multicountry 
analysis. Lancet. 2003;362:111−7 (http://www.who.int/entity/health_financing/documents/lancet-catastrophic_expenditure.pdf, accessed 06 
May 2015)
Ke Xu. Distribution of health payments and catastrophic expenditures: methodology (discussion paper EIP/HSF/DP.05.2). Geneva: World Health 
Organization; 2005 (http://www.who.int/entity/health_financing/documents/dp_e_05_2-distribution_of_health_payments.pdf,  
accessed 06 May 2015).
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Headcount ratio of impoverishing health expenditure
Abbreviated name Headcount ratio of impoverishing health expenditure
Indicator name Headcount ratio of impoverishing health expenditure
Domain Health systems
Subdomain HSS
Associated terms Health financing
Definition Proportion of the population (or sub-population) facing impoverishing health expenditures.
Numerator Total number of households with impoverishing health expenditure.
Denominator Total number of households.
Disaggregation/ 
additional dimension
Subnational variables available in survey data
Method of measurement Financial protection indicators are based on information collected from population-based household expenditure surveys implemented by or in 
close collaboration with national statistical bureaus. Datasets from these surveys are typically obtained through technical contacts in-country 
but may also be available publically or for direct purchase. The two most common surveys are Household Budget Surveys and Living Standards 
Measurement Surveys.
Such surveys include questions that elicit information on a household’s total consumption expenditure (i.e. monetary and in-kind payments on all 
goods and services, plus the monetary value of the consumption of home-made products). The main components of the consumption aggregate 
include expenses on food, non-food (clothing, household articles etc.), utilities (gas, telephone, electricity, etc.), education, health, and housing. 
Survey data allows for construction of the three key variables (i.e. total expenditure, food expenditure and out-of-pocket health expenditure) 
needed for the calculation of the headcount ratio of impoverishing health expenditure.
Method of estimation Headcount ratios are the estimated total number of households facing impoverishing health expenditures over the total number of households. A 
household is identified as facing impoverishing health expenditures when its out-of-pocket health expenditures push it below a poverty line (i.e. 
a household is above the poverty line when taking its total expenditure gross of out-of-pocket payments but below the poverty line when taking 
total expenditure net of out-of-pocket payments). The poverty line is defined as subsistence level food expenditure estimated as the average food 
expenditure per equivalent adults of households in the 45th−55th food budget share distribution. When actual food spending falls below this 
amount, then capacity-to-pay is defined as total expenditures net of actual food spending.
Measurement frequency Every 1–5 years depending on implementation of population-based household expenditure surveys led by national statistics offices
Monitoring and 
evaluation framework
Impact
Preferred data sources Population-based household expenditure surveys
Other possible data sources Health surveys with a module collecting expenditure data
Further information 
and related links
Analyzing health equity using household survey data. Washington, DC: World Bank Group; 2008 (http://www.worldbank.org/en/topic/health/
publication/analyzing-health-equity-using-household-survey-data, accessed 06 May 2015).
Ke Xu, David B Evans, Kei Kawabata, Riadh Zeramdini, Jan Klavus, Christopher J L Murray. Household catastrophic health expenditure: a multicountry 
analysis. Lancet. 2003;362:111−7 (http://www.who.int/entity/health_financing/documents/lancet-catastrophic_expenditure.pdf, accessed 06 
May 2015)
Ke Xu. Distribution of health payments and catastrophic expenditures: methodology (discussion paper EIP/HSF/DP.05.2). Geneva: World Health 
Organization; 2005 (http://www.who.int/entity/health_financing/documents/dp_e_05_2-distribution_of_health_payments.pdf,  
accessed 06 May 2015).
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International Health Regulations (IHR) core capacity index
Abbreviated name International Health Regulations (IHR) core capacity index
Indicator name International Health Regulations (IHR) core capacity index
Domain Health systems 
Subdomain HSS
Associated terms Health security
Definition Percentage of attributes of 13 core capacities that have been attained at a specific point in time. The 13 core capacities are: (1) National legislation, 
policy and financing; (2) Coordination and National Focal Point communications; (3) Surveillance; (4) Response; (5) Preparedness; (6) Risk 
communication; (7) Human resources; (8) Laboratory; (9) Points of entry; (10) Zoonotic events; (11) Food safety; (12) Chemical events; (13) 
Radionuclear emergencies.
Numerator Number of attributes attained.
Denominator Total number of attributes.
Disaggregation/ 
additional dimension
 
Method of measurement Based on a set of attributes of 13 core capacities from a standard WHO instrument.
Method of estimation
Measurement frequency Biannual
Monitoring and 
evaluation framework
Output
Preferred data sources Key informant survey
Other possible data sources
Further information 
and related links
IHR core capacity monitoring framework: checklist and indicators for monitoring progress in the development of IHR core capacities in States Parties. 
Geneva: World Health Organization; 2013 (http://apps.who.int/iris/bitstream/10665/84933/1/WHO_HSE_GCR_2013.2_eng.pdf,  
accessed 29 March 2015).
World Health Assembly governing body documentation: official records. Geneva: World Health Organization (http://apps.who.int/gb/or/,  
accessed 29 March 2015).
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Annex 2
Additional indicators 
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Additional indicators
Indicator name Definition
Disaggregation / 
additional dimensions
Health status
Mortality by age and sex
Life expectancy at age 60 years The average number of years that a person of 60 years of age could expect to 
live if exposed to the sex- and age-specific death rates prevailing at the time 
of his/her 60th birthday
Sex
Healthy life expectancy at birth  The average number of years that a person can expect to live in "full health" 
by taking into account years lived in less than full health due to disease  
and/or injury
Sex
Mortality by cause
Distribution of causes of death in 
health facilities
Percentage distribution of main causes of death in health facilities, expressed 
as a percentage of total deaths in health facilities
Age (under 5, 5+ years),  
vaccine-preventable diseases
Morbidity
Leading outpatient diagnosis 
(morbidity)
Rate per 1000 population and percentage distribution of the main diagnostic 
categories
Age (under 5, 5+ years), sex
Leading inpatient admissions by 
diagnosis
Number, rate per 1000 population and percentage distribution of the main 
diagnostic categories
Age (under 5, 5+ years), sex
Neglected tropical disease incidence 
rates
Number of cases of neglected tropical disease (Buruli ulcer, dengue, rabies, 
trachoma, yaws, leprosy, Chagas disease, trypanosomiasis, leishmaniasis, 
dracunculiasis, lymphatic filariasis, onchocerciasis, schistosomiasis, 
cysticercosis/taeniasis, echinococcosis, foodborne trematodiases, soil-
transmitted helminths) per 100 000 population
Age, disease, sex
Prevalence of severe mental disorders Number of cases of severe mental disorders per 100 000 population Age, sex, type of disorder
Prevalence of visual impairment Number of persons living with severe visual impairment  
per 100 000 population
By cause, age, sex
Risk factors
Nutrition
Children aged under 5 years who are 
underweight
Percentage of children aged under 5 years whose weight-for-age is below -2 
standard deviations of the WHO Child Growth Standards median 
Place of residence, sex,  
socioeconomic status
Percentage of women of reproductive 
age who are underweight
Percentage of women aged 15–49 years with low BMI (< 18.5 kg/m2) Place of residence, socioeconomic status
Minimum acceptable diet Percentage of children aged 6–23 months of age who receive a minimum 
acceptable diet
The additional indicators are indicators which are considered relevant and desirable but did not meet all the criteria mentioned above or  
currently have serious measurement challenges.
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Additional indicators
Indicator name Definition
Disaggregation / 
additional dimensions
Urinary iodine concentration in 
children aged 6–12 years
Median urinary iodine concentration (μg/L) in children aged 6–12 years Place of residence, sex,  
socioeconomic status
Households that have iodized salt Percentage of households that have iodized salt (> 15 ppm) Place of residence, socioeconomic status 
Also: compute by children aged  
< 5 years living in households with 
iodized salt
Lifestyle
Prevalence of heavy episodic drinking Percentage of adults (15+ years) who have had at least 60 grams or more of 
pure alcohol on at least one occasion weekly (approximately equivalent to 
standard alcoholic drinks)
Place of residence, sex,  
socioeconomic status  
Also: adolescents (5 or more  
standard drinks)
Abstainers Percentage of adults (15+ years) in a given population who have not 
consumed any alcohol during their lifetime
Age, place of residence, sex, 
socioeconomic status  
Also: not in last 12 months
Low consumption of fruit and 
vegetables among adults
Percentage of adults (aged 18+ years) who eat less than five servings of fruit 
and/or vegetables (400 grams) on average per day (age-standardized)
Place of residence, sex,  
socioeconomic status
Total energy intake from saturated 
fatty acids 
Age-standardized mean percentage of total energy intake from saturated 
fatty acids in persons aged 18+ years
Place of residence, sex,  
socioeconomic status
Raised cholesterol among adults Age-standardized prevalence of raised total cholesterol among persons aged 
18+ years (defined as total cholesterol ≥ 5.0 mmol/L or 190 mg/dL), and 
mean total cholesterol
Place of residence, sex,  
socioeconomic status
Risk factors infections
Safe injecting practices among 
injecting drug users
Needles/syringes distributed per person who injects drugs per year Age (<25/25+ years), sex 
Multiple sexual partnerships Percentage of women and men aged 15–49 years who have had sexual 
intercourse with more than one partner in the last 12 months
Age (15–19, 20–24 and 25–49), sex
Discriminatory attitudes towards 
people living with HIV
Percentage of women and men aged 15–49 years who report discriminatory 
attitudes towards people living with HIV in two standard survey questions 
(respond “No” or “It depends” to any of two questions)
Age, HIV status, sex
Risk factors injuries
Prevalence of female genital 
mutilation
Percentage of women aged 15–49 years who have undergone female genital 
mutilation/cutting
Age, place of residence,  
socioeconomic status
Non-partner sexual violence 
prevalence 
Percentage of women aged 20–29 years who have ever experienced sexual 
violence by a non-partner from age 15 years
Age
130
Additional indicators
Indicator name Definition
Disaggregation / 
additional dimensions
Seat-belt wearing rate Percentage of car occupants (i.e. drivers and passengers) who use seat-belts
Helmet wearing rate Percentage of motor occupants (i.e. drivers and passengers) who use helmets
Environmental risk factors
Population with basic hand-washing 
facilities with soap and water at home
Percentage of population with soap and water at a hand-washing facility 
commonly used by family members.
Place of residence (urban, rural), 
socioeconomic status  
Also: proportion of schools providing 
basic drinking-water, sanitation and 
hygiene
Service coverage
Reproductive, maternal, newborn, child and adolescent health
Timing of first antenatal visit Percentage of pregnant women aged 15–49 years who had their first 
antenatal visit in the first trimester (before 16 weeks)
Age, place of residence,  
socioeconomic status,  type of provider
Zinc for treatment of diarrhoea Percentage of children aged 0–59 months with diarrhoea receiving zinc 
supplementation
HIV services
HIV-testing in key populations Number of people tested HIV positive linked to care in the last 12 months 
(disaggregated by key population)
Key population
Pregnant women counselled and 
tested for HIV
Percentage of women who were counselled during antenatal care for their 
most recent pregnancy, accepted an offer of testing and received their test 
results, among all women who were pregnant at any time in the two years 
preceding the survey
Prevention of mother-to-child 
transmission during breastfeeding
Percentage of HIV-exposed breastfed infants whose mothers are receiving 
antiretroviral therapy at 3 months (and 12 months)
Early infant testing coverage Percentage of HIV-exposed infants born within the last 12 months who 
received an HIV test within 2 months of birth
Test result
Cotrimoxazole prophylaxis among 
HIV-positives who are eligible
Percentage of eligible HIV-positive individuals who receive cotrimoxazole 
(CTX) prophylaxis according to national guidelines
Needles/syringes distribution Needles/syringes distributed per person who injects drugs  
Coverage of prevention programmes 
among key populations
Percentage of sex workers/men who have sex with men/people who inject 
drugs exposed to HIV prevention programmes (respond “Yes” to two specific 
exposure questions in surveys)
Age, sex
Male circumcision Percentage of men aged 15–49 years who are circumcised Age, place of residence, sex, 
sociocultural variables,  
socioeconomic variables
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Additional indicators
Indicator name Definition
Disaggregation / 
additional dimensions
HIV/TB
TB status assessment among HIV-
positive people 
Percentage of adults and children enrolled in HIV care who had their TB status 
assessed and recorded during their last visit 
Confirmed cases of MDR-TB Number of confirmed cases of MDR-TB detected during a specified time period Patterns of drug resistance,  
treatment history
Malaria
Household ownership of insecticide 
treated net (ITN)
Percentage of households with at least one ITN Place of residence, socioeconomic status
Treatment-seeking behaviour for 
children with fever
Percentage of children under 5 years of age with fever in the previous two 
weeks for whom advice or treatment was sought
Place of care-seeking  
(public, private)
Access to insecticide treated net (ITN) 
in the household
Percentage of population at risk with access to an ITN in the household. Each ITN is assumed to be used by 
two people
Appropriate treatment among 
children treated for malaria
Percentage receiving first-line antimalarial treatment among those children 
under 5 years of age with fever in the last two weeks who received any 
antimalarial
 
Annual blood examination rate Annual blood examination rate
Malaria diagnostic testing rate Percentage of suspected malaria cases that had a diagnostic test
Malaria test positivity rate Percentage of confirmed malaria cases (by microscopy or rapid diagnostic 
test) among all tested cases
Neglected tropical diseases
Neglected tropical diseases treatment 
coverage
 Buruli ulcer, cutaneous leishmaniasis, 
trachoma
Neglected tropical diseases preventive 
chemotherapy coverage
 Lymphatic leishmaniasis, 
schistosomiasis, soil-transmitted 
helminthiasis
Foodborne trematode infections 
preventive therapy coverage
Percentage of the population at risk of foodborne trematode infections 
reached by preventive chemotherapy
School-aged children dewormed (in 
target countries)
Percentage of targeted school children who received deworming treatment in 
a given time period
Noncommunicable diseases (NCDs)
Drug therapy and counselling to 
prevent heart attacks and stroke
Percentage of eligible persons (defined as aged 40 years and older with a 
10-year cardiovascular disease risk ≥ 30%, including those with existing 
cardiovascular disease) receiving drug therapy and counselling (including 
glycaemic control) to prevent heart attacks and strokes
Age, sex
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Additional indicators
Indicator name Definition
Disaggregation / 
additional dimensions
Cataract surgical rate and coverage Percentage of people who received cataract surgery among those in need in a 
specified time period
Age, sex
Use of assistive devices among people 
with disabilities
Percentage of people with disabilities who have and use appropriate assistive 
devices
Health systems
Quality and safety of care
Cause-specific case fatality rates for 
major causes 
Cause-specific deaths per 100 admissions for major causes and overall in 
health facilities 
Age (under 5, 5+ years), overall and 
cause-specific, facility-specific
Antenatal care:  
blood pressure measured 
Percentage of women who had blood pressure measured at the last antenatal 
visit
Age, place of residence,  
socioeconomic status, type of facility
Antenatal care:  
tested for syphilis
Percentage of women attending antenatal care services who were tested for 
syphilis
Age, place of residence,  
socioeconomic status, type of facility
Antenatal care:  
treated for syphilis
Percentage of women attending antenatal care services who tested positive 
for syphilis and received treatment
Age, first/any visit, place of residence, 
socioeconomic status  
Also: add whose sexual contacts were 
traced
Antenatal corticosteroid use Percentage of newborns with confirmed ultrasound gestational age of less 
than 34 weeks whose mothers received antenatal corticosteroids
Prevention of postpartum 
haemorrhage in health facilities
Percentage of women receiving oxytocin immediately after the birth of 
the baby (within 1 minute of delivery), before the birth of the placenta, 
irrespective of mode of delivery
Severe systemic infection/sepsis  
in the postnatal period
Percentage of women in health facilities with severe systemic infection/sepsis 
in the postnatal period, including readmissions (after birth in a facility)
Newborns receiving essential 
newborn care 
Percentage of newborns who received all four elements of essential newborn 
care: immediate and thorough drying, immediate skin-to-skin contact, 
delayed cord clamping, and initiation of breastfeeding in the first hour
Neonatal sepsis Newborns with suspected severe bacterial infection who receive appropriate 
antibiotic therapy (infant reportedly stopped feeding well and/or stopped 
moving on its own) 
Feeding of children born to  
HIV-positive mothers
Percentage of children born to HIV-positive women who are feeding in line 
with national guidelines on HIV and infant feeding 
Pneumonia treatment (children) Percentage of children who are correctly prescribed an antibiotic for 
pneumonia 
Male partner testing for HIV among 
women attending antenatal care
Percentage of pregnant women attending antenatal care whose male partner 
was tested for HIV in the last 12 months
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Additional indicators
Indicator name Definition
Disaggregation / 
additional dimensions
Knowledge of HIV transmission 
among young women and men 
Percentage of young women and men (15–24 years) who correctly identify 
ways of preventing the sexual transmission of HIV and who reject major 
misconceptions about HIV transmission
Age (15–19, 20–24 years), place of 
residence, sex, socioeconomic status
Cancer survival rates Percentage of persons with cancer who survive at least 5 years after diagnosis, 
after correction for background mortality in a given time period (cohort)
By cancer site
30-day hospital case fatality rate – 
acute myocardial infarction (stroke)
Percentage of hospital inpatients with primary diagnosis of acute myocardial 
infarction (stroke) who died within 30 days after admission
Postoperative sepsis Postoperative sepsis as a percentage of all surgeries Age, sex
Postoperative pulmonary embolism/
thrombosis rate
Percentage of cases of postoperative pulmonary embolus or deep vein 
thrombosis among all major surgeries
Hospitals with systems for adverse 
event reporting and learning for 
patient safety 
Hospital readmission rates Percentage of unplanned and unexpected hospital readmissions for tracer 
conditions (acute myocardial infarction, pneumonia, asthma, diabetes)
Waiting time to elective surgery Average inpatient waiting time for elective (i.e. non-urgent) surgeries – 
cataract, coronary angioplasty, hip replacement, knee replacement)
Patient satisfaction Percentage of survey respondents who report to be satisfied or very satisfied 
with the health services
Age, place of residence, sex, 
socioeconomic status
Neonatal death reviews Percentage of neonatal deaths occurring in the facility that were audited Also: perinatal death reviews
General service readiness Percentage of health facilities that have a basic set of equipment and 
amenities present on the day of the visit
Facility type, managing authority  
Also: average number of items per facility
Access
Hospital admission rates Number of hospital admissions per person per year Age, sex 
Bed occupancy rate Percentage of available beds that have been occupied over a given period Also: average length of stay (for selected 
interventions)
Surgery rate Number of surgeries by type (minor/major, specifics) per 1000 population Age, place of residence, sex, 
socioeconomic status
Caesarean section rate Percentage of deliveries by caesarean section Age, place of residence, 
socioeconomic status
Medical devices/essential 
technologies
Density of medical equipment per million population By type (magnetic resonance imaging, 
computed tomography [CT] scanners)
Access to palliative care Consumption of morphine-equivalent strong opioid analgesics (excluding 
methadone) per death from cancer in a given time period
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Additional indicators
Indicator name Definition
Disaggregation / 
additional dimensions
Opioid agonist pharmacotherapy 
used for the treatment of opioid 
dependence (maintenance)
Availability of opioid agonist pharmacotherapy (such as with methadone, 
buprenorphine or buprenorphine/naloxone) for maintenance treatment of 
opioid dependence. 
Health workforce
Turnover rate Percentage of health workers leaving public sector employment (dentists, 
midwifery personnel, nursing personnel, pharmacists, physicians, physician 
associates) in the last year
By cadre  
Also: age (< 30, 30–49, 50+ years), 
location, (urban/rural), place of 
employment, sex 
National human resources for health 
self-sufficiency
Percentage of foreign-trained, non-national health workers (dentists, 
midwifery personnel, nursing personnel, pharmacists, physician generalists, 
physician specialists, physician associates)
By cadre  
Also: age (< 30, 30–49, 50+ years), 
location, (urban/rural), place of 
employment, sex, sector (public/private/
other)
Health policy
Policy index Existence of a up-to-date national health strategy and national health plans 
linked to health needs and priorities
Additional indicators
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The Global Reference List of 100 Core Health Indicators is a standard set of 100  
indicators prioritized by the global community to provide concise information on 
the health situation and trends, including responses at national and global levels.
 
It contains indicators of relevance to country, regional and global reporting across 
the spectrum of global health priorities relating to the post-2015 health goals of the 
Sustainable Development Goals (SDGs). These include the Millennium Development 
Goals (MDGs) agenda, new and emerging priorities such as noncommunicable 
diseases, universal health coverage and other issues in the post-2015 development 
agenda.
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1211 Geneva 27
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